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Abstract 
The first chapter of this dissertation introduces and discusses the synthesis of a series of 
substituted quinolines as glycogen synthase kinase-3 (GSK-3) inhibitors.  GSK-3 is highly 
associated with Alzheimer’s disease (AD), and it is suggested that inhibition of this enzyme 
could alleviate the symptoms of AD. Total 16 novel substituted quinolines were designed and 
synthesized, and their bio-activities were evaluated on MC65 cell protection assay. Four of the 
most active compounds were selected to test their enzyme inhibitory activities on GSK-3 and 
protein kinase C assays. Among these compounds, 4-{[6-methoxy-4-methyl-5-(3-
(trifluoromethyl)phenoxy)quinolin-8-ylamino]methyl} phenol (1.5) shows the highest MC65 cell 
protection and GSK-3 enzyme inhibitory activities and potential enzyme specificity. Structure-
activity relationship (SAR) was built as well, and the binding mode was simulated via 
computational method to interpret the observed SAR. Although additional bio-evaluation is 
needed, compound 1.5 is a promising lead compound for the development of more active and 
less toxic drug for the counteraction of AD. 
The second chapter introduces the progress on the total synthesis of myriceric acid A. 
Myriceric acid A is a triterpene-type natural product which was isolated from the young twigs of 
Myrica cerifera. It is a non-peptide endotheline-1 (ET-1) receptor antagonist. The total synthesis 
of this natural product started from the stereoselective synthesis of bicyclic intermediate (R)-
5,8a-dimethyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione [(-)-2.28]. Then a new method 
was developed to enatioselectively synthesize the tricyclic intermediate (4aR,8R,8aR)-8-(tert-
butyldimethylsilyloxy)-1,4a,8a-trimethyl-4,4a,4b,5,6,7,8,8a,9,10-decahydro phenanthren-2(3H)-
one [(+)-2.72] which used the synthesized optically-pure (4aR,5R)-5-(tert-
butyldimethylsilyloxy)-1,4a-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one [(-)-2.53] 
derived from (-)-2.28 and -trimethylsilylvinyl ethyl ketone via a cascade reductive Michael 
addition – aldol condensation reaction. After functional group inter-conversion, the desired 
tricyclic intermediate (4a'S,8a'R)-1',1',4a',8a'-tetramethyldecahydro-1'H-spiro[[1,3]dioxolane-
2,2'-phenanthren]-8'(3'H)-one [(-)-2.33] was synthesized. An intramolecular cascade Michael 
addition-aldol condensation reaction was designed to construct the triterpene-skeleton of 
myriceric acid A, and the desired starting material for this reaction was prepared with the 
trimethyl{(4a'R,8a'R)-1',1',4a',8a'-tetramethyl-3',4',4a',4b',5',6',8a',9',10',10a'-decahydro-1'H-
  
spiro[(1,3)dioxolane-2,2'-phenanthrene]-8'-yloxy}silane [(-)-2.81] and 3,3-dimethyl-7-oxo-
octanal (2.46) via Mukaiyama aldol condensation reaction. The resulting pentacyclic compound 
was further transformed to the desired ester (6a'R,8a'R,12a'S,12b'R,14b'R)-ethyl 
4',4',6a',11',11',14b'-hexamethyl-8'-oxo-2',4',4a',5',6',6a',8',8a',9',10',11',12',12a',12b',13',14',14a', 
14b'-octadecahydro-1'H-spiro[(1,3) dioxolane - 2, 3 '- picene]-8a'-carboxylate (-)-2.106. The 
further investigation on total synthesis of myriceric acid A will be pursued in future. 
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Abstract 
The first chapter of this dissertation introduces and discusses the synthesis of a series of 
substituted quinolines as glycogen synthase kinase-3 (GSK-3) inhibitors.  GSK-3 is highly 
associated with Alzheimer’s disease (AD), and it is suggested that inhibition of this enzyme 
could alleviate the symptoms of AD. Total 16 novel substituted quinolines were designed and 
synthesized, and their bio-activities were evaluated on MC65 cell protection assay. Four of the 
most active compounds were selected to test their enzyme inhibitory activities on GSK-3 and 
protein kinase C assays. Among these compounds, 4-{[6-methoxy-4-methyl-5-(3-
(trifluoromethyl)phenoxy)quinolin-8-ylamino]methyl} phenol (1.5) shows the highest MC65 cell 
protection and GSK-3 enzyme inhibitory activities and potential enzyme specificity. Structure-
activity relationship (SAR) was built as well, and the binding mode was simulated via 
computational method to interpret the observed SAR. Although additional bio-evaluation is 
needed, compound 1.5 is a promising lead compound for the development of more active and 
less toxic drug for the counteraction of AD. 
The second chapter introduces the progress on the total synthesis of myriceric acid A. 
Myriceric acid A is a triterpene-type natural product which was isolated from the young twigs of 
Myrica cerifera. It is a non-peptide endotheline-1 (ET-1) receptor antagonist. The total synthesis 
of this natural product started from the stereoselective synthesis of bicyclic intermediate (R)-
5,8a-dimethyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione [(-)-2.28]. Then a new method 
was developed to enatioselectively synthesize the tricyclic intermediate (4aR,8R,8aR)-8-(tert-
butyldimethylsilyloxy)-1,4a,8a-trimethyl-4,4a,4b,5,6,7,8,8a,9,10-decahydro phenanthren-2(3H)-
one [(+)-2.72] which used the synthesized optically-pure (4aR,5R)-5-(tert-
butyldimethylsilyloxy)-1,4a-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one [(-)-2.53] 
derived from (-)-2.28 and -trimethylsilylvinyl ethyl ketone via a cascade reductive Michael 
addition – aldol condensation reaction. After functional group inter-conversion, the desired 
tricyclic intermediate (4a'S,8a'R)-1',1',4a',8a'-tetramethyldecahydro-1'H-spiro[[1,3]dioxolane-
2,2'-phenanthren]-8'(3'H)-one [(-)-2.33] was synthesized. An intramolecular cascade Michael 
addition-aldol condensation reaction was designed to construct the triterpene-skeleton of 
myriceric acid A, and the desired starting material for this reaction was prepared with the 
trimethyl{(4a'R,8a'R)-1',1',4a',8a'-tetramethyl-3',4',4a',4b',5',6',8a',9',10',10a'-decahydro-1'H-
  
spiro[(1,3)dioxolane-2,2'-phenanthrene]-8'-yloxy}silane [(-)-2.81] and 3,3-dimethyl-7-oxo-
octanal (2.46) via Mukaiyama aldol condensation reaction. The resulting pentacyclic compound 
was further transformed to the desired ester (6a'R,8a'R,12a'S,12b'R,14b'R)-ethyl 
4',4',6a',11',11',14b'-hexamethyl-8'-oxo-2',4',4a',5',6',6a',8',8a',9',10',11',12',12a',12b',13',14',14a', 
14b'-octadecahydro-1'H-spiro[(1,3) dioxolane - 2, 3 '- picene]-8a'-carboxylate (-)-2.106. The 
further investigation on total synthesis of myriceric acid A will be pursued in future. 
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Chapter 1 - Synthesis of quinolines as glycogen synthase kinase 3-
beta (GSK 3-) inhibitors possessing neural protective activities 
 1.1 Introduction – GSK-3 and its relationship with Alzheimer’s disease (AD)  
Glycogen synthase kinase-3 are the thirdly discovered kinases for controlling the activity 
of glycogen synthase enzyme, and, in human body, two isoforms of glycogen synthase kinase-3 
exist, which are named as glycogen synthase kinase-3 alphaGSK-3) and glycogen synthase 
kinase-3 beta (GSK-3).1 GSK-3 is found having a high level of concentration  in central 
nervous system (CNS) tissue and playing an important role in many neuronal cellular activities.
2
 
The imbalanced activity of GSK-3 is associated with many CNS degenerative diseases, such as 
Alzheimer’s disease (AD).3 
AD now is the most common type of dementia, and about 50 - 80 % of dementia patients 
are diagnosed as AD patients.
4a
 Development of this disease is highly associated with the 
increase of age, and most of AD patients are 65 or older. This disease is aggravated over time. At 
the early stage, AD only induces a short-term memory loss; but the advanced-stage AD causes 
cognitive impairment, long term memory loss, and loss of motor functions as well.
4b 
Most AD 
patients die in about 9 years after the diagnose of the disease. Till now, there is still no cure for 
the AD because the detailed pathological mechanism is still not known. However, considering 
that most of AD patients are elderly and slowing down the AD development could reduce their 
suffer and prolong their life presently, all of the available therapies are aiming alleviate the 
symptoms.
4
  
AD shows two main pathological characters: extracellular toxic amyloid beta (A) 
oligomer deposits and intracellular fibrillary tangles.
4
 Toxic A oligomer is composed of the 
toxic A peptide which is cleaved from the amyloid precursor protein (APP), and the 
intracellular tangles are made of the hyper-phosphorylated tau proteins.
4b
 These toxic A 
oligomer and fibrillary tangles induce the neuronal cell death.
4b
 GSK-3 is indirectly or directly 
associates with the formations of A oligomer and fibrillary tangles.3 In AD’s brain, GSK-3 is 
highly expressed and deregulated.
3
 Highly expressed GSK-3 hyper-phosphorylates tau protein 
to produces fibrillary tangles.
4b
 Inhibition of GSK-3 by lithium chloride shows protection effect 
on neural cells.
5
 In AD mice model, lithium chloride treatment reduces the A oligomer 
2 
 
production.
8
 In clinical trial, combination of lithium with drug Divalporex which has been shown 
to inhibit GSK-3 is used to reduce the hyper-phosphorylation of tau.8 Therefore, GSK-3 is a 
potential target for alleviation of the AD symptoms. 
There are only 2 types of FDA approved drugs for AD in the market now;
6
 however, 
these drugs either have strong side-effects or show less therapeutic effect than expected after 
long-term study.
7  
Research on discovering new drug with better therapeutic effect and less side-
reactions for AD are highly demanded and carrying out by scientists. Drug candidates for AD  
which are targeting GSK-3 have been reported as well.3,8,9 Among these reported inhibitors, 
only two candidates are currently in the clinical trial for AD, which are Np-12 (phase I)
8
 and 
tideglusib (phase II)
9
; however, there is still no conclusive result is reported yet. The rest of the 
GSK-3 inhibitors are still in the different stages of drug discovery.9  
Figure 1.1 : Structure of Np-12 and tideglusib 
N
N
S
Me
O
O
N S
NO
O
Np-12 (Phase I) tideglusib (Phase II)  
It is worthy to note that most of these reported GSK-3 inhibitors are pyrimidine analog, 
pyridine analog, pryarzole and thiazole analog compounds (Table 1.1).
3,8
 To expand the 
structural diversity of drug candidates and enhance the possibility to develop more effictive 
medicine for AD, novel GSK-3 inhibitors as AD drug candidates possessing different structural 
characters a.  
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Table 1.1 : First three of the largest groups of reported GSK-3 inhibitors 
3,8
  
 Numbers of compounds 
reported 
Example 
Pyrimidine analog 
N
N
 
Around 1500, about 160 of 
them have IC50 under 100 nM; 
CGP60474, IC50: 10 nM.
N
N
H
N Cl
N
H
HO
 
Pyridine analog 
N
 
Around 1400, about 120 of 
them have IC50 under 100 nM; N
H
N
N
Cl Cl
N
H
N
O2N
CT20026, IC50: 4 nM.
NH2
N
MeO
 
Pryarzole analog 
N
H
N
 & 
N
S  
Around 700, about 80 of them 
have IC50 under 100 nM; 
S
NO2N NH
N
H
O
O
Me
ARA014418, IC50: 101 nM.  
 
In this study, a focus library of quinoline compounds were designed and synthesized as 
the novel type of GSK-3 inhibitors possessing neural cell protection activities.  
 
 1.2 Design and syntheses of quinoline compounds  
In this section, the design and syntheses of quinolines are described and discussed. 
Initially, reported compounds PQ-1
10
 and PQ-7
10
 which were firstly prepared by Dr. 
Aibin Shi in Dr. Duy H. Hua’s laboratory were tested their activities on MC65 cell protection 
assay, and the EC50 is 147 ± 20 nM for PQ-1 and 691 ± 27 nM for PQ-7, respectively (Details 
about the MC65 cell assay will be introduced in the section 1.3). Structures of PQ-1 and PQ-7 
are depicted in Figure 1.2. Total four substituents are attached on their quinoline core, and they 
are 4-methyl group, 5-(3-triflouromethylphenoxyl) group, 6-methoxyl and 8-amino group. For 
PQ-1 and PQ-7, the structural difference is the substituent connected at the 8-amino group. PQ-
1 has an alkyl amino group, and PQ-7 contains furan moiety in the 8-amino substituent. With 
these positive feedbacks from neuronal cell protection assay, PQ-1 and PQ-7 were selected as 
the lead compounds to develop a library of novel quinolines with higher neuronal cell protection 
activities. 
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Figure 1.2 : Structure of PQ-1 and PQ-7
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Decided by the lead compounds, two categories of compounds, PQ-1 derivatives and 
PQ-7 derivatives, were designed and synthesized. PQ-7 derivative compounds are introduced 
firstly.  
 By altering the furan moiety with other heterocycles or aromatic structures, compounds 
1.1 – 1.8 were initially designed and synthesized.  
Amino quinolone 1.17
10
 was coupled with benzofuran-2-carboxylaldehyde to form 
compound 1.1 via reductive amination reaction (Scheme 1.1). 
Scheme 1.1 : Synthesis of compound 1.1 
N
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O
Me
MeOF3C
O
1.1
N
NH2
O
Me
MeOF3C
1.17
+
O
O
H
cat. AcOH, 
NaCNBH3,MeOH
65% yield
 
The optimal procedure for this reductive amination reaction was explored. 
Initially, acetic acid and sodium cyanoborohydride were planned to be added only after 
compound 1.17 and the aldehyde were completely transferred into the imine intermediate.  
However, after stirring at 25 
o
C over 14 hours, less than 10% of the starting materials were 
transferred into the desired imine, and the rest stayed unchanged. The imine formation is an 
equilibrium process. Since amino group (–NH2) of compound 1.17 is not a strong nucleophile, 
the attack to the aldehyde carbonyl is demoted. Therefore, the reaction reaches equilibrium after 
forming little amount of imine and stop (Scheme 1.2).  
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Scheme 1.2: Incomplete formation of imine intermediate 
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The alternative strategy was to add acetic acid and sodium cyanoborohydride after 
compound 1.17 and aldehyde were stirred at 25 
o
C for 30 minutes; then, this mixture was stirred 
at 25 
o
C for 14 hours. Sodium cyanoborohydride could reduce the imine intermediate to generate 
desired product, and the disappearing of imine intermediate in the reaction mixture drives 
reaction equilibrium going forward to the right to complete the reaction. The problem of this 
method is that sodium caynoborohydride could also slowly reduce the aldehyde during long 
reaction period, and this process consumes both the aldehyde and reducing reagent. To solve this 
problem, excess amount of aldehyde (1.2 eq.) and sodium cyanoborohyride (3.0 eq.) are used in 
the reaction. This method is proven to be effective for synthesizing designed compounds, but the 
drawback is the yields are moderate. It might because the formed secondary amine could also 
undergo reductive amination reaction with the aldehyde to yield a dialkylated byproduct, which 
could consume the desired product. 
Besides furans, sulfur-containing heterocyclic aldehydes were coupled with compound 
1.17 as well. With thiazole-2-carboxylaldehyde and 5-phenyl thiophene-2-carboxylaldehyde, 
compound 1.2 and 1.3 were synthesized via the reductive amination reaction under the optimized 
condition, respectively (Scheme 1.3). 
Scheme 1.3 : Syntheses compound 1.2 and 1.3 
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3,5-Dimethoxy-4-hydroxyl benzaldehyde, 4-hydroxyl benzaldehyde, were also coupled 
with compound 1.17 to give compounds 1.4 and 1.5 (Scheme 1.4). 
Scheme 1.4 : Syntheses of compound 1.4 and 1.5 
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Bi-quinoline structures were designed as well. Amino quinoline 1.17 was treated with 
carboxylaldehyde substituted quinoines
11
 to give compound 1.6 and 1.7, respectively (Scheme 
1.5). 
Scheme 1.5 : Syntheses of compound 1.6 and 1.7 
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Till then, all of the designed compounds were the N-alkylated derivatives of 1.17. To 
explore the potential of other functionality, an N-amidation product 1.8 was therefore designed 
and synthesized. To prepare compound 1.8, furfural was oxidized by hydrogen peroxide with 
selenium dioxide as a catalyst to yield 2-furoic acid.
12
 This carboxylic acid was treated with 
thionyl chloride (SOCl2) to give compound 1.18 which was directly introduced into compound 
1.17 in dry tetrahydrofuran (THF) solution at 0 
o
C to give compound 1.8 (Scheme 1.6).
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Scheme 1.6 : Synthesis of compound 1.8 
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Prepared compounds 1.1 – 1.8 were tested their cell protection activities on MC65 cell 
protection assay, and compound 1.5 is turned out to be the most active one with EC50 = 120 ± 10 
nM (Testing results are summarized in section 1.3). This compound is six times more active than 
PQ-7, which indicates the success of structure modification. From this stage, compound 1.5 was 
selected as lead compound for the further structure modification (Figure 1.3). Compounds 1.9 – 
1.12 are all derived from compound 1.5. 
Figure 1.3 : Structure of compound 1.5 
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By keeping the 8-(4-hydroxylbenzyl) amino group unchanged, 6-methoxy group of 
compound 1.5 was modified into 6-hydroxyl group to generate structure of compound 1.9. To 
prepare 1.9, compound 1.17 was treated with boron tribromide (BBr3) in dry dichloromethane 
(DCM) over 14 hours to generated intermediate 1.19 which was coupled with 4-hydroxy 
benzaldehye by the same method as that for the synthesis of compound 1.5 to yield compound 
1.9 (Scheme 1.7). However, the desired product 1.9 could not dissolve well in most of the 
common solvents. Various solvents combinations were tried for column chromatographic 
purification, but pure product could not be obtained. Finally, to remove the impurities, a 
recrystallization procedure was carried out after the column chromatography. Therefore, the 
overall yield of this reaction was lower than compound 1.5.   
Scheme 1.7 : Synthesis of compound 1.9 
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5-(3-Trifluoromethylphenoxyl) group of compound 1.5 was also modified into 5-(3-
fluorophenoxyl), 5-phenoxyl and hydrogen to generate the structures of compounds 1.10, 1.11, 
1.12, respectively (Figure 1.3).  
Figure 1.4 : Structures of designed 1.10, 1.11 and 1.12 
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To synthesize these designed compounds, amino quinolines 1.27, 1.28 and 1.31 were 
needed to be prepared. 
Amino quinolines 1.27 and 1.28 were prepared in the same method as that of compound 
1.17.
10
 Bromide 1.20 was treated with potassium 3-fluorophenolate and potassium phenolate 
respectively to give SNAr products 1.21 and 1.22. 3-Fluoro, an electron-withdrawing group, 
decreased the reactivity of the phenolate, and, therefore, the reaction yield was lower than that of 
1.22. Removals of the acetate groups of 1.21 and 1.22 were furnished by refluxing in 
hydrochloric acid (HCl) and ethanol (EtOH) solution to give anilines 1.23 and 1.24 respectively 
in quantitative yields. Methyl vinyl ketone was added dropwisely into a mixture of compound 
1.23, arsenic pentoxide hydrate in phosphoric acid at 120 
o
C to give nitro quinoline 1.25. Nitro 
quinoline 1.26 was synthesized in the same way by using compound 1.24 as the starting material. 
The nitro group in compounds 1.25 and 1.26 was reduced by iron powder and acetic acid to give 
amino quinolines 1.27 and 1.28 (Scheme 1.8). 
Scheme 1.8 : Syntheses of compounds 1.27 and 1.28 
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1.20 R = F or H Compound 1.21: R = F Yield: 65 %
Compound 1.22: R = H Yield: 80 %
Compound 1.23: R = F Yield: 95 %
Compound 1.24: R = H Yield: 98 %
Compound 1.25: R = F Yield: 35 %
Compound 1.26: R = H Yield: 45 %
Compound 1.27: R = F Yield: 95 %
Compound 1.28: R = H Yield: 96 %  
N-Acetyl-p-anisidine was treated with 20 % nitric acid to yield nitration–deacetylation 
product 1.29 in one pot. Aniline 1.29 reacted with methyl vinyl ketone, arsenic pentoxide hydrate 
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in phosphoric acid to furnish the synthesis of nitro quinoline 1.30. Reduction of 1.30 with iron 
powder in acetic acid gave quinoline 1.31 (Scheme 1.9).  
Scheme 1.9 : Synthesis of compound 1.31 
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Quinoline synthesis is the key step in the syntheses of designed quinolines, and a possible 
mechanism is proposed herein (Scheme 1.10). 
Scheme 1.10 : Proposed mechanism for quinoline synthesis reaction 
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This quinoline synthesis reaction starts with Michael addition of the aniline –NH to 
methyl vinyl ketone. This is proven by the isolation of the Michael-addition intermediate 1.35 
from the synthesis of compound 1.17 (R = 3-trifluoromethylphenoxyl) (Scheme 1.11).
10
 Intra-
molecular Friedel-Craft reaction followed by dehydration are carried out to furnish the cyclic 
structure construction.   
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Scheme 1.11 : Isolation of the Michael addition product from the synthesis of 1.17
10 
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An oxidation step is needed to finish the synthesis of aromatic quinoline structure. This 
reaction was carried out with and without argon protection, and the reaction yields did not show 
significant difference. This indicates that the oxidizing reagent is not the oxygen in the air. Under 
heating, As2O5 decomposes to give As2O3 and oxygen (Scheme 1.12);
14 
hence, As2O5 probably is 
the oxygen source to provide the oxygen in situ to furnish the oxidation. Work-up of the reaction 
with sodium hydroxide gave free quinoline compounds. 
Scheme 1.12 : Oxygen from As2O5
14
 
As2O5 As2O3  +  O2  
In the proposed mechanism above, the intramolecular Friedel-Craft reaction is the key 
step for quinoline structure construction. A detailed mechanism of this step is proposed as well to 
interpret the reaction outcomes.  Firstly, the Michael addition products are divided into 2 groups: 
(1) with aryloxyl at 6-position (compound 1.32, 1.23, 1.24); (2) without aryloxyl at 6-position 
(compound 1.30) (Scheme 1.13). 
Scheme 1.13 : Two groups of compounds for mechanism proposal 
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For group (1) compounds, there are two possible mechanisms for the intramolecular 
Friedel-Craft reaction (Scheme 1.14). Pathway (a) is the aniline nitrogen undergoes 
deprotonation firstly to free the long pair electrons and then donates this long pair of electrons to 
initiate the Friedel-Craft process; pathway (b) is the 6-oxygen donates one long pair of electrons 
to initiate the Friedel-Craft reaction. Considering the reaction is carried out in the highly acidic 
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environment, the deprotonation of the aniline nitrogen could be slow. Hence, it is more 
reasonable that pathway (b) is the predominate route for the Friedel-Craft reaction. A di-cation 
intermediate 1.37 was formed after the dehydration. To stabilize the structure, the nitrogen could 
be easily deprotonated to yield a free amine intermediate 1.38 which is the resonance structure of 
compound 1.33. 
Scheme 1.14 : Possible mechanisms for the intramolecular Friedel-Craft reaction 
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Mechanism (b) could perfectly interpret the observed reaction outcomes.  For different 
quinolines, the yield changes from 25 % of 1.17 [R = 3-(trifluoromethyl) phenoxyl], 35 % of 
1.25 (R = 3-fluoropehnxoyl) to 45 % of 1.26 (R = phenoxyl). With stronger electron 
withdrawing groups attached, the reaction yield is lower. It might because that the electron 
withdrawing group destabilized the quinone cation intermediate 1.36. The electron withdrawing 
abilities comparison is: -CF3 > -F > -H; hence, the yield is 1.17 < 1.25 < 1.26. 
For the group (2) compound 1.31, since no aryloxyl group is available at 6-position, 
pathway (a) is the only possible mechanism to give the desired product. Meanwhile, the 
disappearing of 6-aryloxyl significantly reduces the steric hindrance in the Friedel-Craft reaction 
step; hence, a higher yield (87 %) is achieved. 
Compounds 1.10, 1.11 and 1.12 were prepared from quinolines 1.27, 1.28 and 1.31 
respectively by using the same method as that of synthesis of compound 1.5 (Scheme 1.15). 
 
 
13 
 
Scheme 1.15 : Syntheses of compounds 1.10, 1.11, 1.12 
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Till now, syntheses of PQ-7 derivative compounds are all described and discussed. The 
syntheses of PQ-1 derivative compounds will be introduced.  
First PQ-1 derivative compound, compound 1.13, was synthesized by a Michael addition 
reaction of compound 1.17 with acrylamide in acetonitrile (Scheme 1.16). 
Scheme 1.16 : Synthesis of compound 1.13 
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With the synthesized amino quinolins 1.27, 1.28 and 1.30 in hand, three new PQ-1 
derivative compounds were prepared. Compounds 1.27, 1.28 and 1.30 were treated with iodide 
1.39 and sodium bicarbonate as the base in DMF to yield N-substituted compounds 1.40, 1.41, 
1.42, respectively. The imido groups were deprotected by refluxing in hydrazine ethanol solution 
to give compounds 1.14, 1.15 and 1.16 (Scheme 1.16). 
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Scheme 1.17 : Syntheses of compounds 1.14, 1.15, 1.16 
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All the designed quinoline compounds were synthesized and discussed, and, in the next 
section, bio-evaluation results of these novel quinoline compounds are summarized.  
 
 1.3 Bio-evaluation results for synthesized quinoline compounds  
The synthesized quinoline compounds 1.1 – 1.16 were firstly treated with succinic acid to 
generate the corresponding succinic salt. These prepared salts were used to screen their bio-
activity on MC65 cell protection assay.  
MC65 cell possesses a SC gene which could produce C99 fragment APP.15 This APP 
eventually could be cleaved to generate toxic A peptide which induces cell death.15 
Tetracycline (TC) is introduced to MC65 cells to suppress SC gene’s expression.15 Designed 
quinoline compounds were incubated with MC65 cells in the absence of TC to test their cell 
protection activity against the A peptide induced cyto-toxicity.15 This work was carried out by 
Dr. Izumi Maezawa and Dr. Lee-Way Jin. The cell protection activity results of compounds 1.1 – 
1.16 are summarized in Table 1.2.   
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Table 1.2 : EC50 (M) and TD50 (M) Values of quinoline compounds on MC65 protection 
assay 
 EC50 TD50  EC50 TD50  EC50 TD50 
1.1 0.46 ± 
0.10 
> 50 
1.2 2.39 ± 
0.06 
20.32 ± 
1.22 
1.3 
0.39 ± 0.02 
14.50 ± 
1.68 
1.4 0.48 ± 
0.03 
2.91 ± 
0.15 
1.5 0.12 ± 
0.01 
1.38 ± 
0.08 
1.6 
0.13 ± 0.01 
3.35 ± 
0.36 
1.7 0.19 ± 
0.02 
> 50 
1.8 3.47 ± 
0.32 
> 50 
1.9 
0.30 ± 0.01 
3.31 ± 
0.30 
1.10 0.70 ± 
0.01 
2.60 ± 
0.20 
1.11 0.53 ± 
0.01 
4.00 ± 
0.38 
1.12 
2.62 ± 0.15 
20.54 ± 
0.21 
1.13 0.50 ± 
0.02 
> 50 
1.14 0.60 ± 
0.02 
7.28 ± 
0.25 
1.15 
0.42 ± 0.01 
8.16 ± 
0.01 
1.16 17.62 ± 
0.37 
> 50 
PQ-1 0.15 ± 
0.20 
2.09 ± 
0.02 
PQ-7 0.69 ± 0.03 42.82 ± 
2.43 
 
To explore the mechanism, four of the most active compounds 1.5 (EC50 = 0.12 ± 
0.01M), 1.6 (EC50 = 0.13 ± 0.01 M), 1.7 (EC50 = 0.19 ± 0.02M) and 1.9 (EC50 = 0.30 ± 
0.01M) were selected to test their enzyme inhibitory activities on GSK-3ADP-GloTM kinase 
assay
16
 and protein kinase C (PKC)-PepTag
TM
 kinase assay
17
. These works were done by Sahani 
Weerasekara and Dr. Keshar Prasain in Dr. Duy Hua’s lab. 
On GSK-3 ADP-GloTM kinase assay, there are four steps to test the enzyme inhibitory 
activities of designed quinolines (Figure 1.5).
16
 Firstly, the compound, enzyme, ATP and 
substrate are incubated at 25 
o
C for 1 hour; then, ADP-Glo
TM
 reagent is introduced to stop the 
enzyme reaction and deplete the unreacted ATP. Thirdly, the remaining ADP is converted into 
ATP by the kinase detection reagent. At last, via a luciferase/luciferin reaction, the newly 
synthesized ATP is used to generate a light signal which is measured by luminometer. The 
measure luminescence is correlated with the concentration of ADP which is generated from the 
kinase reaction and therefore reflects the enzyme activity.  
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Figure 1.5 : Procedure for operating GSK-3 ADP-GloTM kinase assay16  
 
On PKC PepTag
TM
 kinase assay, a dye molecule attached eleven amino acids residue is 
used as the substrate, and, at pH = 7.4, this substrate held +1 net charge. There are three steps to 
test the enzyme inhibitory activities of designed quinolines (Figure 1.5).
17
 Firstly, the kinase 
reaction is carried out by the incubation of compound with the substrate, ATP and enzyme at pH 
= 7.4 and 31 
o
C for 45 minutes. After the kinase reaction, the phosphorylated substrate would 
held -1 net charge at the reaction pH while the unphosphorylated substrate stays unchanged. 
Secondly, the enzyme is destroyed to stop the reaction, and the phosphorylated substrate and the 
unphosphorylated substrate are separated by electrophoresis. At last, the fluorescence intensities 
of the bands from the electrophoresis experiment are measured, and these intensities are 
correlated with the enzyme activity.  
17 
 
Figure 1.6 : Procedure for operating PKC PepTag
TM
 kinase assay
17
 
 
 
Results on the enzyme inhibitory assays are summarized in Table 1.3. 
Table 1.3 : Enzyme inhibition activities of 1.5, 1.6, 1.7 and 1.9 on GSK-3 and PKC assays 
Quinoline GSK-3 PKC 
PQ-1 > 1 mM 35 ± 8 nM 
PQ-7 > 1 M 42.3 nM 
1.5 35 ± 6.36 nM  240 ± 21.2 M  
1.6 > 1 mM 216.3 nM 
1.7 > 1mM  400 ± 13.7 M 
1.9 158 ± 19.1 nM  750 ± 9.3 M  
 
 1.4 Discussion  
Designed quinoline compounds were synthesized and evaluated their bio-activities on 
both cell and enzymes assays. From these bio-evaluation results, a structure-activity relationship 
(SAR) could be derived, which may help to the development of a higher efficient and lower toxic 
drug candidate for AD therapy in future. Moreover, to explore the mechanism, a computational 
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experiment was also carried out to simulate the binding mode of the designed quinolines with 
GSK-3. All of these works are discussed in this section. 
1.4.1 Structure-activity relationship of the synthesized quinoline compounds 
From results of MC65 cell protection assay, a SAR could be derived (Figure 1.7). 
Figure 1.7 : Structures activity relationship of synthesized quinoline compounds 
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Structural modifications of PQ-1 do not give a positive feedback. The new synthesized 
PQ-1 analog compounds do not show better cell protection activities, and changes made on the 
PQ-1’s structure impair the bio-activity. From the result of the enzyme inhibitory assays, PQ-1 
is PKC inhibitor instead of GSK-3 inhibitor which indicates PQ-1 protects the neuronal cell 
through  different mechanism. Since this research is aiming to discover a GSK-3 inhibitor, PQ-
1 derivatives are not considered for deriving the SAR.  
Among the PQ-7 derivatives, compound 1.5 shows the highest cell protection activity 
and GSK-3 inhibitory activity. Some PQ-7 derivative compounds (compound 1.6 and 1.7) were 
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also examined their GSK-3 inhibitory activities; but the results indicate they are not the GSK-
3 inhibitors. Hence, only the compounds derived from 1.5 are used to derive the SAR. 
Compound 1.5 possesses the highest cell protection activity (EC50 = 120 ± 10 nM). 
Comparing with quinoline 1.5, compounds 1.4 shares the same substitution groups on the 4-, 5- 
and 6- positions of quinoline core, and the difference is the functionality which is connected to 8-
amino group. The cell protection results suggest the importance of 4-hydroxybenzyl group to the 
activity of designed compounds. Any changes on this portion of the molecule cause the decrease 
of the activity. Structure of compound 1.4 is very similar to compound 1.5; however, the addition 
of two methoxyl groups on the phenyl ring decreases quinoline 1.4 ‘s activity (EC50 = 480 ± 30 
nM)  four times comparing to compound 1.5. 5-Aryloxy group is also very important. Removal 
of the 5-aryloxy group in compound 1.5 gives compound 1.12, and compound 1.12 (EC50 = 
26.20 ± 0.15 M) almost lose the cell protection activity. Trifluoro group on the 5-aryloxy is also 
proven to be unsubstitutable for the activity, and the replacements of it with fluoro [compound 
1.10 (EC50 = 700 ± 10 nM)] or hydrogen [compound 1.11 (EC50 = 530 ± 10 nM)] decrease the 
activity. Replacement of the methoxy group with hydroxyl group at 6- position [compound 1.9 
(EC50 = 300 ± 10 nM)] did not improve the activity neither.  
In summary, 3-trifluoromethylphenoxyl at 5- position, methoxyl at 6- position and 4-
hydroxybenzyl at 8-amino position are all important to the designed quinoline compound activity. 
To modify 1.5’s structure to get more effective GSK-3 inhibitors, the functions of these  
substitutions in inhibiting GSK-3 should be learned.  The best way to acquire these information 
is from the co-crystal structure of GSK-3 with compound 1.5. However, this experiment dose 
not have to chance to be carried out yet. Hence, a computational docking experiment was carried 
out to simulate the binding mode of 1.5 to GSK-3. The design of the docking experiment and 
the results are summarized in the next section.  
1.4.2 Computational experiment and the result 
To understand the mechanism of 1.5‘s inhibitory activity on GSK-3, a computer-
docking experiment was carried out, and the result is introduced and discussed in this section.  
To begin with, the structural properties of GSK-3is briefly introduced herein. Figure 
1.8 shows one of the reported GSK-3 crystal structures in both cartoon and surface 
representations.
18
 GSK-3 has a small N-terminal domain and large C-terminal domain. The 
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kinase domain lies in the space between these two domains and is responsible for the kinase 
reaction.
18
 This domain is divided into three regions by their functions: ATP-binding pocket, 
phosphate transfer region and substrate binding groove.
18
 
Figure 1.8 : Cartoon and surface representations of GSK-318: (a) Cartoon representation; 
(b) Surface representation (Green: carbon; Red: oxygen; Blue: nitrogen; Yellow: sulfur) 
 
Studies indicate that some residues in the kinase domain are extremely important to the 
enzyme’s activity.18,19 In the ATP-binding pocket, residues Asp133 and Val135 are suggested to 
be vital for the binding the ATP molecule to enzyme. Adenylyl imidodiphosphate (AMP-PNP) 
which has similar structure as the ATP was co-crystalized with GSK-3 to mimic the binding 
mode of ATP molecule with the enzyme.
19
 From the structure of the co-crystal, hydrogen-
bonding interactions are detected between residues Asp133 and Val135 with the adenylyl group 
of the AMP-PNP.
19
 Moreover, these hydrogen-bonding interactions are conserved in the co-
crystal structures of GSK-3 with some of its ATP-competitive inhibitors, such as staurosporine, 
indirubin-3’-monoxime and alsterpaullone (Figure 1.9).19 In the phosphate transfer region, Lys85 
and Lys183 are responsible for the enzyme’s binding to the phosphates in AMP-PNP molecule.19 
In the substrate binding groove, two residues, Phe67 and Try216, are suggested to control the 
enzyme’s activity.3,20 F67A mutant GSK-3 lose its activity on the phosphorylation of substrate 
peptide, which indicates that Phe67 is vital for GSK-3’s substrate recognition.20 Residue 
Try216 could be self-phosphorylated to be the pTry216 by GSK-3,  and pTry216 has a 
conformational change comparing with Try216. The enzyme is activated to hyperphosphorylate 
the substrate, such as tau, after Try216 is phosphoryated.
2
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Figure 1.9 : Structures of staurosporine, indirubin-3’-monoxime and alsterpaullone19  
H
N
N N
O
O
MeO
HN
Staurosporine
N
H
NH
O
N
HO
Indirubin-3'-monoxime
HN
O
H
N
NO2
Alsterpaullone  
Autodock Vina was used as the computer docking program.
21
 The 3D structure of 
compound 1.5 was constructed via Chem3D 11.0. The exact binding site of compound 1.5 to 
GSK-3 was unknown; therefore, compound 1.5 was docked in whole kinase domain. Docking 
conformation of 1.5 with the lowest binding energy was supposed to simulate the real binding 
mode of compound 1.5. 
The crucial step for the computer docking is to choose the right crystal structure of GSK-
3and the criterions are rationally investigated. Since computer docking by Autodock Vina is a 
rigid docking process,
21 
the 3D structure of GSK-3 for docking should mimic the real structure 
of the enzyme in the enzyme and inhibitor (compound 1.5) complex. For GSK-3, it has 
different structural characters for different types of inhibitors. If compound 1.5 is an ATP-
competitive inhibitor and binds into the ATP-binding pocket, it would block ATP molecule bind 
to the enzyme. Hence, the Try216 would not have chance to be phosphorylated, and the enzyme 
would be in an inactive state. Moreover, it is highly possible that the compound conserved some 
similar interactions as other ATP-competitive inhibitors do. To resemble the similar interactions, 
the key residues in the ATP binding pocket should have the similar conformations as those of  
the same residues in other known GSK-3-inhibitor co-crystals. If compound 1.5 is a substrate 
competitive inhibitor and binds to the substrate binding groove of GSK-3, the enzyme is highly 
possible in its activated state. Since residue Try216 phosphorylation is self-phosphorylation 
process (in other words, intramolecular process), this phosphorylation process is fast in the 
presence of ATP (the enzyme assay environment). When the inhibitor binds into the substrate 
binding groove, it is highly possible that the Try216 is phosphorylated and the enzyme is in 
active state. Unfortunately, the exact binding site of compound 1.5 with GSK-3 is not clear. In 
other words, whether compound 1.5 is an ATP-competitive inhibitor or substrate competitive 
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inhibitor was not known. Hence, the protein structures for both possible cases should be 
considered.  
Considering the ideal docking would probe the ATP binding pocket and substrate binding 
groove with equal chance in one experiment, the ideal protein structure should be able to 
perfectly mimic the real protein for each case. In other words, the ideal protein crystal structure 
used for docking should possess the ATP binding pocket which should be the same as the one in 
the inactive enzyme, and a substrate binding pocket which should be the same as the one in the 
active enzyme! This seemed impossible. However, after screening the available crystal structures 
of GSK-3,22 fortunately, file 1O9U23 is finally found to satisfy this criterion. It had the same 
ATP binding pocket as the inactive enzyme, and the phosphorylation of residue Try216 caused 
the conformational change in the substrate binding pocket compares with the inactive enzyme.
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This enzyme is overlaid with inactive enzyme
18 
to show the difference in the substrate binding 
pocket (Figure 1.10) . 
Figure 1.10 : Overlay of crystal structure 1O9U (Green) with inactive enzyme (pdb: 1I09) 
(Pink) 
 
Meanwhile, crystal structure 1O9U is also overlaid with the crystal structure of GSK-3 
which was complex with the known ATP-competitive inhibitor (alsterpaullone, pdb: 1Q3W)
19
 to 
compare the conformations of key residues in the ATP binding pocket. From the overlay, it is 
obvious that the key residues (Asp133, Val135, Lys85, Lys183) in the ATP-binding pocket and 
phosphate transfer region share very similar conformations. Therefore, it is highly possible that 
the docking environment in the ATP-binding pocket is well mimicked the “real” case if 
compound 1.5 is an ATP-competitive inhibitor (Figure 1.11). 
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Figure 1.11 : Overlay of crystal structure 1O9U (Green) with enzyme complex with ATP-
competitive inhibitor (pdb: 1Q3W) (Yellow) 
 
Crystal structure for docking (file: 1O9U) was added hydrogens by MOL Probity 
program
24
 before docking experiment, and the results are displayed in Figure 1.12. 
Figure 1.12 : Docking result of compound 1.5 with GSK-3 
 
From the docking result, the conformation with lowest binding energy is displayed in 
Figure 1.12. Compound 1.5 binds into the substrate binding groove of GSK-3, instead of ATP-
binding pocket. A hydrogen bonding interaction between hydroxyl group on the benzyl ring and 
residue Arg96 is discovered in the result. π-π Interaction is also found between the quinoline core 
of compound 1.5 and residue Phe67 in the computer simulation. Trifluoromethyl group is found 
having close contacts with residues Asp181 and Cys218. 
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Docking result suggests that compound 1.5 is a substrate-competitive inhibitor; hence, 
this could explain high enzyme inhibitory selectivity. Since GSK-3 and PKC have distinct 
substrate binding areas, the substrate-competitive inhibitors “fit” for the GSK-3 would not “fit” 
in PKC.  
Figure 1.13 : Overlay of crystal structure of GSK-3 1O9U (Green) with PKC-1XJD 
(Yellow) 
 
The observed SAR could also be interpreted by the docking result. In docked 
conformation, compound 1.5 opens its structure to support itself binds in the substrate binding 
groove; therefore, the “length” of the molecule is important. A shorter molecule (compound 1.16) 
has less possibility to conserve this type of binding to GSK-3. Meanwhile, the trifluoromethyl 
group and 4-hydroxyl group on the benzyl ring are two terminals of the structure and have 
important interactions with residues of GSK-3to secure the binding of 1.5.  As discussed above, 
residue Phe67 is important for substrate recognition of the enzyme
20
; hence, the detected π-π 
interaction might responsible for the deactivation of the enzyme. 
To sum up, via the computational experiment, the binding mode of compound 1.5 to 
GSK-3 is simulated. The importance of the required substitutions and quinoline core are 
demonstrated and explained. The information acquired from the SAR and computational 
experiment provides clues for designing more effective GSK-3 inhibitors, and this work will be 
discussed in the next section.  
 1.4.3 Future work 
 The novel quinoline analog compounds with higher bio-activities and less toxicities are 
being expected to be developed in future. Since the most active quinoline compound till now is 
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1.5, this compound is used as the lead compound. Aiding by the information obtained from the 
SAR analysis and computational experiment, some novel GSK-3 inhibitors derived from 1.5 is 
proposed herein. 
The criterions for designing new 1.5-derived inhibitors are discussed firstly. From the 
derived SAR, the threefold molecular structure is required for the inhibitor’s activity; 4-
hydoxybenzyl group, 5-(3-trifluoromethylphenoxyl) group and 6-methoxyl group are also 
important to the quinoline 1.5’s activity. Roles of the threefold structure and these substituents 
are interpreted by computer simulation. The threefold structure is essential for binding to the 
wide substrate binding groove of GSK-3; 4-hydroxyl group acts as the hydrogen bond donor; 
trifluoromethyl group has polar-polar interactions with residues in the substrate binding groove, 
and quinoline core is proposed to be responsible for the deactivation of enzyme via π-π 
interaction with Phe67. According to these information, the new designed inhibitors should 
maintain the threefold structure to ensure secure binding to wide-opened area; at the two 
terminals of the molecule, functional groups should be carefully designed to ensure an 
interaction with residues in the substrate binding groove. From the rigid docking result, it is 
worthy to note that the quinoline core of 1.5 is not in the perfectly parallel position of the phenyl 
ring of Phe67, which indicates this π-π interaction may not be well-established. Since this π-π 
interaction is proposed to be important for enzyme’s deactivation, enhancement on this π-π 
interaction is supposed to increase the designed inhibitor’s activity. Hence, modifications made 
on the structure of 1.5 are aiming to improve this π-π interaction. To achieve this purpose, the 
stereo-position of the quinoline core could adjusted by modify the whole structure; or other 
aromatic moieties could be used to instead of quinoline.  
Moreover, to assist design new inhibitors, two parameters, log P Octanol/Water and log S, are 
predicted by computer simulation method for each proposed molecules. log P Octanol/Water Value is 
used to estimate the lipophilicity of the drug candidates.
25
 The definition is, in the mixture of 
octanol and water at the equilibrium, the log value of the solute concentration in octanol minus 
the log value of the solute concentration in water (Equation 1.1).
25
 log P Value is important 
parameter for CNS drugs: with higher log P value, the drug candidate has higher chance to pass 
the blood-brain barrier (BBB) by diffusion, which has better bio-availability. 
Equation 1.1 : Definition of log P Octanol/Water 
log P Octanol/Water =  log c solute in octanol – log c solute in water  = log [c solute in octanol / c solute in water ]  
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log S Value is also very important for the bio-availability of drug candidates.  It is 
defined as the log value of the drug’s solubility in water (Equation 1.2).26 The higher of log S, the 
better solubility of the drug in water, and the better the drug distribution in body.
26
 For CNS 
drugs, the higher log S indicates a better diffusion to penetrate the BBB to reach the brain.
26
  
Equation 1.2 : Definition of log S 
log S = log solubility water 
The log P and log S Values could be predicated by the computer program: ALOGPS 
2.1.
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Meanwhile, Lipinski’s the rules-of-five for designing more drug-like molecules are also 
utilized to evaluate the proposed inhibitors.
28
 The rules-of-five are including: log P should be in 
the range of -0.4 – +5.6; molecular weight should be in the range of 180 – 500; number of atoms 
should be in the range of 20 – 70; rotatable bonds should be less than 10; hydrogen bond donors 
should less than 5; hydrogen bonding acceptors less than or equal to 10; for CNS drugs, total 
nitrogen and oxygen atoms’ number [n(N+O)] should less than or equal to 5, and the other rule is 
log P – n(N+O)  > 0.
28
  
According to the discussed, three compounds are designed, and their properties are 
predicted and summarized in Table 1.4 
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Table 1.4 : Structure and predicted properties of the newly designed quinolines 
 1.5 1.43 1.44 1.45 
Structure N
HN
O
Me
MeO
OH
F3C
 
N
HN
O
Me
MeO
HO
CF3  
N
H
HN
O
Me
MeO
OH
F3C
 
HN
O
OH
HO
 
log POctanol/Water 5.50 5.62 5.44 4.93 
log SWater  -6.25 -5.63 -6.20 -5.35 
Molecular weight 454.15 454.15 458.18 357.14 
Number of atoms 54 54 58 46 
Rotatable bonds 8 8 8 7 
Hydrogen bond 
donors 
2 2 2 3 
Hydrogen bond 
acceptors 
3 3 3 1 
n(N+O) 5 5 5 4 
log P - n(N+O) + 0.50 + 0.62 + 0.44 +0.93 
 
By exchanging position of the terminal substituents (3-trifluoromethylphenoxyl group 
and 4-hydroxybenzyl group), compound 1.43 is designed. If the hydroxyl group and 
trifluoromethyl group of the compound 1.43 could assumable the similar binding mode as that of 
1.5,  the quinoline core of 1.43 will have a chance to adjust its position towards Phe67, which 
may strengthen the π-π interaction. By reducing quinoline core of 1.5 into benzopiperidine, the 
compound 1.44 is designed. From the docking result of 1.5, only the non-nitrogen containing 
aromatic ring of the quinoline has the π-π interaction with Phe67, and nitrogen containing 
portion of quinoline sits apart from Phe67. The piperidine of the 1.44 will have chair 
conformation; therefore, with the π-π interaction unchanged, this chair-conformation piperidine 
is expected to have a new hydrophobic-hydrophobic interaction with benzyl’s methylene group 
of Phe67, which also could strengthen the binding of inhibitor to Phe67 of GSK-3. By replacing 
the quinoline core of 1.5 in to naphthalene, compound 1.45 is designed. The trifluoromethyl 
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group is changed into hydroxyl group to reduce the log P value. The naphthalene core of 1.45 is 
expected to improve π-π interaction with Phe67.  
The log P and log S values of these designed inhibitors are predicted and summarized in 
Table 1.4. From the results, all of these newly designed GSK-3 inhibitors are satisfying the 
rules-of-five and expected  to be the qualified CNS drug candidates.  
Syntheses of these designed GSK-3 inhibitors are proposed herein as well. 
Compound 1.43 could be synthesized via the same synthetic route as compound 1.5. 
Phenolate 1.46 will be treated with bromide 1.20 to give compound 1.47. Following the same 
quinoline synthesis procedure, 1.48 will be prepared. Hydrogenantion with Pd/C as catalyst 
could remove the benzyl group and reduce the nitro group in one-pot to give 1.49.
29
 Amino 
quinoline 1.49 will be coupled with 3-trifluoromethyl benzaldehyde to give desired 1.43 
(Scheme 1.18). 
Scheme 1.18 : Synthesis of compound 1.43 
OK
O
+
DMF
NO2
NHAc
O
Me
1. HCl, EtOH
2. Methyl vinyl ketone,
    As2O5, H3PO4
Br
1.46 1.20
NO2
NHAc
O
Me
O
O
1.47
NO2
O
O
Me
N
Me
O
1.48
Pd/C, H2
NH2
O
O
Me
N
Me
1.49
HO
CF3
CHO
, cat. AcOH, NaCNBH3
HN
O
O
Me
N
Me
HO
CF3
1.43  
Compound 1.44 could be directly generated by reduction of the quinoline of compound 
1.5. In 2010, a hydroxyapatite (HAP) supported Pd nanoparticle is reported to be used to regio-
selectively reduce the quinoline in good yield (Scheme 1.19).
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Scheme 1.19 : Quinoline reduction with HAP supported Pd nanoparticle
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N
O
Me HAP-Pd (0), H2, toulene
N
H
O
Me
87% yield
1.50 1.51  
29 
 
Hence, compound 1.44 could be prepared under this reduction condition with compound 
1.5 as the starting material (Scheme 1.20). 
Scheme 1.20 : Synthesis of compound 1.44
 
HAP-Pd (0), H2, touleneN
HN
O
Me
MeO
OH
F3C
N
H
HN
O
Me
MeO
OH
F3C
1.5 1.44  
The synthesis of compound 1.45 could be start with the commercial available compound 
1.52. Similar as the synthesis of 1.43, bromide 1.52 will be treated with phenolate 1.53 to 
generate compound 1.54. Hydrogenantion with Pd/C as catalyst could remove the benzyl group 
and reduce the nitro group in 1.54 in one-pot to give 1.55.
29 
 Compound 1.53 will coupled with 
4-hydroxyl benzaldehyde to give desired 1.45 (Scheme 1.21). 
Scheme 1.21 : Synthesis of compound 1.45 
O
+
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1.53 1.52
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O
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O
1.55
CHO , cat. AcOH, NaCNBH3
HN
O
HO
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OK
O
HO
HO
OH  
In summary, with the information from the SAR study and computational docking of 
compound 1.5,  three new GSK-3 inhibitors are designed which will provide a direction for 
further investigation on discovering more effective GSK-3 inhibitor.  log P and log S Values of 
these proposed compounds are predicted as well, and these inhibitors are also evaluated by the 
rules-of-five. The designing ideas for these new inhibitors is described, and the syntheses of 
these compounds are also proposed. 
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 1.4.4 Concerns  
Although the bio-evaluation experiments gave very promising results, a few issues are 
still needed to be taken into account. Firstly, it still lacks of convincing evidence that designed 
quinolines could inhibit the GSK-3 in cell system. The difficulty in solving this problem is the 
GSK-3-overexpressed cell system is difficult to obtain. Therefore, at this stage, this experiment 
cannot carried out. Also, whether the designed quinoline compound could reduce the hyper-
phosphorylation of tau level and/or A oligomer production in an AD mice model is needed to 
be determined. This experiment is crucial to predict the designed inhibitor’s therapeutic effect 
and should be performed if the requirements for this experiment, such as funding, mice model, 
could be satisfied. 
 
1.5 Conclusion  
A focus library of quinoline compounds was designed, synthesized, and their bio-
activities evaluated on cell and enzymes assays. Compound 1.1 - 1.7 were synthesized from 1.17 
with various aldehydes via reductive amination reactions. Amide 1.8 was synthesized from 1.17 
with 1.18, and compound 1.18 was prepared from furfural. A deprotection of methoxyl of 1.17 
with BBr3 was performed to give 1.19, and compound 1.19 reacted with 4-hydoxybenzaldehyde 
to give compound 1.9. Compound 1.27, 1.28 and 1.31 were prepared in similar reaction 
sequences as that of compound 1.17 from the same starting material 1.20. From 1.27, 1.28, 1.31, 
similar reductive amination reactions were performed with 4-hydoxybenzaldehyde to yield 
compound 1.10, 1.11 and 1.12. Compound 1.13 was prepared from 1.17 with acrylamide via 
Michael addition reaction. 1.14, 1.15 and 1.16 were synthesized via a SN2 reaction and 
deprotection reaction from 1.27, 1.28 and 1.31, respectively.  
Bio-activities of compounds 1.1 – 1.16 were evaluated on MC65 cell protection assay. 
Most of quinoline compounds were found to have cell protection activities in nanomolar ranges. 
Four of the most active compounds were selected to test their enzyme inhibitory activities on 
GSK-3 and PKC enzyme assays.  Compound 1.5 is found to be the most active compound in 
the synthesized quinoline compounds.  A structure activity relationship of designed quinolines is 
derived. The binding mode of 1.5 with GSK-3 was simulated by the computational method, and 
several important interactions are shown in the result. The information acquired from the SAR 
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study and docking experiment gives clues for designing more effective GSK-3 inhibitors, and 
three novel GSK-3 inhibitors are proposed. Meanwhile, synthetic routes of these proposed 
inhibitors are suggested. In future, inhibition of GSK-3β in cell system and the level of 
phosphorylated tau in in vivo AD model by quinolines’ need to be performed.   
 
1.6 Experimental Section 
General procedure:  Melting points were tested on Thomas Hoover capillary melting 
point apparatus. Nuclear magnetic resonance spectra were obtained at 400 MHz for 
1
H and 100 
MHz for 
13
C in deuteriochloroform and reported in  ppm, unless otherwise indicated. Low-
resolution mass spectra were taken from an API 2000-triple quadrupole ESI-MS/MS mass 
spectrometer (from Applied Biosystems).  Benzofuran-2-carboxylaldehyde, thiazole-2-
carboxylaldehyde, 5-phenyl thiophene-2-carboxylaldehyde, 3,5-dimethoxy-4-hydroxyl 
benzaldehyde, 4-hydroxyl benzaldehyde and furfural, and aldehydes for synthesizing compounds 
1.1, 1.2, 1.3, 1.4, 1.5 and 1.8 were purchased from Aldrich chemical Co..  Arcylamide was 
purchase from Fisher Scientific Co. Quinoline-4-carboxylaldehyde and quinoline-8-
carboxylaldehyde for synthesizing 1.6 and 1.7 were prepared by Dr. Laxman Pokerhel in Dr. 
Duy Hua’s laboratory11.  
 
 N-(Benzofuran-2-ylmethyl)-6-methoxy-4-methyl-5-(3-trifluoromethylphenoxy) 
quinolin-8-amine (1.1). 
N
HN
O
Me
MeOF3C
O
1.1  
A solution of 25.0 mg (0.071 mmol) of 6-methoxy-4-methyl-5-(3-(trifluoromethyl) 
phenoxy)quinolin-8-amine (1.17) and 11.3 mg (0.078 mmol)  2-benzofurancaboxaldehyde in 1 
mL of dried methanol (distilled over magnesium) was stirred under argon at 25
o
C for 30 minutes. 
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To it, 2 drops of acetic acid was added. The mixture was stirred at 25 
o
C for 30 minutes. Then, 
3.4 mg (0.213 mmol) of sodium cyanoborohydride were added, the solution was stirred 12 hours, 
diluted with 30 mL of aqueous ammonium chloride solution, and extracted three times with ethyl 
acetate. The combined extract was washed with water, brine, dried (MgSO4), concentrated, and 
column chromatographed using a mixture of hexane and diethyl ether (1:1) as an eluent to 22.1 
mg (65% yield) of compound 1.1 as a yellow oil.  
1
H NMR δ 8.44 (d, J = 4.4 Hz, 1H), 7.52 (d, J 
= 5.6 Hz, 1H), 7.47 (d, J = 7.6 Hz, 1H), 7.33 (t, J = 7.6 Hz, 1H), 7.27 (td, J = 7.6, 1.6 Hz, 1H), 
7.25 – 7.20 (m, 2H), 7.11 (dd, J = 4.4, 0.8 Hz, 1H), 7.08 (s, 1H), 6.91 (dd, J = 8.0, 2.0 Hz, 2H, 
overlap with NH), 6.71 (d, J = 0.8 Hz, 1H), 6.64 (s, 1H), 4.74 (s, 2H, CH2N), 3.79 (s, 3H, OMe), 
2.63 (s, 3H, Me);  
13
C NMR δ 159.8, 155.5, 155.2, 150.9, 145.3, 143.9, 143.0, 133.9, 132.1 (q, 
2
JCF = 32 Hz, C-CF3), 130.2, 128.6, 126.5, 125.3, 124.5, 124.2, 123.6 (q, 
1
JCF = 239 Hz, CF3), 
123.0, 121.1, 118.3, 118.2 (q, 
3
JCF = 4 Hz), 112.3 (q, 
3
JCF = 4 Hz), 111.4, 104.1, 93.9, 56.8, 41.8, 
23.4; MS (electrospray), m/z 501.3 (M+Na)
+
. The succinic salt of 1.1 was generated by 
dissolving 20 mg (0.042 mmol) of 1.1 with 5 mg (0.042 mmol) of succinic acid in 4 mL of 
methanol. Then the methanol was concentrated off, the residue was dissolved in 1 mL 
acetonitrile, diluted with 10 mL deionized water and lyophilized to give a quantitative yield of 
the succinic salt of 1.1. 
 6-Methoxy-4-methyl-N-(thiazol-2-ylmethyl)-5-(3-trifluoromethylphenoxy)quinolin-8-
amine (1.2). 
N
HN
O
Me
MeOF3C
S N
1.2  
Prepared via the same procedure as compound 1.1. Starting from 25.0 mg (0.071 mmol) of 
compound 1.17 and 8.8 mg (0.078 mmol) 2-thiazolecarboxaldehyde gave 22.7 mg (72% yield) 
of compound 1.2 as a light yellow oil. 
1
H NMR δ 8.46 (d, J = 4.4 Hz, 1H), 7.77 (d, J = 3.6 Hz, 
1H), 7.32 (t, J = 7.6 Hz, 1H), 7.29 (d, J = 3.6 Hz, 1H), 7.25 – 7.20 (m, 2H), 7.11 (d, J = 3.6 Hz, 
1H), 7.07 (s, 1H, NH), 6.91 (dd, J = 8.4, 2.4 Hz, 1H), 6.57 (s, 1H), 4.94 (d, J = 5.6 Hz, 2H, 
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CH2N), 3.71 (s, 3H, OMe), 2.62 (s, 3H, Me); 
13
C NMR δ 171.2, 159.7, 150.8, 145.4, 143.6, 
143.0, 142.9, 134.0, 132.1 (q, 
2
JCF = 33 Hz, C-CF3), 130.2, 126.8, 125.3, 124.5, 124.1 (q, 
1
JCF = 
271 Hz, -CF3), 119.6, 118.3, 118.2 (q, 
3
JCF = 4 Hz), 112.3 (q, 
3
JCF = 4 Hz), 94.5, 56.7, 46.3, 23.4; 
MS (electrospray ionization), m/z 468.2 (M+Na)
+
. Succinic salt of 1.2 was prepared in the same 
way as compound 1.1 by dissolving 20 mg (0.045 mmol) of 1.2 and 5.3 mg (0.045 mmol) of 
succinic acid in 4 mL methanol. 
 6-Methoxy-4-methyl-N-[(5-phenylthiophen-2-yl) methyl]-5-(3-trifluoromethyl phenoxy) 
quinolin -8 - amine (1.3). 
N
HN
O
Me
MeOF3C
S
1.3  
Prepared via the same procedure as compound 1.1. Starting from 25.0 mg (0.071 mmol) of 
compound 1.17 and 12.6 mg (0.078 mmol) of 5-phenyl thiophene-2-carboxaldehyde gave 27.1 
mg (78% yield) of compound 1.3 as a green oil. 
1
H NMR δ 8.44 (d, J = 4.4 Hz, 1H), 7.57 (d, J = 
7.4 Hz, 2H), 7.38 – 7.19 (m, 6H), 7.11 – 7.08 (m, 2H), 6.93 – 6.86 (m, 2H), 6.62 (s, 1H), 4.75 (d, 
J = 5.2 Hz, 2H, CH2N), 3.78 (s, 3H, OMe), 2.62 (s, 3H, Me); 
13
C NMR δ 159.8, 150.9, 145.3, 
144.0, 143.9, 142.9, 142.2, 134.6, 134.0, 132.1 (q, 
2
JCF = 32 Hz, C-CF3), 130.2, 129.1, 127.6, 
126.5, 126.4, 125.9, 125.3, 124.5, 124.1 (q, 
1
JCF = 270 Hz, CF3), 123.0, 118.3, 118.2 (q, 
3
JCF = 4 
Hz), 112.3 (q, 
3
JCF = 4 Hz), 94.1, 56.8, 43.6, 23.3; MS (electrospray), m/z 521.0 (M+H)
+
. 
Succinic salt of 1.3 was prepared in the same way as compound 1.1 by starting with 20 mg 
(0.040 mmol) of 1.3 and 4.8 mg (0.040 mmol) of succinic acid.  
34 
 
 2,6-Dimethoxy-4-{[6-methoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinolin-8-
ylamino]methyl}phenol (1.4). 
N
HN
O
Me
MeOF3C
OO
OH
MeMe
1.4  
Prepared via the same procedure as compound 1.1. Starting from 25.0 mg (0.071 mmol) of 
compound 1.17 and 14.2 mg (0.078 mmol) of 3, 5-dimethoxy-4-hydroxybenzaldehyde  gave 
27.3 mg (75% yield) of compound 1.4 as a yellow solid. Melting point: 173 - 175 
o
C;  
1
H NMR δ 
8.41 (d, J =  4.4 Hz, 1H), 7.34 (t, J =  8.4 Hz, 1H), 7.22 (d, J =  7.1 Hz, 1H), 7.10 (d, J =  4.0 Hz, 
1H), 7.03 (s, 1H), 6.94 (dd, J = 8.4, 2.0 Hz, 1H), 6.72 (bs, 1H, OH), 6.71 (s, 2 H), 6.49 (s, 1H), 
5.55 (s, 1H, NH), 4.48 (d, J = 4.0 Hz, 2H), 3.88 (s, 6H, 2 OMe), 3.75 (s, 3H, OMe), 2.62 (s, 3H, 
Me);  
13
C NMR δ 159.9, 151.0, 147.5, 145.1, 144.6, 142.9, 134.2, 134.0, 132.1 (q, 2JCF = 33 Hz, 
C-CF3), 130.2, 130.1, 126.2, 125.3, 124.5, 124.1 (q, 
1
JCF = 271 Hz, CF3), 118.4, 118.2 (q, 
3
JCF = 
4 Hz), 112.1 (q, 
3
JCF = 4 Hz), 104.5, 93.8, 56.7 (OMe), 56.6 (2 OMe), 48.7, 23.4; MS 
(electrospray), m/z 537.5 (M+Na)
+
, 515.2 (M+H)
+
. Succinic salt of 1.4 was prepared in the same 
way as compound 1.1 by starting with 20 mg (0.039 mmol) of 1.4 and 4.5 mg (0.039 mmol) of 
succinic acid.  
 
 4-{[6-Methoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinolin-8-ylamino]methyl} 
phenol (1.5). 
N
HN
O
Me
MeOF3C
OH
1.5  
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A solution of 25.0 mg (0.071 mmol) of 6-methoxy-4-methyl-5-(3-
(trifluoromethyl)phenoxy)quinolin-8-amine (1.17) and 9.5 mg (0.078 mmol)  p-
hydoxybenzaldehyde in 1 mL of dried methanol (distilled over magnesium) was stirred under 
argon at 25
o
C for 30 minutes. To it, 2 drops of acetic acid was added. The mixture was stirred at 
25 
o
C for 1 hour. Then, 13.4 mg (0.213 mmol) of sodium cyanoborohydride were added, the 
solution was stirred 12 hours, diluted with 30 mL of aqueous ammonium chloride solution, and 
extracted three times with ethyl acetate. The combined extract was washed with water, brine, 
dried (MgSO4), concentrated, and column chromatographed using a mixture of hexane and 
diethyl ether (1:1). The column purified product was washed with 3 mL hexane and diethyl ether 
(1:1) to give pure 1.5 26.4 mg (82 %) as yellow solid. Melting point: 170 - 171
o
C;  
1
H NMR δ 
8.41 (d, J = 4.0 Hz, 1H), 7.35 - 7.32 (m, 3H), 7.25 - 7.21 (m, 1H), 7.11 - 7.06 (m, 2H), 6.93 (dd, 
J = 8.0, 2.4 Hz, 1H), 6.83 (d, J = 8.0 Hz, 2H), 6.71 (s, 1H, OH), 6.47 (s, 1H), 4.80 (s, 1H, -NH,), 
4.48 (d, J = 4.4 Hz, 2H, CH2N), 3.74 (s, 3H, OMe), 2.61 (s, 3H, Me); 
13
C NMR δ 159.9, 155.3, 
151.1, 145.1, 144.5, 143.1, 133.9, 132.2 (q, 
2
JCF = 33 Hz, C-CF3), 130.9, 130.2, 129.3, 126.1, 
125.2, 124.6, 124.2 (q, 
1
JCF = 271 Hz, CF3), 118.4, 118.2 (q, 
3
JCF = 4 Hz), 115.8, 112.3 (q, 
3
JCF = 
4 Hz), 93.8, 56.7, 47.8, 23.4; MS (electrospray), m/z 477.0 (M+Na)
+
, 455.1 (M+H)
+
. Succinic 
salt of 1.5 was prepared in the same way as compound 1.1 by starting with 20 mg (0.044 mmol) 
of 1.5 and 5.2 mg (0.044 mmol) of succinic acid.  
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 6-Methoxy-4-methyl-N-(quinolin-4-ylmethyl)-5-(3-trifluoromethylphenoxy)quinolin-8-
amine (1.6). 
N
HN
O
Me
MeOF3C
N
1.6  
A solution of 25.0 mg (0.071 mmol) of 6-methoxy-4-methyl-5-(3-
(trifluoromethyl)phenoxy)quinolin-8-amine (1.17) and 12.5 mg (0.078 mmol)  quinoline-4-
caboxaldehyde in 1 mL of dried methanol (distilled over magnesium) was stirred under argon at 
25
o
C for 30 minutes. To it, 4 drops of acetic acid was added. The mixture was stirred at 25 
o
C for 
1 hour. Then, 3.4 mg (0.213 mmol) of sodium cyanoborohydride were added, the solution was 
stirred 12 hours, diluted with 30 mL of aqueous ammonium chloride solution, and extracted three 
times with ethyl acetate. The combined extract was washed with water, brine, dried (MgSO4), 
concentrated, and column chromatographed using a mixture of hexane and diethyl ether (1:1). 
The column purified product was washed with 3 mL hexane and diethyl ether (1:1) to give pure 
1.6 28.3 mg (75 %) as yellow solid. Melting point: 155 
o
C – 159 oC. 1H NMR: δ 8.88 (d, J = 4.4 
Hz, 1H), 8.44 (d, J = 4.4 Hz, 1H), 8.21 (d, J = 8.4 Hz, 1H), 8.15 (d, J = 8.8 Hz, 1H), 7.79 (t, J = 
3.2 Hz, 1H), 7.64 (t, J = 6.4 Hz, 1H), 7.55 (d, J = 3.6 Hz, 1H), 7.34 (t, J = 8.0 Hz, 1H), 7.22 (d, J 
= 7.6 Hz, 1H), 7.13 (d, J = 8.4 Hz, 1H), 7.07 (s, 1H), 7.00 (t, J = 6.0 Hz, 1H), 6.95 (dd, J = 8.0, 
2.0 Hz, 1H), 6.40 (s, 1H), 5.09 (d, J = 5.6 Hz, 2H), 3.65 (s, 3H), 2.65 (s, 3H); 
13
C NMR: δ 159.8, 
151.0, 150.8, 148.6, 145.4, 144.1, 144.0, 143.1, 134.0, 132.2 (q, 
2
JCF = 33 Hz, C-CF3), 130.7, 
130.2, 129.6, 127.1, 126.8, 126.7, 125.4, 124.7, 124.2 (q, 
1
JCF = 271 Hz, CF3),  123.0, 119.5, 
118.4, 118.2 (q, 
3
JCF = 4 Hz),  112.3 (q, 
3
JCF = 4 Hz), 93.9,  56.8, 44.9, 23.3; MS, m/z 490.2 
(M+H)
+
. Succinic salt of 1.6 was prepared in the same way as compound 1.1 by starting with 20 
mg (0.041 mmol) of 1.6 and 4.8 mg (0.040 mmol) of succinic acid. 
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 6-Methoxy-4-methyl-N-(quinolin-8-ylmethyl)-5-(3-trifluoromethylphenoxy) quinolin -
8-amine (1.7).  
N
HN
O
Me
MeOF3C
N
1.7  
Prepared via the same as compound 1.4. Starting from 25.0 mg (0.071 mmol) of compound 1.17 
and 12.2 mg (0.078 mmol) of quinoline-8-caboxaldehyde gave 26.5 mg (76% yield) of 
compound 1.7 as yellow solid. Melting point: 158 - 160 
o
C;  
1
H NMR δ 9.05 (m, 1H), 8.42 (d, J 
= 4.4 Hz, 1H), 8.20 (d, J = 8.4 Hz, 1H), 7.85 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 6.8 Hz, 1H), 7.52 (t, 
J = 7.6 Hz, 1H), 7.47 (dd, J = 7.2, 4.4 Hz, 1H), 7.32 (t, J = 8.4 Hz, 1H), 7.20 (d, 8.4 Hz, 1H), 
7.09 – 7.07 (m, 3H), 6.91 (d, J = 7.2 Hz, 1H), 6.61 (s, 1H), 5.31 (d, J = 6 Hz, 2H, CH2N), 3.65 (s, 
3H, -OMe), 2.61 (s, 3H, Me); 
13
C NMR δ 160.0, 151.2, 149.8, 146.8, 145.0, 144.8, 142.7, 137.0, 
136.7, 134.1, 132.1 (q, 
2
JCF = 32 Hz, C-CF3), 130.2, 128.6, 128.1, 127.4, 126.7, 125.9, 125.2, 
124.5, 124.2 (q, 
1
JCF = 270 Hz, CF3), 121.4, 118.3, 118.1 (q, 
3
JCF = 3 Hz), 112.3 (q, 
3
JCF = 3 Hz), 
93.8, 56.7 (OMe), 43.8 (CH2N), 23.4 (Me);  MS (electrospray), m/z 512.2 (M+Na)
+
, 490.2 
(M+H)
+
. Succinic salt of 1.7 was prepared in the same way as compound 1.1 by starting with 20 
mg (0.041 mmol) of 1.7 and 4.8 mg (0.040 mmol) of succinic acid. 
 N-[6-Methoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinolin-8-yl]furan-2-
carboxamide (1.8). 
N
HN
O
Me
MeOF3C
O
O
1.8  
Furfural (200 mg, 2.1 mmol), selenium dioxide (9 mg, 0.08 mmol) and 280 mg (4.2 mmol) of 50 % 
hydrogen peroxide were mixed with 10 mL THF. This mixture was heated to reflux for 3 hours 
and cooled to room temperature, diluted with 10 mL ethyl acetate. This mixture was washed with 
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5 % aq. sodium hydroxide. Obtained aqueous solution was acidified with 2N HCl to pH = 3 ~ 4 
and extracted with ethyl acetate 3 times. The combined organic layer was washed with water, 
brine, dried with MgSO4 and concentrated to give 2-furoic acid 200 mg (98 % yield) which is 
pure enough to do next step.  
12 mg of 2-Furoic acid (0.11 mmol) was refluxed in 2 mL thionyl chloride under argon. The 
excess thionyl chloride was distilled off under vacuum to give compound 1.18 with quantitative 
yield. Compound 1.18 was dissolved in 1 mL dry THF, and this solution was cooled to -78
o
C.  
To this solution was added compound 1.17 (35 mg, 0.11 mmol) in 1 mL THF. The mixture was 
stirred at -78 
o
C until all the 1.17 was dissolved. Then this solution was warmed to 25 
o
C and 
stirred overnight. . The reaction solution was diluted with aqueous sodium bicarbonate solution, 
and extracted three times with ethyl acetate. The combined extract was washed with water, brine, 
dried (MgSO4), concentrated, and column chromatographed using a mixture of hexane and ethyl 
acetate (1:1) as an eluent to give 30.5 mg (75% yield) of compound 1.8 as a white solid. Melting 
point: 201 - 204
o
C;  
1
H NMR δ 11.0 (s, 1H, -NH), 9.0 (s, 1H), 8.60 (d, J = 4.0 Hz, 1H), 7.65 (s, 
1H), 7.33 (t, J = 7.6 Hz, 1H), 7.28 (d, J = 4.0 Hz, 1H), 7.25 (d, J = 8.9 Hz, 1H), 7.20 (d, J = 3.5 
Hz, 1 H), 7.11 (s, 1H), 6.94 (d, J = 7.4 Hz, 1H), 6.62 (d, J = 3.5 Hz, 1H), 3.91 (s, 3H, OMe), 2.70 
(s, 3H, Me);  
13
C NMR δ 169.3, 159.1, 156.8, 153.4, 150.0, 148.4, 146.6, 145.0, 143.6, 134.3 (q, 
2
JCF = 96 Hz, C-CF3), 131.5, 130.4, 125.4, 125.1, 122.7 (q, 
1
JCF = 278 Hz, CF3), 118.7, 118.3 (q, 
3
JCF = 4 Hz), 115.5, 112.8, 112.4 (q, 
3
JCF = 4 Hz), 105.3, 56.8 (OMe), 23.4 (Me); MS 
(electrospray), m/z 465 (M+Na)
+
, 443.3 (M+H)
+
. Succinic salt of 1.8 was prepared in the same 
way as compound 1.1 by starting with 30 mg (0.068 mmol) of 1.8 and 8.1 mg (0.068 mmol) of 
succinic acid. 
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 8-Amino-4-methyl-5-(3-trifluoromethylphenoxy)quinolin-6-ol (1.19). 
N
NH2
HO
O MeF3C
1.19  
To compound 1.17 (98.2 mg, 0.282 mmol) in 2 ml dried dichloromethane (distilled over calcium 
hydride) at 0 
o
C was added 1 ml 1.0 M BBr3’s dichloromethane solution (4.0 eq); then this 
mixture was warmed to 25
o
C and stirred overnight. The reaction solution was diluted with 
aqueous sodium bicarbonate solution, and extracted three times with dichloromethane. The 
combined extract was washed with water, brine, dried (MgSO4), and concentrated to give 78.2 
mg of compound 1.19 as brown solid which is pure enough for next step. Melting point: 133 - 
135
o
C; 
1
H NMR δ 8.46 (d, J = 4.4 Hz, 1H), 7.38 (t, J = 8.0 Hz, 1H), 7.29 (d, J = 7.2 Hz, 1H), 
7.14 (s, 1H), 7.08 (d, J = 3.6 Hz, 1H), 6.93 (d, J = 7.6 Hz, 1H), 6.73 (s, 1H), 5.40 (bs, 1H, OH), 
5.30 – 5.10 (bs, 2H, NH2), 2.55 (s, 3H); 
13
C NMR δ 159.1, 147.8, 145.4, 144.2, 141.8, 134.9, 
133.1 (q, 
2
JCF = 37 Hz, C-CF3) 130.9, 125.1, 124.5, 124.2, 123.0 (q, 
1
JCF = 270 Hz, CF3), 119.5, 
118.2 (q, 
3
JCF = 4 Hz), 112.5 (q, 
3
JCF = 4 Hz), 100.5, 22.7 (Me); MS (electrospray), m/z 335.1 
(M+H)
+
. 
 8-(4-Hydroxybenzylamino)-4-methyl-5-(3-trifluoromethylphenoxy)quinolin-6-ol (1.9). 
1.9
N
HN
HO
MeOF3C
OH
 
50.0 mg (0.149 mmol) of compound 1.19 was stirred with 20.0 mg (0.163 mmol) of p-
hydroxybenzaldehyde in 2 mL dry methanol for 30 minutes until the solid dissolved. Then 3 
drops of acetic acid was injected, and this brown mixture was stirred for 30 minutes at 25 
o
C. To 
it 28.5 mg (0.450 mmol) of sodium cyanoborohydride were added, the solution was stirred 12 
hours. Yellow solid participated out from the solution. This mixture was diluted with 30 mL of 
aqueous ammonium chloride solution, and extracted three times with ethyl acetate. The 
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combined extract was washed with water, brine, dried (MgSO4), concentrated, and column 
chromatographed using a mixture of hexane and diethyl ether (1:1) as an eluent; the obtained 
product was recrystallized with 2 mL of  hexane and diethyl ether (1:1) to give 34.2 mg (52% 
yield) of compound 1.10 as yellow solid; mp: 194 - 195
o
C;  
1
H NMR (DMSO-d6) δ 9.64 (bs, 1H, 
NH), 9.28 (s, 1H, OH), 8.37 (d, J = 4.0 Hz, 1H), 7.47 (t, J = 8.4 Hz, 1H), 7.28 (d, J = 7.6 Hz, 1H), 
7.20 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 4.4 Hz, 1H), 7.01 (s, 1H), 6.97 – 6.93 (m, 2H), 6.72 (d, J = 
8.4 Hz, 2H), 6.36 (s, 1H), 4.32 (d, J = 6 Hz, 2H), 2.51 (s, 3H, Ar-Me; overlap with DMSO-d6 
signal);  
13
C NMR (DMSO-d6) δ 160.2, 157.1, 149.5, 144.4, 144.37, 141.3, 133.6, 131.6, 130.9 
(q, 
2
JCF = 31 Hz, -C-CF3), 130.1, 129.1 125.5, 124.6, 124.5 (q, 
1
JCF = 270 Hz, CF3), 123.1, 119.5, 
118.3 (q, 
3
JCF = 4 Hz), 115.9, 112.0 (q, 
3
JCF = 4 Hz), 97.2, 46.7 (CH2N), 23.1 (Me); MS 
(electrospray), m/z 441.5 (M+H)
+
. Succinic salt of 1.9 was prepared in the same way as 
compound 1.1 by starting with 30 mg (0.068 mmol) of 1.9 and 8.1 mg (0.068 mmol) of succinic 
acid. 
 4-Acetamino-5-nitro-2-(3-fluorophenyloxy) anisole (1.21). 
NO2
NHAc
O
O
Me
F
1.21  
Mixture of 3-fluorophenol (300.0 mg, 2.678 mmol) and potassium t-butoxide (300.5 mg, 2.678 
mmol) in 10 mL dried t-butanol (distilled over sodium) was stirred at 25 
o
C for 12 hours under 
argon. Then, t-butanol was concentrated off under vacuum to yield the potassium 3-
fluorophenolate as a yellow solid. The yielded 3-fluorophenolate in 4 mL dry DMF (distilled 
over calcium hydride) was added into N-(5-bromo-4-methoxy-2-nitrophenyl)acetamide 1.20 
(722.5 mg, 2.500 mmol) in 4 mL dry DMF at 60 
o
C under argon. Then this solution was stirred 
at 120
o
C for 24 hours. The cooled solution was poured onto ice-water with vigorous stirring. The 
participated solid was collected by filtration and recrystallized with ethanol to give 520.5 mg (65% 
yield) of compound 1.21 as a light yellow solid. Melting point: 125 - 126
o
C; 
1
H NMR δ 10.46 (s, 
1H, NH),  8.37 (s, 1H),  7.78 (s, 1H), 7.37 (td, J =  8.4, 6.4 Hz, 1H), 6.94 (td, J = 7.6, 2.4 Hz, 1H), 
6.89 (dd, J = 8.0, 2.0 Hz, 1H), 6.81 (dt, J = 9.6, 2.4 Hz, 1H), 3.95 (s, 3H, OMe), 2.23 (s, 3H, Me);  
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13
C NMR δ 169.2 (C=O), 164.7 (d, 1JCF = 247 Hz, CF), 156.2 (d, 
3
JCF = 11 Hz), 152.9, 145.7, 
131.141 (d, 
3
JCF = 10 Hz), 131.137, 115.4 (d, 
4
JCF = 3.6 Hz), 112.3 (d, 
2
JCF = 21 Hz), 110.7, 
108.7, 107.8, 107.5, 56.7 (OMe), 25.8 (Me); MS (electrospray), m/z 343.3 (M+Na)
+
. 
 
 4-Acetamino-5-nitro-2-phenyloxyanisole (1.22). 
NO2
NHAc
O
O
Me
1.22  
Prepared via the same procedure as compound 1.21. Potassium phenolate was made from 360 
mg (3.825 mmol) of phenol and 429.3 mg (3.825 mmol) of potassium t-butoxide. Starting from 
the obtained phenolate and compound 1.20 (982 mg, 3.400 mmol) gave 821.0 mg (yield 80%) of 
compound 1.22 as yellow solid. Melting point: 124 - 126
o
C;  
1
H NMR δ 10.46 (s, 1H, NH), 8.25 
(s, 1H), 7.80 (s, 1H), 7.49 - 7.39 (m, 2H), 7.29 - 7.22 (m, 1H), 7.12 - 7.09 (m, 2H), 3.96 (s, 3H, 
OMe), 2.23 (s, 3H, Me); 
13
C NMR δ 169.2, 154.7, 154.3, 145.4, 131.4, 130.4, 125.8, 120.4, 
109.20, 109.18, 108.48, 108.47, 56.7 (OMe), 25.7 (Me); MS (electrospray), m/z 325.3 (M+Na)
+
. 
 4-Amino-5-nitro-2-(3-fluorophenyloxy) anisole (1.23). 
NO2
NH2
O
O
Me
F
1.23  
Compound 1.21 (310.0 mg, 0.968 mmol) was stirred with 35 mL conc. HCl and ethanol (1:7)’s 
solution at reflux for 2 hours. This solution was poured onto ice-water mixture, stirred for 30 
minutes. The resulted solid was collected by filtration, washed with water, vacuum dried to give 
240.3 mg of 1.23 (95 %, yield) as organge solid which is pure enough for next step. Melting 
point: 120 - 121
o
C;  
1
H NMR δ 7.70 (s, 1 H), 7.34 (td, J =  8.4, 6.4 Hz, 1H), 6.92 (td, J = 7.6, 2.4 
Hz, 1H), 6.87 (dd, J = 8.0, 2.0 Hz, 1H), 6.81 (dt, J = 9.6, 2.4 Hz, 1H), 6.13 (s, 1H), 5.96 (s, 2H, 
42 
 
NH2), 3.90 (s, 3H, OMe); 
13
C NMR δ 163.6 (d, 1JCF = 247 Hz, CF), 156.2 (d, 
3
JCF = 10 Hz), 
154.4, 142.2, 141.9, 131.1 (d, 
3
JCF = 10 Hz), 126.7, 115.7 (d, 
4
JCF = 3 Hz), 112.2 (d, 
2
JCF = 20.6 
Hz), 108.3, 107.9 (d, 
2
JCF = 24 Hz), 106.1, 56.6 (OMe);  MS (electrospray), m/z 279.2 (M+H)
+
. 
 4-Amino-5-nitro-2-phenyloxyanisole (1.24). 
NO2
NH2
O
O
Me
1.24  
Prepared via the same procedure as compound 1.23. Deprotection of compound 1.22 (260.0 mg, 
0.839 mmol) gave 213.7 mg (98% yield) of 1.24 as yellow solid. Melting point: 162 - 163
o
C;  
1
H 
NMR δ 7.65 (s, 1H), 7.44 - 7.40 (m, 2H), 7.27 - 7.23 (m, 1H), 7.12 - 7.09 (m, 2H), 6.01 (s, 1H), 
6.10 – 5.3 (bs, 2 H, NH2), 3.92 (s, 3H, OMe);  
13
C NMR δ 155.8, 154.7, 142.1, 142.0, 130.4, 
125.6, 120.8, 108.0, 104.6, 56.6 (OMe); MS (electrospray), m/z 261.2 (M+H)
+
. 
 6-Methoxy-4-methyl-8-nitro-5-(3-fluorophenyloxy)quinoline (1.25). 
NO2
O
O
Me
F
N
Me
1.25  
A mixture of compound 1.23 (240.0 mg, 0.863 mmol) and H3AsO4 (395.2 mg, 1.736 mmol) in 3 
mL 85 % H3PO4 was heated to 120 
o
C.  Methyl vinyl ketone (90.8 mg, 1.290 mmol) was added 
dropwise into this mixture. After stirring for 30 minutes, this dark solution was quickly poured 
onto ice-water mixture. This mixture was basified to pH = ~ 10 with 2N NaOH, and extracted 
with dichloromethane 3 times. The combined extract was washed with water, brine, dried 
(MgSO4), concentrated, and column chromatographed using a mixture of hexane and ethyl 
acetate (2:1) as an eluent to give 99.0 mg (35% yield) of compound 1.25 as brown solid. Melting 
point: 167 - 169
o
C;  
1
H NMR δ 8.76 (d, J = 4.3 Hz, 1H), 7.88 (s, 1H), 7.28 - 7.21, (m, 2H), 6.78 
(td, J = 2.4, 0.16 Hz, 1H), 6.76 - 6.56 (m, 2H), 3.89 (s, 3H, OMe), 2.73 (s, 3H, Me); 
13C NMR δ 
163.9 (d, 
1
JCF = 246 Hz, CF), 159.1 (d, 
3
JCF =10 Hz), 150.9, 148.4, 146.9, 143.9, 140.1, 136.2, 
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130.8 (d, 
3
JCF = 10 Hz), 125.9, 125.3, 111.9, 110.9 (d, 
4
JCF = 3 Hz), 109.7 (d, 
2
JCF = 21 Hz), 
103.3 (d, 
2
JCF = 25 Hz), 57.4 (OMe), 23.4 (Me);  MS (electrospray), m/z 329.3 (M+H)
+
. 
 6-Methoxy-4-methyl-8-nitro-5-phenyloxyquinoline (1.26). 
NO2
O
O
Me
N
Me
1.26  
Prepared via the same procedure as compound 1.25. Starting from methyl vinyl ketone (89.8 mg, 
1.275 mmol), 1.24 (220.0 mg, 0.846 mmol), H3AsO4 (387.0 mg, 1.689 mmol) and 3 mL 85% 
H3PO4 gave 118.0 mg (45 % yield) of compound 1.26 as brown solid. Melting point: 170 - 
172
o
C;  
1
H NMR δ 8.76 (d, J = 4.3 Hz, 1H), 7.88 (s, 1H), 7.28 - 7.21 (m, 2H), 7.22 (d, J = 2.0 Hz, 
1H), 7.05 (t, J = 6.0 Hz, 1H), 6.81 - 6.78 (m, 2H), 3.89 (s, 3H, OMe), 2.73 (s, 3H, Me);  
13
C 
NMR δ 158.0, 150.9, 148.6, 146.5, 144.3, 140.8, 136.4, 130.4, 130.0, 125.8, 125.5, 122.7, 120.8, 
115.2, 112.2, 57.4 (OMe), 23.5 (Me);  MS (electrospray), m/z 311.2 (M+H)
+
.  
 8-Amino-6-methoxy-4-methyl-5-(3-fluorophenyloxy)quinoline (1.27). 
NH2
O
O
Me
F
N
Me
1.27  
 
Compound 1.25 (35.0 mg, 0.106 mmol) and iron powder (33.6 mg, 0.636 mmol) was mixed with 
5 mL aqueous 10 % AcOH solution and heated to reflux for 2 hours. The mixture was cooled to 
25 
o
C and diluted with water. This mixture was firstly extracted with 20 mL THF, then, followed 
by diethyl ether 2 times. The combined organic solution was washed with water and brine, dried 
(MgSO4), concentrated, and column chromatographed using a mixture of hexane and diethyl 
ether (1:1) as an eluent to give 29.0 mg (92% yield) of compound 1.27 as yellow solid. Melting 
point: 146 - 147 
o
C; 
1
H NMR δ 8.45 (d, J = 4.3 Hz, 1H), 7.19 (dd, J = 8.2, 6.6 Hz, 1H), 7.08 (d, J 
= 4 Hz, 1H), 6.8 (s, 1H), 6.67 (td, J = 8.2, 2.3 Hz, 1H), 6.60 (dd, J = 8.2, 2.3 Hz, 1H), 6.48 (dt, J 
44 
 
= 10.9, 2.0 Hz, 1H), 5.15 (bs, 2H, NH2), 3.85 (s, 3H, OMe), 2.62 (s, 3H, Me); 
13
C NMR δ 164.0 
(d, 
1
JCF = 244 Hz), 161.0 (d, 
3
JCF = 10 Hz), 150.7, 145.6, 143.6, 143.0, 134.0, 130.4 (d, 
3
JCF = 9 
Hz), 127.6, 125.1, 124.7, 111.0 (d, 
4
JCF = 3 Hz), 108.4 (d, 
2
JCF = 21 Hz), 102.9 (d, 
2
JCF = 25 Hz), 
98.0, 56.4 (OMe), 22.9 (Me); MS (electrospray), m/z 299.3 (M+H)
+
. 
 8-Amino-6-methoxy-4-methyl-5-phenyloxyquinoline (1.28). 
NH2
O
O
Me
N
Me
1.28  
Prepared via the same procedure as compound 1.27. Starting from compound 1.26 (57 mg, 0.184 
mmol), iron (62.0 mg, 1.100 mmol) and 10 mL aqueous 10% AcOH solution gave 47.4 mg  (92% 
yield) of compound 1.28 as brown solid. Melting point: 145 - 146 
o
C; 
1
H NMR δ 8.44 (d, J = 4.3 
Hz, 1H), 7.26 - 7.20 (m, 2H), 7.03 (dd, J = 4.4, 0.8 Hz, 1H), 6.97 (t, J = 3.6 Hz, 1H), 6.79 - 6.76 
(m, 3H), 5.15 (bs, 2H, NH2), 3.78 (s, 3H, OMe), 2.63 (s, 3H, CH3); 
13
C NMR δ 159.7, 150.8, 
145.5, 143.3, 143.26, 134.1, 129.7, 128.0, 125.0, 124.9, 121.5, 115.0, 98.4, 56.8 (OMe), 23.4 
(Me); MS (electrospray), m/z 281.4 (M+H)
+
. 
 4-Methoxy-2-nitrobenzenamine (1.29) 
NO2
NH2
O
Me
1.29  
N-Acetyl-p-anisidine (2.0 g, 12.0 mmol) was mixed with 20 % nitric acid, and this mixture was 
heated to reflux for 1 h and poured onto the ice-water mixture. After vigorous stirring for 10 
minutes, the solid was collected by filtration to give crude product. The crude product was 
purified by recrystallization in ethanol to give 413 mg (33 % yield) of compound 1.29 as brown 
solid. 
1
H NMR δ 7.54 (d, J = 3.2 Hz, 1H), 7.08 (dd, J = 9.3, 4.3 Hz, 1H), 6.76 (d, J = 9.3 Hz, 1H), 
3.79 (s, 3H); MS, m/z 169.0 (M+H)
+
. 
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 6-methoxy-4-methyl-8-nitroquinoline (1.30). 
NO2
O
Me
N
Me
1.30  
Prepared via the same procedure as compound 1.25. Starting from methyl vinyl ketone (275 mg, 
3.93 mmol), 1.29 (440.0 mg, 2.62 mmol), H3AsO4 (1.20 g, 5.24 mmol) and 12 mL 85% H3PO4 
gave 500.0 mg (87 % yield) of compound 1.30 as brown solid. Melting point: 159 - 162 
o
C; 
1
H 
NMR (CDCl3) δ 8.77 (d, J = 4 Hz, 1H), 7.67 (d, J = 2.8 Hz, 1H), 7.40 (d, J = 2.8 Hz, 1H), 7.33 - 
7.34 (m, 1H), 4.00 (s, 3H, OMe), 2.70 (s, 3H, CH3). 
13
C NMR δ 156.1, 149.9, 143.4, 135.3, 
130.3, 123.8, 115.6, 106.2, 56.4 (OMe), 19.4 (Me); MS (electrospray), m/z 241.0 [M+Na]
+
, 
219.1 [M+H]. 
 8-Amino-6-methoxy-4-methylquinoline (1.31). 
NH2
O
Me
N
Me
1.31  
Prepared via the same procedure as compound 1.27. Starting from compound 1.30 (250 mg, 1.15 
mmol), iron (385.0 mg, 6.88 mmol) and 60 mL aqueous 10% AcOH solution gave 212 mg  (98% 
yield) of compound 1.31 as brown solid. Melting point: 88 - 91 
o
C; 
1
H NMR δ 8.48 (d, J = 4.4 
Hz, 1H), 7.17 (dd, J = 4.4, 0.8 Hz, 1H), 6.59 (d, J =  2.4 Hz, 1H), 6.55 (d, J = 2.4 Hz, 1H), 5.13 
(bs, 2H, NH2), 3.80 (s, 3H, OMe), 2.61 (s, 3H, CH3); 
13
C NMR δ 158.8, 145.8, 144.8, 142.9, 
135.1, 129.9, 122.8, 101.2, 91.5, 55.4 (OMe), 19.4 (Me);. MS (electrospray), m/z 189.3 [M+H]. 
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 4-{[5-(3-Fluorophenoxy)-6-methoxy-4-methylquinolin-8-ylamino]methyl}phenol 
(1.10).  
N
HN
O
Me
MeOF
OH
1.10  
Prepared via the same procedure same as compound 1.5. Starting from compound 1.27 (34.0 mg, 
0.114 mmol) and p-hydroxbenzaldehyde (15.3 mg, 0.125 mmol) gave 29.2 mg (65 %) of 
compound 1.12 as yellow solid. Melting point: 168 - 169 
o
C; 
1
H NMR δ 8.41 (d, J = 4.8 Hz, 1H), 
7.28 (d, J = 8.0 Hz, 2H), 7.19 (dt, J = 8.4, 6.8 Hz, 1H), 7.10 (dd, J = 4.4, 0.8 Hz, 1H), 6.79 (d, J 
= 8.0 Hz, 2H), 6.66 (td, J = 6, 0.4 Hz, 1H), 6.62 (dd, J = 8.4, 0.4 Hz, 1H),  6.51 - 6.49 (m, 3H), 
5.02 (s, 1H, OH), 4.44 (s, 2H, CH2N), 3.79 (s, 3H, OMe), 2.65 (s, 3H, Me); 
13
C NMR  δ 164.0 (d, 
1
JCF = 247 Hz), 161.2 (d, 
3
JCF = 10 Hz), 155.4, 151.2, 145.0, 144.3, 143.4, 133.7, 130.7, 130.4 (d, 
3
JCF = 10 Hz), 129.4, 126.4, 125.2, 124.7, 115.8, 111.0 (d, 
4
JCF = 3 Hz), 108.3 (d, 
2
JCF = 21 Hz), 
103.0 (d, 
2
JCF = 21 Hz), 93.9, 56.8 (OMe), 47.8 (CH2N), 23.4 (Me); MS (electrospray), m/z 
427.1 (M+Na)
+
. Succinic salt of 1.10 was prepared in the same way as compound 1.1 by starting 
with 20 mg (0.047 mmol) of 1.10 and 5.5 mg (0.047 mmol) of succinic acid. 
 4-[(6-methoxy-4-methyl-5-phenoxyquinolin-8-ylamino)methyl]phenol (1.11). 
N
HN
O
Me
MeO
OH
1.11  
Prepared via the same procedure same as compound 1.5. Starting from compound 1.28 (58.0 mg, 
0.207 mmol) and p-hydroxbenzaldehyde (27.8 mg, 0.228 mmol) gave 73.9 mg (84 %) of 
compound 1.11 as yellow solid. Melting point: 181 - 182 
o
C; 
1
H NMR δ 8.41 (d, J = 4.0 Hz, 1H), 
7.31 – 7.23 (m, 4H), 7.08 (d, J = 4.4 Hz, 1H), 6.95 (t, J =7.2 Hz, 1H), 6.81 - 6.79 (m, 4H), 6.54 
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(s , 1H), 6.53 (bs, 1H, OH), 6.08 (bs, 1H, NH), 4.45 (s, 2H, CH2N), 3.79 (s, 3H, OMe), 2.67 (s, 
3H, Me); 
13
C NMR δ 159.8, 155.4, 151.3, 144.9, 144.0, 143.7, 133.8, 130.7, 129.7, 129.4, 126.8, 
125.04, 125.0, 121.4, 115.7, 115.1, 94.32, 94.30, 56.9 (OMe), 47.8 (CH2N), 23.5 (Me); MS 
(electrospray), m/z 409.2 (M+Na)
+
, 387.1 (M+H)
+
. Succinic salt of 1.11 was prepared in the 
same way as compound 1.1 by starting with 20 mg (0.052 mmol) of 1.11 and 6.1 mg (0.052 
mmol) of succinic acid. 
 8-Amino-6-methoxy-4-methylquinoline (1.12). 
N
HN
O
Me
Me
OH
1.12  
Prepared via the same procedure same as compound 1.5. Starting from compound 1.31 (100.0 
mg, 0.532 mmol) and p-hydroxbenzaldehyde (71.4 mg, 0.585 mmol) gave 114.2 mg (73%) of 
compound 1.12 as yellow solid. Melting point: 164 
o
C; 
1
H NMR δ  8.43 (d, J = 4.4 Hz, 1H), 7.24 
(d, J = 8.0 Hz, 2H), 7.20 (d, J = 4.0 Hz, 1H), 6.76 (d, J = 8.4 Hz, 2H), 6.46 (d, J = 2.8 Hz, 1H), 
6.43 (bs, 1H, -OH), 6.34 (d, J = 1.6 Hz, 1H), 6.07 (bs, 1H, -NH), 4.38 (d, J = 4.8 Hz, 2H), 3.90 (s, 
3H, -OMe), 2.62 (s, 3H, Ar-Me); 
13
C NMR δ 159.4, 155.4, 146.2, 144.2, 143.4, 134.8, 130.8, 
129.9, 129.3, 122.9, 115.6, 97.2, 89.3, 55.4, 47.5, 19.5 ; MS, m/z 295.2 (M+H)
+
. Succinic salt of 
1.12 was prepared in the same way as compound 1.1 by starting with 20 mg (0.068 mmol) of 
1.12 and 8.1 mg (0.068 mmol) of succinic acid. 
 
 6-Methoxy-8- (3-phtalimidopropylamino)-4-methyl-5-(3-fluorophenyloxy)quinoline 
(1.33). 
N
HN
O
Me
O Me
N
O
O
F
1.33  
48 
 
The solution of compound 1.27 (25.0 mg, 0.084 mmol), 3-iodopropylphthalimide (26.0 mg, 
0.084 mmol) and NaHCO3 (7.0 mg, 0.084 mmol) mixed with 0.5 mL dry DMF (distilled over 
calcium hydride) under argon. This mixture was heated to 80 
o
C for 48 hours. After cooling to 25 
o
C, this mixture was diluted with water, extracted with ethyl acetate 3 times, washed with water, 
brine, dried (MgSO4), concentrated, and column chromatographed using a mixture of hexane and 
diethyl ether (1:1) as an eluent to recover 13.5 mg of compound 1.27 and give 17.0 mg (85% 
yield, basing on recovered compound 1.27) of compound 1.33 as yellow solid. Melting point: 
146 - 147 
o
C; 
1
H NMR δ 8.36 (d, J = 4.3 Hz, 1H), 7.86 - 7.82 (m, 2H), 7.73 - 7.69 (m, 2H), 7.18 
(dt, J = 7.2, 6.4 Hz, 1H), 7.04 (d, J = 4 Hz, 1H), 6.65 (td, J = 8.2, 2.3 Hz, 1H), 6.60 (dd, J = 8.2, 
2.3 Hz, 1H), 6.52 (bs, 1H, -NH), 6.50 - 6.42 (m, 2H), 3.91 (t, J = 6.7 Hz, 2H, CH2N), 3.83 (s, 3H, 
OMe), 3.43 (q, J = 5.4 Hz, 2H, CH2N), 2.60 (s, 3H, Ar-Me), 2.19 (pent, J = 7.0 Hz, 2H, CH2); 
13
C NMR δ 168.7 (C=O), 163.9 (d, 1JCF = 244 Hz), 161.2 (d, 
3
JCF = 10 Hz), 151.1, 144.9, 144.3, 
142.8, 134.2, 132.3, 130.4 (d, 
3
JCF = 10 Hz), 126.1, 125.1, 124.5, 123.5, 111.0 (d, 
4
JCF = 3 Hz), 
108.3 (d, 
2
JCF = 21 Hz), 102.9 (d, 
2
JCF = 25 Hz), 93.1, 56.9 (OMe), 41.2 (CH2N), 36.2 (CH2N), 
28.2 (CH2), 23.3 (Me); MS (electrospray), m/z 508.2 (M+Na)
+
, 486.2 (M+H)
+
.  
 6-Methoxy-8- (3-phtalimidopropylamino)-4-methyl-5-phenyloxyquinoline (1.34). 
N
HN
O
Me
O Me
N
O
O
1.34  
Prepared via the same procedure as compound 1.33. Starting from compound 1.28 (37.0 mg, 
0.133 mmol), 3-iodopropylphthalimide (41.0 mg, 0.133 mmol) and NaHCO3 (12.0 mg, 0.133 
mmol)  gave 17.3 mg (89 % yield, basing on the recovered compound 1.28 ) of compound 1.34 
and recovered compound 1.28 27.1 mg. Melting point: 164 - 165 
o
C; 
1
H NMR δ 8.36 (d, J = 4.3 
Hz, 1H), 7.85 - 7.82 (m, 2H), 7.72 - 7.69 (m, 2H), 7.23 (t, J = 7.4 Hz, 1H), 7.01 (d, J = 4.3 Hz, 
1H), 6.93 (t, J = 7.4 Hz, 1H), 6.77 (d, J = 8.6 Hz, 2H), 6.49 - 6.46 (m, 2H), 3.91 (t, J = 6.6 Hz, 
2H, CH2N), 3.83 (s, 1H, OMe), 3.43 (q, J = 7.0 Hz, 2H, CH2N), 2.61 (s, 3H, Ar-Me), 2.20 (pent, 
J = 7.0 Hz, 2H, CH2); 
13
C NMR δ 168.7, 159.8, 151.2, 144.9, 144.0, 143.0, 134.2, 134.0, 132.3, 
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129.7, 126.5, 125.0, 124.8, 123.5, 121.4, 115.1, 93.4, 57.0 (OMe), 41.2 (CH2N), 36.2 (CH2N), 
28.2 (CH2), 23.3 (Me); MS (electrospray), m/z 468.3 (M+H)
+
. 
 2-[3-(6-Methoxy-4-methylquinolin-8-ylamino)propyl]isoindoline-1,3-dione (1.35). 
N
HN
O
Me
Me
N
O
O
1.35  
Prepared via the same procedure as compound 1.33. Starting from compound 1.31 (70.0 mg, 
0.372 mmol), 3-iodopropylphthalimide (115.0 mg, 0.372 mmol) and NaHCO3 (31.0 mg, 0.372 
mmol) gave 57.3 mg (86 % yield, basing on the recovered compound 1.31 ) of compound 1.35 
and recovered compound 1.31 35.5 mg. 
1H NMR δ 8.40 (d, J = 4.3 Hz, 1H), 7.88 - 7.80 (m, 2H), 
7.72 – 7.65 (m, 2H), 7.14 (d, J = 3.8 Hz, 1H), 6.41 - 6.40 (m, 2H, ArH & NH), 6.28 (d, J = 2.3 
Hz, 1H), 3.91 (s, 3H, OMe), 3.87 (t, J = 6.6 Hz, 2H, CH2N), 3.36 (q, J = 6.6 Hz, 2H, CH2N), 
2.59 (s, 3H, CH3), 2.13 (pent, J = 7.0 Hz, 2H, CH2); 
13C NMR δ 168.7 (CO), 159.3, 146.3, 144.3, 
142.8, 135.0, 134.2, 132.3, 129.7, 123.5, 122.9, 96.4, 89.0, 55.4 (OMe), 40.9 (CH2N), 36.2 
(CH2N), 28.1 (CH2), 19.5 (Me); MS (electrospray), m/z 398.0 [M+Na]
+
, 376.3 [M+H]
+
. 
 3-[6-Methoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinolin-8-
ylamino]propanamide (1.13). 
N
HN
O
Me
MeOF3C
NH2
O
1.13  
Compound 1.17 (70.0 mg, 0.201 mmol) and acrylamide (14.3 mg, 0.201 mmol) was dissolved in 
3 mL acetonitrile in a sealed tube. The system was degased with argon and heated to 120 
o
C for 
30 hours. The solvent was concentrated off, and residue was directly column chromatographed 
using a mixture of hexane and diethyl ether (1:1) as an eluent to give 48.2 mg (57% yield) of 
compound 1.13 as a light brown solid. Melting point: 170 - 172
o
C;  
1
H NMR δ 8.40 (d, J = 4.4 
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Hz, 1H), 7.33 (t, J = 8.0 Hz, 1H), 7.20 (d, J = 7.6 Hz, 1H), 7.08 – 7.05 (m, 2H), 6.93 (d, J = 8.0 
Hz, 1H), 6.58 – 6.49 (m, 2 H), 5.75 (broad s, 1H, NH), 5.56 (broad s, 1H, NH), 3.83 (s, 3H, 
OMe), 3.71 (t, J = 6.4 Hz, 2H, CH2N), 2.72 (t, J = 6.4 Hz, 2H. CH2CO), 2.61 (s, 3H, Me); 
13
C 
NMR δ 173.6, 159.8, 151.0, 145.2, 144.2, 142.8, 134.0, 132.1 (q, 2JCF = 32 Hz, C-CF3), 130.2, 
126.3, 125.4, 124.6 124.1 (q, 
1
JCF = 268 Hz, CF3), 118.4, 118.2 (q, 
3
JCF = 4 Hz), 112.2 (q, 
3
JCF = 
4 Hz), 93.7, 56.9 (OMe), 39.9 (CH2), 35.7 (CH2), 23.3 (Me); MS (electrospray), m/z 442.6 
(M+Na)
+
, 420.4 (M+H)
+
. Succinic salt of 1.13 was prepared in the same way as compound 1.1 
by starting with 40 mg (0.095 mmol) of 1.13 and 11.2 mg (0.095 mmol) of succinic acid. 
 6-Methoxy-8-[(3-aminopropyl)amino]-4-methyl-5-(3-fluorophenyloxy)quinoline (1.14). 
N
HN
O
Me
MeOF
NH2
1.14  
Compound 1.33 (17.0 mg, 0.035 mmol) in 6 mL 20 % hydrazine in ethanol’s solution was heated 
to reflux overnight. After concentrating ethanol off, the residue was diluted with 10 % aqueous 
K2CO3 solution, extracted with dichloromethane 3 times, dried over K2CO3, concentrated and 
column chromatographed using a mixture of dichloromethane and methanol (4:1) as an eluent to 
give 7.5 mg (58% yield) of compound 1.14 as yellow solid. Melting point: 96 - 97 
o
C; 
1
H NMR δ 
8.38 (d, J =  4.4 Hz, 1H), 7.18 (dt, J =8.0, 7.6 Hz, 1H), 7.05 (d, J = 4.3 Hz, 1H), 6.66 (td, J =  8.2, 
2.3 Hz, 1H), 6.61 (dd, J = 8.2, 2.3 Hz, 1H), 6.58 - 6.46 (m, 2H), 6.41 (bs, 1H), 3.85 (s, 3H, OMe), 
3.42 (t, J = 6.6 Hz, 2H, CH2N), 3.00 (t, J = 7.0 Hz, 2H, CH2N), 2.66 (bs, 2H, NH2), 2.60 (s, 3H, 
Ar-Me), 2.17 (pent, J = 6.6 Hz, 2H); 
13
C NMR δ 164.0 (d, 1JCF = 243 Hz), 161.3 (d, 
3
JCF = 10 
Hz), 151.2, 144.9, 144.6, 142.9, 133.9, 130.5 (d, 
3
JCF = 10 Hz), 126.1, 125.2, 124.6, 111.0 (d, 
4
JCF = 3 Hz), 108.3 (d, 
2
JCF = 22 Hz), 102.8 (d, 
2
JCF =  25 Hz), 93.2, 56.9 (OMe), 41.4 (CH2N), 
40.5 (CH2N), 32.2 (CH2), 23.1 (Me); MS (electrospray), m/z 356.2 (M+H)
+
. Succinic salt of 1.14 
was prepared in the same way as compound 1.1 by starting with 5 mg (0.014 mmol) of 1.14 and 
1.6 mg (0.014 mmol) of succinic acid. 
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 6-Methoxy-8-[(3-aminopropyl)amino]-4-methyl-5-phenyloxyquinoline (1.15). 
N
HN
O
Me
MeO
NH2
1.15  
Prepared via the same procedure same as compound 1.11. Starting from compound 1.34 (17.3 
mg, 0.036 mmol) gave 7.2 mg (59% yield) of compound 1.15 as yellow solid. Melting point: 130 
- 131 
o
C; 
1H NMR δ 8.33 (d, J = 4.3 Hz, 1H), 7.21 (t, J = 8.6 Hz, 2H), 6.98 (d, J =4.4 Hz, 1H), 
6.92 (t, J = 8.6 Hz, 1H), 6.75 (d, J = 8.6 Hz, 2H), 6.49 (s, 1H), 6.30 (bs, 1H, NH), 4.35 (bs, 2H, 
NH2), 3.81 (s, 3H, OMe), 3.42 (t, J = 6.2 Hz, 2H, CH2N), 3.10 (t, J = 6.6 Hz, 2H, CH2N), 2.60 (s, 
Ar-Me), 2.11 (pent, J = 6.2 Hz, 2H, CH2); 
13
C NMR δ 159.8, 151.3, 144.9, 144.1, 143.3, 133.9, 
129.7, 126.7, 125.0, 124.9, 121.4, 115.0, 93.9, 57.1 (OMe), 41.2 (CH2N), 39.4 (CH2N), 29.9 
(CH2), 23.4 (Me); MS (electrospray), m/z 338.1 (M+H)
+
. Succinic salt of 1.15 was prepared in 
the same way as compound 1.1 by starting with 5 mg (0.015 mmol) of 1.15 and 1.8 mg (0.015 
mmol) of succinic acid. 
 6-Methoxy-8-[(3-aminopropyl)amino]-4-methylquinoline (1.16). 
N
HN
O
Me
Me
NH2
1.16  
Prepared via the same procedure same as compound 1.11. Starting with compound 1.35 (20 mg, 
0.093 mmol) gave compound 1.16 12.1 mg (56 %, yield) as yellow oil. 
1H NMR δ 8.41 (d, J = 
4.3 Hz, 1H), 7.16 (d, J = 4.6 Hz, 1H), 6.42 (d, J = 2.3 Hz, 1H), 6.32 (d, J = 2.3 Hz, 1H), 6.27 (bs, 
1H, NH), 3.92 (s, 3H, OMe), 3.35 (t, J = 6.3 Hz, 2H, CH2N), 2.90 (t, J =7.0 Hz, 2H, CH2N), 2.59 
(s, 3H, Me), 1.92 (pent, J = 6.6 Hz, 2H, CH2); 
13C NMR δ 159.2, 146.6, 144.2, 142.9, 135.0, 
129.7, 122.9, 96.3, 88.8, 55.4 (OMe), 41.3 (CH2N), 40.4 (CH2N), 33.0 (CH2), 19.5 (Me); MS 
(electrospray), m/z 245.2 (M+H)
+
. Succinic salt of 1.16 was prepared in the same way as 
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compound 1.1 by starting with 10 mg (0.041 mmol) of 1.16 and 4.8 mg (0.040 mmol) of succinic 
acid. 
Procedure for enzyme inhibition assays 
PKC assays:  Enzyme (PKC) was incubated with substrate (P-L-S-R-T-L-S-V-A-A-K, c = 0.4 
μg/μl in H2O), the activator solution (1 mg/ml phosphatidylserine in water), substrate protection 
solution, and the test compounds (inhibitors) in the buffer solution (100 mM HEPES, 6.5 mM 
CaCl2, 5 mM DTT, 50 mM MgCl2, and 5 mM ATP) at 30 
o
C for 45 minutes. The system was 
warmed to 100 
o
C for 10 minutes to stop the enzyme reaction, and the reaction was loaded into 
the agarose gel placed in a horizontal gel electrophoresis chamber. The electrophoresis was 
carried out for 30 minutes at 100 V. The photograph of the gel was taken under UV by Kodak 
Gel Logic 1500 Digital Imaging System, and quantification of both phosphorylated and 
nonphosphorylated substrates were carried out by Imagequant 5.2 software (Molecular 
Dynamics/Amersham Biosciences). 
GSK-3β assays.  Enzyme (GSK-3) was incubated with substrate, ATP, and the test compound 
for 40 minutes at room temperature. Then, an equal amount of ADP-Glo™ Reagent was 
introduced into the reaction mixture and incubated at room temperature for 40 minutes. 10 μL of 
kinase detection reagent was added and incubated at room temperature for further 30 minutes. 
The luminescence of the mixture was measured using a Glo Max multi detection luminometer. 
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Chapter 2 - Progress on total synthesis of (+)-Myriceric acid (A) 
 2.1 Introduction   
2.1.1 Endotheline-1 peptide and bio-activity, isolation and structure characterization of (+)-
myriceric acid A 
In 1988, a vasoconstrictor peptide was isolated from the culture supernatant of porcine 
endothelial cell (EC) by Yanasigawa et al., which is now known as endothelin-1 (ET-1).
1 
The 
structure of ET-1 was determined by the same group and shown in Figure 2.1.
1
 ET-1 is 21-
residue peptide which contains four cysteines. It has a fused bicyclic structure which is built up 
by two disulfide bridges
 
(Cys1-Cys15 and Cys3-Cys11) and essential for ET-1’s activity. 
Destruction of this bicyclic structure led the ET-1 to be inactive.
2
  
Figure 2.1 : Structures of ET-1
1 
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The ET-1 preferring vasoconstrictory receptor, which is termed as ETA receptor, was 
firstly identified by DNA-cloning and expression methodology from bovine lung.
3
 Bovine’s ETA 
receptor is found in vascular smooth muscle cells and contains 427 amino acids, and its 
molecular mass is about 48.5 kilodaltons.
3
 It is considered as the member of the superfamily of 
G-protein coupled receptors (GPCR) because of their high homology in the transmembrane 
domains.
2 
 Till now, no crystal structure of human ETA receptor is reported.  
Signal transduction for vascular constriction starts from the binding of ET-1 to ETA on 
the membrane of vascular muscle cell.
4
 This binding could increase the formation of inositol 
triphosphate (IP3) in the vascular muscle cell, and the elevated level of IP3 could stimulate the 
sarcoplasmic reticulum (SR) to release calcium into cytoplasm. The increased cytosolic 
concentration of free calcium eventually induces the vasoconstriction (Figure 2.2). 
4,5
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Figure 2.2 : Vascular signal transduction for constriction
4
 
 
ET-1 is known as the most potent mammalian vasoconstrictor peptide (EC50 = 4.0 ± 2.2 × 
10
-1 
nM in porcine right proximal coronary artery assay) and characterized by its long lasting 
vasoconstriction effect and high difficulty in rinsing out from the system. ET-1 induced 
vasoconstriction is closely associated with calcium ion concentration; vasoconstriction could not 
occur in calcium-free environment or significantly reduced in the presence of calcium channel 
blocker. 
1 
Studies indicates that ET-1 and/or its receptors are involved in many cardiovascular 
diseases such as: heart failure, coronary vasospasm and hypertension.
4
 Applications of ET-1 
receptor antagonists gave promising therapeutic effects on these diseases.
2,4
 For example, 
Bosentan,  a non-selective ET-1 receptor antagonist, is in market for pulmonary hypertension
 
(Figure 2.3).
4
 However, because of the strong side effects of these drugs, for example, the 
hepatotoxicity from Bosentan, the discovery of new ET-1 receptor antagonist with less toxicity 
and higher efficiency have been continued.  
Figure 2.3 : Structure of Bosentan
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In 1996, Sakurawi, K. et al. found that the methanol extract of fresh Myrica cerifera’s 
twigs could prevent the ET-1-induced cytosolic free calcium concentration increase in rat aortic 
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smooth muscle A7r5 cells with IC50 of 35 g/mL.
6
 Further purification gave a more active 
fraction (IC50 = 0.11 g/mL).
6
 At last, a pure compound was obtained by semi-preparative 
reverse phase high performance liquid chromatography (HPLC).
6
 This compound inhibits not 
only on ET-1 induced cytosolic calcium concentration increase (IC50 = 0.0075 g/mL) but also 
specifically antagonized ET-1’s binding to ETA (IC50 = 0.04 g/mL).
6
 This compound is now 
known as myriceric acid A.  
The structure of myriceric acid A was proposed on the results from high resolution mass 
spectrometry, 
1
H NMR and 
13
C NMR.
6
 Myriceric acid A showes a mass of 632.3715, and its 
molecular formula is calculated as C39H52O7. Results of NMR experiments indicates the existing 
of a trans-caffeoyl group and a triterpene moiety (Figure 2.4).  
Figure 2.4 : Structure of myriceric acid A
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Isolated myriceric acid A was methylated by diazomethane, and the caffeoyl acid ester 
was hydrolyzed off by sodium hydroxide to give ester alcohol 2.1. Compound 2.1 was acetylated 
by acetic anhydride to form the diester 2.2 which is crystalline solid (Scheme 2.1).
6
  
Scheme 2.1 : Synthesis of compound 2.2
6
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The crystal structure of 2.2 is resolved by X-ray analysis and shown in Figure 2.5. The 
absolute configuration of compound 2.2 was assigned according to the positive Cotton effect in 
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the circular dichroism (CD) experiment.
6,7
 This X-ray structure plus NMR experiments results 
confirmed the structure of myriceric acid A. 
Figure 2.5 : Crystal structure of compound 2.5
6 
 
2.1.2 Semi-synthesis of myriceric acid A 
The semi-synthesis of myriceric acid A was accomplished in 1997 by Konoike, T. et al..
8
 
This partial synthesis used oleanolic acid as the starting material via 14 steps to give final 
product myriceric acid A. The retro-synthetic analysis is shown in Scheme 2.2.
8
 As the authors 
mentioned in the article, direct acylation of 27-hydroxy group with caffeic acid could not be 
achieved with  an acceptable yield; hence, final product myriceric acid A was prepared from 
compound 2.3 in alternative strategy. Compound 2.3 could be converted from compound 2.4, 
and compound 2.4 was derived from oleanolic acid. 
Scheme 2.2 : Retro-synthetic analysis of partial synthesis of myriceric acid A
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The semi-synthesis of myriceric acid started with the oxidation of the 3-hydroxy group in 
oleanolic acid (500 mg, $309.00 form Sigma-Aldrich). Jones oxidation of oleanolic acid gave 
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compound 2.5. Olefin functionality in 2.5 was epoxidized by ozone, and the epoxide ring was 
opened by the attack of carboxylate nearby to give lactone 2.6 in one pot. Compound 2.6 was 
treated with nitrosyl chloride to form the unstable nitrite 2.7. Light irradiation of 2.7 gave desired 
product compound 2.8 via Barton reaction
9
 (Scheme 2.3). 
Scheme 2.3 : Partial synthesis of myriceric acid A (Part 1)
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Ozone is a strong oxidizing reagent, and, in most cases, ozone reacts with olefin to form 
the trioxolane. The dissect of O-O bond in trioxolane yields the carbonyl compound to furnish 
the olefin cleavage. However, for olefin with strong steric hindrance, the epoxidation to the 
double bonds by ozone is preferred, and this is called “partial cleavage” of the olefin.10 
The mechanism of Barton’s reaction is described herein to explain the transformation 
from compound 2.7 into 2.8.
9 
Under the light irrigation, nitrosol moiety could be decomposed to 
give oxygen radical and nitric oxide radical. The formed oxygen radical abstract the hydrogen to 
give the hydroxyl group and hydrocarbon radical. This hydrocarbon radical reacts with the nitrc 
oxide radical nearby to form new nitroso compound which could be epimerized to oxime. 
Scheme 2.4 : Barton’s reaction mechanism 
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Reduction of oxime 2.8 with titanium trichloride gave imine 2.9. This imine was highly 
stable because of the “shielding” effect given by the pentacyclic structure, and the hydrolyzation 
of this imine was furnished by sodium nitrite in acetic acid. The mechanism was probably via an 
hydroxyl-azoimine intermediate (-C=N=N-OH), and this azoimine hydrolyzed readily to give 
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aldehyde 2.11. However, partial of the formed aldehyde 2.11 reacted with nearby hydoxy group 
to give acetal 2.10. This acetal 2.10 was hydrolyzed under basic condition to regenerate aldehyde 
2.11. C3-carbonyl group in 2.11 was then protected with ethylene glycol to give acetal 2.12, and 
acetylation of C12-hydroxy group in 2.12 was carried out with acetic anhydride in pyridine to 
give 2.13. 12-13 Olefin regeneration and aldehyde reduction in 2.14 was achieved by lithium 
ammonia reductive elimination. The mechanism of this step was discussed in the paper. Authors 
indicated that the aldehyde functionality acted as “electron transporter” in this process. It initially 
obtained electrons from lithium and, then, transferred them to the 12-carbon to reduce the acetate 
off. The formed anion underwent elimination of the lactone, and the aldehyde was reduced then 
to give desired 2.14 (Scheme 2.5).
8
 
Scheme 2.5 : Partial synthesis of myriceric acid A (Part 2)
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It’s worthy to note that the reactivity relationships between 27- position C-H and 12-
position C-H. The intramolecular reactions between these two positions are much easier to 
proceed because a six-member ring transition state is readily achieved to facilitate the reaction 
(Figure 2.6). Examples are Barton’s reaction9 and the transformation of 2.14 from 2.13. This 
interesting discovery could be applied into the total synthesis of myriceric acid A.  
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Figure 2.6 : Intramolecular six-member ring transition state  
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Compound 2.14 was treated with 2 N HCl to give ketone 2.15. The installation of 27-
position caffeic acid ester was furnished in three steps by starting with 2.15 via Horner-
Wadsworth-Emmons (HWE) olefination reaction. Alcohol 2.15 was firstly treated with 
diethylphosphonoacetic acid and carbonyldiimidazole (CDI) to give the ester 2.3. Ester 2.3 
reacted with benzaldehyde 2.16 to give 2.17 readily. Deprotection of 2.17 with trifluoroacetic 
acid finally gave desired product myriceric acid A (Scheme 2.6).
8 
 Scheme 2.6 : Partial synthesis of myriceric acid A (Part 3)
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2.1.3 Importance of total synthesis of myriceric acid A 
The semi-synthesis of myriceric acid A was accomplished;
8
 however, so far, no total 
synthesis of myriceric acid A has been reported, and  this work is still highly needed for the 
following reasons. 
Firstly, total synthesis of myriceric acid A will led to the intermediates and/or compounds 
derived from it to assist the study of its structure-activity relationship (SAR). As mentioned 
above, myriceric acid A is a non-peptide ET-1-specific antagonist in the reported natural 
products, and it has great potential in the treatment of ET-1 and/or ET-1 receptor related diseases, 
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such as: heart failure and pulmonary hypertension
3
. Hence, the study of its SAR will not only 
provide information to disclose the therapeutic mechanism but also lead to the development of 
more potent drug candidates. Unlike total synthesis, the partial synthesis of myriceric acid A 
only gave compounds with very limited numbers and structural varieties which is not enough for 
SAR study; however, as depicted in Figure 2.7 below, many useful and interesting intermediates 
and novel compounds could be synthesized via the methodology for the total synthesis of 
myriceric acid A and used for the SAR study. 
Figure 2.7 : Intermediates could be synthesized in total synthesis of myriceric acid A 
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Secondly, total synthesis of myriceric acid A may provide a protocol to synthesize other 
triterpene-type natural products.  As the largest group of the isolated compounds in the natural 
products, triterpene-type natural products are reported to have various novel biological properties, 
such as antioxidant, antibiotic, anticancer activities, etc..
11
 However, the applications of these 
compounds are limited because of their low availability from natural sources. Therefore, 
obtaining triterpene-type natural products via chemical method is one of possible solutions to 
solve this problem. The methods developed to construct the triterpene skeleton and modify the 
functionalities in the total synthesis of myriceric acid A could also be used to synthesis of other 
triterpene compounds directly or after modification. Hence, the protocol for synthesis of similar 
type of triterpene compounds can be developed based on the achievement of the total synthesis 
of myriceric acid A. The semi-synthesis method for myriceric acid A which started from 
63 
 
oleanolic acid could only be used to synthesize myriceric acid and only suitable for a limited 
number of triterpene compounds (Figure 2.8).
11 
Figure 2.8 : Few examples of the reported triterpene-type natural products
11
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2.1.4 Progress made by Angelo Aguilar
12
 
This project was initially carried out by a former graduate student, Dr. Angelo Aguilar, in 
Hua’s laboratory.12 His work will be briefly introduced in this section.  
Initially, 2-methyl-1,3-cyclohexanedione was treated with ethyl vinyl ketone to give a 
Michael addition product 2.27 in a quantitative yield. Then enantio-selective intramolecular aldol 
condensation was carried out with ketone 2.27, D-phenylalanine and D-camphorsulfonic acid 
(D-CSA) to give two ring enone-ketone (-)-2.28 with 95%ee. Selective reduction of (-)-2.28 with 
0.25 eq. sodium borohydride gave alcohol (-)-2.29 in high yield (Scheme 2.7). 
Scheme 2.7 : Progress made by Aguilar (Part 1)
12
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Robinson annulation of alcohol (-)-2.29 with ethyl vinyl ketone was carried out by using 
sodium methoxide as base to give three ring compound (+)-2.30 in 68% yield. Optical rotation of 
the obtained (+)-2.30 was taken and compared with the value of enantiomerically pure 
compound, which indicated 48%ee of optical purity. Optically impure enone (+)-2.30 was 
reduced by lithium-liquid ammonia, the generated enolate was trapped by methyl iodide to give 
ketone (+)-2.31. Ketone (+)-2.31 was treated with ethylene glycol and pyridinium p-
toluenesulfonate (PPTS) to give the protected compound (-)-2.32. Alcohol (-)-2.32 was oxidized 
by 2-iodoxybenzoic acid (IBX) to give three ring ketone (-)-2.33 (Scheme 2.8). 
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Scheme 2.8 : Progress made by Aguilar (Part 2)
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   To activate the carbonyl’s -H, ketone (-)-2.33 was treated lithium diisopropylamide 
(LDA) and diphenyldisulfide to yield sulfide (+)-2.34. Compound (+)-2.34 then underwent 
Michael addition reaction with methyl vinyl ketone to give (-)-2.35. Removal of the 
phenylsulfide in (-)-2.35 was achieved by the radical reduction reaction with 
azobisisobutyronitile (AIBN) and tributyltin hydride to form a mixture of (-)-2.36 and (-)-2.37. 
Intramolecular aldol condensation of (-)-2.37 furnished the ring formation to yield four ring 
compound 2.38. However, compound (-)-2.36 could not undergo the same aldol condensation to 
give tetracyclic compound. The reason might be the C8-methyl group blocks the enolate of 
methyl ketone attacking the carbonyl from the top face. Stirred with sodium methoxide in 
methanol, compound (-)-2.36 could be transferred into compound (-)-2.37 and finally gave to 
same cyclized compound (-)-2.38 (Scheme 2.9). 
Scheme 2.9 : Progress made by Aguilar (Part 3)
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Sodium nitrile was introduced to enone (-)-2.38 to give a Michael addition product (-)-
2.39, then, enol silyl ether (-)-2.40 was obtained by treating ketone (-)-2.39 with t-
butyldimethylsilyl triflate (TBS-OTf) and triethyl amine. The nitrile in (-)-2.40 was reduced to 
imine 2.41 with diisopropyl aluminum hydride (DIBAL-H). Removal of t-butyldimethylsilyl 
group in 2.41 with tetrabutylammonium fluoride (TBAF) gave hemiaminal 2.42. Under acidic 
condition, hemiaminal 2.42 was hydrolyzed to give aldehyde ketone 2.43 (Scheme 2.10). 
Scheme 2.10 : Progress made by Aguilar (Part 4)
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No further progress was made by Dr. Angelo Aguilar because of the available time, and 
this project was continued by me during my Ph.D period research. The progress I made will be 
introduced and discussed in the following sections. 
 2.2 Retro-synthetic analysis of myriceric acid A 
To get a better understanding and more rational design of this project, retro-synthetic 
analysis was conducted and is descripted in this section. 
Since the synthetic route from compound 2.14 to myriceric acid A have already been 
reported in the partial synthesis of myriceric acid A (Scheme 2.6)
8
, the target molecule of this 
project could be compound 2.14.  Compound 2.14 could be synthesized from compound 2.44 via 
several steps: deoxygenantion of the C16-carbonyl group to methylene, reduction of the C14-
nitrile into alcohol, and the elimination to give 12-13 olefin. Compound 2.44 could be obtained 
from (+)-2.45 after the 17-position -keto-ester formation, 13-position allylic functionalization 
and Michael addition of enone. D, E rings in (+)-2.45 could be constructed via an aldol 
condensation-Michael addition-aldol condensation sequence by using three ring compound (-)-
2.33 and novel keto-aldehyde 2.46 as the starting materials.  Compound (-)-2.33 could be formed 
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from (-)-2.29 via A-ring formation, reductive methylation and functional group interconversion 
(FGI) steps. A new method was developed to solve the problem of getting low enantio-excess of 
the (-)-2.33, and this method will be discussed in the following section. Two ring compound (-)-
2.29 could be synthesized form 1,3-cyclohexanedione. 
Figure 2.9 : Retro-synthesis of 2.14 
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 2.3 Preparation of starting materials for asymmetric synthesis of B, C-ring  
Transformation from 2-methyl-1,3-cyclohexanedione to keto-alcohol (-)-2.29 was 
accomplished by following the Aguilar’s procedure,12 and this section introduces the preparation 
of the starting materials for synthesis of compound (-)-2.29 (Figure 2.10). 
Figure 2.10 : Transformation from 1,3-cyclohexanedione to (-)-2.29 
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According to the literature,
13
 1,3-cyclohexanedione was treated with iodomethane in 
aqueous NaOH solution at 65 
o
C for 1 day to yield the 2-methyl-1,3-cyclohexanedione in high 
yield (Scheme 2.11). 
Scheme 2.11 : Synthesis of 2-methyl-1,3-cyclohexanedione 
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Another required starting material for synthesizing C ring, ethyl vinyl ketone, was 
prepared in 3 steps. This synthesis started with the protection of 3-pentanone with ethylene 
glycol, and the generated acetal was treated with bromine in one pot to give bromide 2.47.
14
 The 
elimination of bromide in 2.47 with sodium hydroxide in methanol generated alkene 2.48.
15 
Removal of the acetal group in 2.48 with catalytic amount of p-toluenesulfonic acid (PTSA) 
gave pure ethyl vinyl ketone (Scheme 2.12). 
Scheme 2.12 : Synthesis of ethyl vinyl ketone 
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With ethyl vinyl ketone and 2-methyl-1,3-cyclohexandione, the two ring enone alcohol  
(-)-2.29 was prepared utilizing the same method as Aguilar
12
 did (Scheme 2.7).  Mechanism for 
the asymmetric intramolecular cyclization to construct C-ring was discussed in Aguilar’s 
dissertation as well.
12 
  
 
2.4 Asymmetric synthesis of A-ring and functionalization of A-B-C ring 
structure 
A novel method for the asymmetric transformation from (-)-2.29 to (-)-2.33 was 
discovered and is discussed in this section (Figure 2.11). 
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Figure 2.11 : Transformation from (-)-2.29 to (-)-2.33 
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The traditional method for the synthesis of A ring from (-)-2.29 was originally reported 
by Honda, T. et al. in 1981
16
 and further investigated
17
 in 2003 by Honda, T, et al.. Starting with 
optically-pure (-)-2.29 could only afford an enantio-rich product (+)-2.30 (48%ee) with moderate 
yield (68%). To obtain the enantio-pure product, an enzyme resolution procedure is required.
17
 
As the only reported method, it has been used by many chemist to prepare three-ring compound 
(+)-2.30 in their synthesis till now. A mechanism was proposed explain the difficulty in the 
formation of enantio-pure product (Scheme 2.13).
17
 
Scheme 2.13 : Mechanistic explanation for the difficulty in preparation of  enantiomerically 
pure (+)-2.30 by traditional method 
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Deprotonation of C8-H by sodium methoxide gave the thermodynamic enolate. Because 
of the steric effect of the C10-methyl group, ethyl vinyl ketone could only approach the enolate 
from its -face to generate Michael addition product 2.49. Intramolecular aldol condensation of 
2.49 catalyzed by sodium methoxide formed desired product (+)-2.30 (blue route in Scheme 
2.13). However, the deprotonation of 5-hydroxy group led to C-ring opening and gave the 
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enolate-aldehyde intermediate 2.50. Intramolecular aldol reaction of intermediate 2.50 could 
generate the opposite enantiomer (+)-2.29 which followed the same reaction sequence to give (-
)-2.30, the undesired enantio-isomer of (+)-2.30, which decreased the optical purity of the final 
product. Meanwhile, the kinetic deprotonation of C3-H in (-)-2.29 gave the kinetic enolate, and 
this enolate could undergo Michael addition with ethyl vinyl ketone as well to give intermediate 
2.51. Cyclization and dehydration of 2.51 formed compound 2.52, the structure isomer of (+)-
2.30, which decreased the yield of desired product.   
Considering the complexity of following steps of myriceric acid A’s total synthesis, an 
enantio-pure tricyclic intermediate is desperately needed. With the traditional synthetic method, 
only enantio-rich tricyclic compound was obtained, and enzyme-resolution step was required to 
get the enantio-pure compound. However, to obtain large quantity of enantio-pure tricyclic 
compound, using enzyme resolution method become impossible if the cost, time, work inputs 
and the lose of the unwanted enantiomer were taken into account. Hence, an enantio-selective A-
ring synthesis reaction is highly demanded. To develop such reaction, many attempts were made. 
One way to prevent the C-ring opening is to block the formation of 5-alkoxide 
intermediate. Hence, the 5-hydroxy group in (-)-2.29 was protected by TBSCl in DMF with 
imidazole as base to give (-)-2.53 (Scheme 2.14). However, Honda, T.
17
 mentioned that the TBS 
group in (-)-2.53 was readily cleaved under sodium methoxide/methanol reflux condition. 
Consequently, other reaction pathways and conditions, instead of traditional Robinson annulation 
condition, should be considered. 
Scheme 2.14 : Preparation of (-)-2.53 
OH
Me
O
(-)-2.29
TBSCl, imidazole, DMF
90% yield
OTBS
Me
O
(-)-2.53  
In 1976, Fortunato and Ganem reported a cascade enone reductive-alkylation reaction. 
The enone was reduced by K-selectride firstly, and the formed enolate was trapped by alkyl 
halides to give the alkylated ketone (Scheme 2.15).
18
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Scheme 2.15 : Cascade K-selectride reductive-alkylation reaction of enone
18 
O
Me
Me
2.54
K-Selectride, THF, MeI, -78oC
O
Me
Me
2.55
Me
98% yield
 
Based on Fortunato’s strategy,18 compound (-)-2.53 was treated with K-selectride to 
reduce the enone moiety to regio-selectively generate the desired enolate 2.56, and ethyl vinyl 
ketone was introduced into the reaction mixture at once. However, at -78 
o
C or elevated 
temperatures, no Michael addition product 2.57 was formed, but only the reduced ketone 2.58 
was detected and isolated (Scheme 2.16). 
Scheme 2.16 : Cascade K-selectride enone reductive-Michael addition reaction of (-)-2.53 
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Another domino reductive-Michael addition reaction was reported by Cheung and 
Snapper with similar bicyclic compound 2.59. Compound 2.59 firstly was reduced by lithium in 
liquid ammonia; then, -unsaturated ketone 2.60 was introduced into the corresponded enolate 
slowly over 30 minutes to give enantio-selective Michael addition product 2.61 (Scheme 2.17). 
To prevent the polymerization of -unsaturated ester, the reaction was protected from light.  
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Scheme 2.17 : Cascade enone reductive-Michael addition reaction of 2.58
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Following the similar strategy, enone (-)-2.53 was reduced by lithium metal in liquid 
ammonia at -35
o
C to give desired enolate 2.56. After evaporation of ammonia and dilution of the 
residue with dry THF, ethyl vinyl ketone in diethyl ether was introduced to the resulted enolate 
2.56 over 30 minutes with protection from light. Unfortunately, no desired Michael addition 
product was detected and isolated after the reaction. From the 
1
H NMR of crude mixture, broad 
signals appeared at 3.0 – 2.0 ppm and 1.5 – 0.8 ppm indicating the formation of polymers of 
ethyl vinyl ketone.  
Scheme 2.18 : Cascade lithium enone reductive-Michael addition reaction of (-)2.53 
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Mukaiyama-type Michael addition reaction was also tried to be applied in the asymmetric 
synthesis of A-ring. The idea is depicted in the Scheme 2.19. 
Scheme 2.19 : Mukaiyama-type Michael addition 
+
O
Lewis acid
Me
OTMS O
Me
O
 
Silyl enol ether 2.62 was prepared by reducing enone (-)-2.29 with lithium/ liq. NH3, the 
enolate was trapped with trimethylsilylchloride (TMSCl) after evaporation of liq. NH3 (Scheme 
2.20). This reaction gave a mixture of desired silyl enol ether and a TMS protected compound 
2.63. Due to the instability of enol silyl ether, the mixture was directly used for the next step 
without purification.  
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Scheme 2.20 : Preparation of silyl enol ether 2.62 
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O
2.63  
A mixture of 2.62 and 2.63 was mixed with ethyl vinyl ketone and treated with boron 
trifluoride etherate (BF3
.
ether). Unfortunately, at -78 
o
C or elevated temperatures, no desired 
Michael addition product was detected. Under reaction conditions, TMS groups were hydrolyzed 
off to give back enone (-)-2.29 and ketone (-)-2.64 (Scheme 2.21). 
Scheme 2.21 : Attempt on Mukaiyama type Michael addition 
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Me
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With compound (-)-2.64 in hand, traditional Robinson annulation reaction was carried 
out with ethyl vinyl ketone. With the reflux with sodium ethoxide in ethanol, no desired product 
was found. Starting material (-)-2.64 was recovered, and ethyl vinyl ketone’s polymers were 
detected.  
Scheme 2.22 : Attempt on Robinson annulation of (-)-2.64 with ethyl vinyl ketone 
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Ethyl vinyl ketone, EtONa, EtOH, reflux
x
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Acid catalyzed Michael addition was also tested with (-)-2.58 and ethyl vinyl ketone. It 
was supposed that under acidic conditions with heating, the ketone would be transferred into its 
enol form. The enol could attack ethyl vinyl ketone to give a Michael addition product. However, 
after heat the mixture of (-)-2.58 and ethyl vinyl ketone with catalytic amount of PTSA for 24 
hours, reaction did not give any progress (Scheme 2.23). 
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Scheme 2.23 : Attempt on acid catalyzed Michael addition of (-)-2.58 with ethyl vinyl 
ketone 
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Ethyl vinyl ketone
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O
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After summarizing these reaction outcomes, it becomes clear that the problem of the 
designed Michael addition is the reactivities of two reactants do not match. When the generated 
enolate 2.56 is complex with boron (from K-selectirde or BF3.ether), it is unreactive towards 
Michael addition. When enolate 2.56 stays in its free form (from lithium reduction or generated 
in-situ by EtONa), it is “hard” and acted as base to promote the polymerization of ethyl vinyl 
ketone. Enol 2.66 was not reactive enough to undergo the Michael addition neither.  
Scheme 2.24 : Self polymerization of ethyl vinyl ketone initiated by enolate 2.56 
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Since attempts on “tuning” the reactivity of Michael donors (enolate 2.56 or enol 2.66) 
were all failed, the other solution for this problem was to “tune” the reactivity of Michael 
acceptor, ethyl vinyl ketone. If the self-polymerization of ethyl vinyl ketone could be slowed 
down or prevented in the presence of “hot” enolate 2.56, the desired Michael addition would be 
preceded smoothly.  
To prevent the polymerization of ethyl vinyl ketone, one solution is to use the alternative 
reagent: -trimethylsilylvinyl ethyl ketone.20 Trimethylsilyl group at  position of vinyl ketone 
blocked this enone’s polymerization. The reason is probably the the enolate derived from the 
Michael addition could be stabilized by overlapping of d-orbital of silicon to prevent the 
polymerization; also, the strong steric hindrance of this bulky siliyl moiety slows down the 
deprotonation process of enone by the enolate 2.56. This silyl group could be readily hydrolyzed 
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off at base-catalyzed intramolecular aldol condensation step which would give the same 
Robinson annulation product as ethyl vinyl ketone. 
Scheme 2.25 : TMS group slows down the deprotonation 
Repeat
O
OTBS
H
+ Me
O
Si
Me Me
Me H
Me
O
Si
Me Me
Me
O
OTBS
HO
Me
SiMe
Me Me
Me
O
Si
Me Me
Me Polymer
+
Me
O
Si
Me Me
Me H
+
Slow down acid-base reaction
 
One of its applications is the total synthesis of stachenone (Scheme 2.26).
21
   
Scheme 2.26 : Application of -trimethylsilyl vinyl ethyl ketone in asymmetric ring 
construction 
H
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1.MeLi,
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2.68 2.69  
The disadvantage of this method is this chemical, -trimethylsilyl vinyl ethyl ketone, is 
not commercially available. Hence, it has to be prepared in the laboratory via a six-step synthesis 
from the commercially available 1,2-dibromoethane.  
The elimination of 1,2-dibromoethane readily gave vinyl bromide (b.p: 16 
o
C), and the 
prepared vinyl bromide was introduced to magnesium to generate vinyl magnesium bromide 
reagent. Vinyl Grignard reagent reacted with TMSCl to give vinyl trimethyl silane which was 
directly distilled out from the reaction mixture (Scheme 2.27).
22 
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Scheme 2.27 : Synthesis of vinyl trimethyl silane
22 
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Vinyl trimethyl silane was treated with bromine at -78
o
C to give an bromine addition 
product, and this crude product underwent an elimination reaction with diethylamine to give -
trimethylsilyl vinyl bromide (2.70). Bromide 2.70 was used to prepare the corresponding 
Grignard reagent with magnesium, and the prepared -trimethylvinyl magnesium bromide was 
treated with propanal to give allyl alcohol 2.71. Oxidation of allyl alcohol with pyridinium 
dichromate (PDC)
23
 gave -trimethylsilyl vinyl ethyl ketone (Scheme 2.28). 
Scheme 2.28 : Synthesis of -trimethyl vinyl ethyl ketone 
TMS
Vinyl trimethyl silane
1. Br2, pentane
2. Diethylamine
TMS
Br
2.70
66% yield, two steps
Mg, propanal
THF
Me
OH
TMS
2.71
PDC
Me
O
TMS
-trimethylsiyl vinyl 
ethyl ketone
86% yield 65% yield
 
With -trimethylsilyl vinyl ethyl ketone in hands, the reductive-Michael addition reaction 
was carried out. Same as before, the bicyclic enone (-)-2.53 was firstly reduced by lithium to 
regio-selectively form the enolate 2.56. After quenching the excess amount of lithium and 
evaporating off ammonia, enolate 2.56 was dissolved in dry diethyl ether. -Trimethylsilyl vinyl 
ethyl ketone was introduced into the mixture at -78
o
C over 30 minutes with protection from light 
to finally give the desired stereo-selective Michael addition product. Annulation with KOH as 
base in MeOH resulted the enantio-pure tricyclic product (+)-2.72 (Scheme 2.29). 
Scheme 2.29 : Stereoselective synthesis of tricyclic compound (+)-2.72 
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O
(-)-2.53
1. Li, liq. NH3, t-BuOH, -35
 oC,
2. -Trimethylsilyl vinyl ethyl ketone,
3. 6% KOH, MeOH, reflux
58% yield, 4 steps
OTBS
Me
O
(+)-2.72  
Compound (+)-2.72 underwent reductive-methylation reaction to give tricyclic 
compound (+)-2.73. The ketone (+)-2.73 was protected by ethylene glycol to form acetal (-)-2.74. 
Deprotection of TBS group in (-)-2.74 with TBAF generated alcohol (-)-2.32. At this stage, the 
optical rotation of obtained (-)-2.32 ([]D = -45
o
, c =0.1 in chloroform) was compared with the 
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reported value of the (-)-2.32 ([]D = -44
o
, c =0.1 in chloroform, 98%ee, measure by chiral 
HPLC),
24 
and the enantio-purity of the obtained (-)-2.32 was calculated as 100%ee. Oxidation of 
alcohol (-)-2.32 with IBX finally gave acetal ketone (-)-2.33 (Scheme 2.30). 
Scheme 2.30 : Synthesis of acetal ketone (-)-2.33 
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To sum up, the desired stereo-selective A-ring construction was finally achieved with the 
reductive-Michael addition-aldol condensation reaction by using -trimethylsilyl vinyl ethyl 
ketone as the building block. Functionalization of the resulted tricyclic compound was proceeded 
smoothly to give the enantio-pure acetal ketone (-)-2.33 for further exploration on the total 
synthesis of myriceric acid A.  
 
 2.5 Synthesis of D, E-rings of myriceric acid A 
In this section, the D, E rings construction from A, B, C-ring compound (-)-2.33 via a 
tandem aldol-Michael-aldol protocol is introduced and discussed (Figure 2.12). 
Figure 2.12 : Transformation from (-)-2.33 to (+)-2.45 
O
O
A
B
C
O
(-)-2.33
O
O
O
(+)-2.45
A
B
C
D
E
H
H
H
H
H
H
H
 
Since Aguliar
12
 already successfully synthesized, functionalized and bio-evaluated the 
tetracyclic compound 2.38, my goal is to synthesize pentacyclic compound (+)-2.45 directly 
from compound (-)-2.33. To achieve this, two possible synthetic approaches could be used: (a) 
D-ring construction via inter-molecular Michael addition-intramolecular aldol condensation by 
77 
 
using tricyclic compound (-)-2.33 (or its derivatives) and monocyclic compound 2.75 which has 
all the structure features of E-ring; (b), D,E-rings construction via intra-molecular Michael 
addition-aldol condensation process by using compound (-)-2.76 which is derived from 
compound (-)-2.33 (Scheme 2.31). 
Scheme 2.31 : Possible synthetic approaches for synthesis of (+)-2.45 
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Approach (a) was firstly attempted. The retro-synthetic analysis of (+)-2.45 via inter-
molecular Michael addition approach is depicted in Scheme 2.32. D-ring in (+)-2.45 could be 
synthesized via an intramolecular aldol condensation reaction from compound 2.77. E-ring 
would be connected with fused A, B, C rings via the intermolecular Michael addition from 
compound (-)-2.33 and enone 2.75. 
Scheme 2.32 : Retro-synthetic analysis of (+)-2.45 in approach (a) 
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Compound 2.75 was prepared from isoprene and diethylamine via a reported 3-step 
synthesis.
25, 26
 Firstly, isoprene reacted with diethylamine and catalytic amount of n-butyllithium 
to give N,N,-diethylgeranylamine 2.78, and the following oxidation of amine was accomplished 
by hydrogen peroxide to give the corresponding N-oxide intermediate, and cyclization reaction 
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of N-oxide was carried out to form the desired monocyclic enone 2.75 in moderate yield 
(Scheme 2.33). 
Scheme 2.33 : Synthesis of compound 2.75 
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With compound 2.75 in hands, the synthesis of (+)-2.45 was tried. The basic idea was to 
use the enolate which derived from (-)-2.33 as the Michael donor to attack the enone 2.75 
(Scheme 2.34). 
Scheme 2.34 : Designed Michael Addition of 2.75 with (-)-2.33 
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Initially, enolate derived from compound (+)-2.34 was used as the Michael donor. With 
the phenylsulfide attached, the pKa of -H of the ketone is lowered to 16; also, this 
phenylsulfide group is an electron-withdrawing group which could stabilize the formed enolate 
to enhance the rate of desired Michael addition reaction. However, after refluxing in THF with 
2.75 and sodium methoxide for 24 hours, no desired product but only the starting materials were 
detected (Scheme 2.35). The reason might be the strong steric effects from the B-ring and C8-
methyl group. The B-ring blocks the enone approaching from the bottom face of (+)-2.34, and 
the C8-methyl group prevents the enone aligning with the enolate from the top. As the result, the 
desired Michael addition reaction cannot proceed.  
Scheme 2.35 : Michael addition of (+)-2.34 with 2.75 
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To reduce the steric hindrance, enolate directly derived from ketone (-)-2.33 was used as 
Michael donor to attack enone 2.75. With sodium methoxide as base, no reaction occurred even 
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the mixture was heated to reflux or to 120 
o
C (in a sealed tube) in methanol for 24 hours. Then, a 
stronger base, sodium t-butoxide, was employed for this reaction. However, after stirring in 
refluxed THF for 24 hours, ketone (-)-2.33 stayed unreacted. Enone 2.75 disappeared, and a new 
compound was detected by TLC. After isolation, the new compound 2.80 is determined as the 
self-Robinson annulation product of 2.75 (Scheme 2.36). 
Scheme 2.36 : Michael Addition of 2.75 with (-)-2.33 with MeONa and t-BuONa 
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In the attempted reactions, the enolate 2.79 was generated in-situ. pKa of -H of ketone 
is around 25 and pKa of hydroxyl in alcohol of around 16; so, the enolate 2.79 is highly reactive 
towards alcohol and easily protonated from the hydroxyl group to give back the ketone (Scheme 
2.37). Therefore, the real concentration of enolate is very low, and, considering that enone 2.75 
was not that reactive as vinyl ketones, the desired Michael addition would proceed extremely 
slow. Meanwhile, from the reaction outcome of the t-BuONa reaction, it could be tell that the 
base has a greater chance to deprotonate the -H of enone to give self-Robinson annulation 
product. It is understandable. Although both the -H of enone 2.75 and ketone (-)-2.33 have 
similar pKa, the enone 2.75’s -H has less steric hindrance than the ketone (-)-2.33, which 
makes the attack by the base much easier. 
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Scheme 2.37 : Generation of two enolates with alkoxide 
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Since the reactions with in-situ generated enloates by alkoxides were all unsuccessful, 
other pathways were to use pure enolate for the Michael addition. The desired enolate could be 
readily obtained by treating ketone (-)-2.33 with LDA. To this enolate in THF was added the 
enone 2.75. Unfortunately, at -78 
o
C, 25 
o
C and 70 
o
C, no desired Michael addition occurred, and 
all the starting material were recovered (Scheme 2.38). 
Scheme 2.38 : Michael addition with LDA-generated enolate 
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Mukaiyama-type Michael addition
27
 was also examined for the synthesis of 2.77. The 
advantage of this reaction was that the Lewis acid’s chelation with enone could increase its 
activity as Michael acceptor to promote the Michael addition. The silyl enol ether (-)-2.81 was 
readily prepared with ketone (-)-2.33 in quantitative yield. 
Scheme 2.39 : Synthesis of (-)-2.81 
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Initially, this type of Michael addition was tried with a weak Lewis acid: lithium ion. The 
1,4-addition reaction of silyl enol ether to -unsaturated ketone in the medium of lithium 
perchlorate and nitromethane (LPNM) was reported (Scheme 2.40).
28
 The authors stated that 
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Lewis acidity of lithium ion increases in nitromethane because of its poor coordination with the 
solvent. With large excessed acidity-increased lithium ion, the Michael addition is catalyzed to 
give the 1,4-addition product.  
Scheme 2.40 : Michael addition of silyl enol ether to  -unsaturated ketone in  LPNM28 
OTMS
+
O
5M LPNM, rt
74 %
O
O
Me
Me
Me
Me
2.82 2.83 2.84  
However, the application of this reaction for the synthesis of 2.77 did not give any 
positive result. After prolong heating, enol silyl ether decomposed to give back the ketone (-)-
2.33, and 2.75 was also recovered. 
Scheme 2.41 : Application of LPNM condition to synthesize 2.77 
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Stronger Lewis acid, BF3 etherate, was used to try on this reaction as well. However, this 
reaction also failed and only provided the hydrolyzed product (-)-2.33 and unreacted 2.75 
(Scheme 2.42). 
Scheme 2.42 : Mukaiyama-type Michael addition for synthesis of 2.77 
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Enamine chemistry
29
 was also attempted for synthesis of 2.77 (Scheme 2.43). However, 
the preparation of enamine 2.85 turned out to be difficult. In the presence of 4 Å molecular sieve 
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and catalytic amount of PTSA, ketone (-)-2.33 and pyrrolidine remianed unchange in refluxed 
toluene for 24 hours. 
Scheme 2.43 : Michael addition for synthesis of 2.77 with enamine 2.85 
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To sum up, all attempts on the intermolecular Michael addition strategies did not give 
any positive results.  The reason might be the strong steric hindrances which were given by the 
C8-methyl group and B-ring of (-)-2.33 and gem-dimethyl groups of 2.75.  C8-Methyl group of 
enolate 2.79 blocks the enone 2.75 approaching from the top side. When enone 2.75 approaches 
the enolate from its bottom, the B-ring of (-)-2.33 blocks the two reactants to align in the right 
position; meanwhile, the gem-dimethyl groups on the enone 2.75 also increase the difficulty for 
the enolate approach and alignment (Figure 2.13). 
Figure 2.13 : Steric hindrance from 8-methyl group of enolate 2.79 and gem-dimethyl 
groups of 2.75  
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The other possible reason for the failures of intermolecular Michael addition strategies 
was the competition reaction: acid-base reaction. The enolate would act as the base instead of 
nucleophile to deprotonate the -H of enone, which could destruct both the Michael donor and 
acceptor and slow down the desired Michael addition (Scheme 2.44). 
 
 
83 
 
Scheme 2.44 : Acid base reaction between the enolate and enone 
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One way to overcome the strong steric effect is to go through the intramolecular approach 
to furnish the construction of pentacyclic structure, which is the above mentioned approach (b). 
The retro-synthetic analysis of compound (+)-2.45 via the approach (b) is depicted in 
Scheme 2.45. Similar as the intermolecular Michael addition approach, D-ring of (+)-2.45 could 
be built up via an intramolecular aldol condensation reaction from compound 2.77; however, the 
E-ring would be constructed via the intramolecular Michael addition from enone-ketone (-)-2.76 
which would be synthesized from (-)-2.33 and ketone-aldehyde 2.46 via intermolecular aldol 
condensation. 
Scheme 2.45 : Retro-synthetic analysis of (+)-2.45 in approach (b) 
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The synthesis of (+)-2.45 via approach (b) started from the preparation of novel ketone 
aldehyde 2.46. The retro-synthetic analysis of ketone aldehyde 2.46 is depicted in Scheme 2.46. 
The aldehyde functionality in 2.46 could be derived from the olefin in compound 2.86 via 
oxidative cleavage reaction. Olefin ketone 2.86 would be prepared from methyl vinyl ketone 
with dialkyl cuprous reagent via a 1,4-addition. The dialkyl cuprous reagent would be prepared 
from the Grignard reagent of bromide 2.87. Bromide 2.87 could be derived from aldehyde 2.89 
via few steps through functional group interconversions.  
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Scheme 2.46 : Retro-synthetic analysis of 2.46 
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Me Me
Br
FGIMe Me
OH
FGI
Me Me
H
O
2.872.882.89  
Aldehyde 2.89 was synthesized from a known procedure in excellent yield (Scheme 
2.47).
30
 This synthesis used allyl alcohol and isobutryaldehyde as the starting materials. The 
reaction went through a hemiacetal formation-dehydration-Claisen rearrangement sequence to 
give desired aldehyde 2.89. 
Scheme 2.47 : Synthesis of 2.89
30 
OH +
Me
Me
H
O cat. PTSA, mesitylene, Dean-Stark reflux
90% yield
Me Me
H
O
2.89Allyl alcohol Isobutyraldehyde  
The olefin aldehyde 2.89 was readily reduced by sodium borohydride in methanol and 5% 
aq. sodium hydroxide mixture to give olefin alcohol 2.88 with quantitative yield. Bromination of 
2.88 firstly tried with triphenylphosphine and tetrabromomethane. The reaction went smoothly to 
give desired bromide 2.87; however, the purification of the product turned out to be difficult.  
Byproduct bromoform which was formed in the reaction has similar boiling point and polarity as 
the product and could not be separated. Hence, the alternative bromination method was utilized. 
Olefin bromide 2.87 was successfully prepared with bromine and triphenylphosphine in DMF 
and purified by distillation in moderate isolation yield (Scheme 2.48).
31
  
Scheme 2.48 : Synthesis of 2.87 
Me Me
H
O
2.89
NaBH4, 5% NaOH aq.  MeOH Me Me
OH
2.88
PPh3, Br2, DMF Me Me
Br
2.87
90% yield 65% yield
 
With the bromide 2.87 in hands, the next step was to prepare the cuprate reagent. The 
first attempt was to use t-BuLi to generate the organolithium reagent 2.90 for synthesizing 
cuprate compound.
32
 Bromide 2.87 was treated with t-BuLi and the reaction was monitored by 
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1
H NMR. After prolong time stirring in THF at various temperatures, the bromide still stayed 
unchanged.  
Scheme 2.49 : Attempt on preparation of lithium reagent from bromide 2.87  
Me Me
Br
2.87
Me Me
Li
t-BuLi, THF
X
2.90
Me Me Cu
2
Li
 
Since the cuprate reagent can also be prepared from Grignard reagent, the back-up 
strategy is to make the corresponding Grignard reagent from bromide 2.87. However, the 
ordinary method for the Grignard reagent formation did not work in this case. With iodine or 
dibromoethane, the reaction was not initiated.  
All the failures of the reactions lie on the high stability of bromide 2.87 which may be 
given by the gem-dimethyl groups. These gem-dimethyl groups in 2.87 shields the bromide 
against the approach of the metal (Figure 2.14).   
Figure 2.14 : Steric effect from the gem-dimethyl group 
Br
Me
Me
MgX
 
To solve this problem, one of the possible methods was to use the activated magnesium
33
 
to prepare the Grignard reagent. A procedure was published by Bonnemann, H. et al. in 1983 for 
preparing the activated magnesium.
33
 Magnesium was stirred with catalytic amount of 
anthracene and 0.1 eq. of methyl iodide in THF for 14 hours to form highly active magnesium 
(Scheme 2.50). The process might start with the formation of methylmagnesium iodide which 
could clean the surface of the metal. Then, anthracene could form the complex with magnesium 
and THF. This is an equilibrium process, and the complex could decompose to give free 
magnesium atom and anthracene. This regenerated magnesium is “solvated” in the solvent (THF) 
and highly reactive. Therefore, after prolong time stirring, metal turnings are smaller in size than 
before, and magnesium “mud” appeares at the bottom of the flask. 
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Scheme 2.50 : Catalytic cycle for the formation of activated magnesium
33 
 
 
 
 
 
With the activated magnesium, Grignard reagent of bromide 2.87 was prepared 
successfully.  The Grignard reagent was introduced to cuprous iodide dimethylsulfide complex
32
 
to give the dialkyl cuprate reagent. The 1,4-addition of methyl vinyl ketone was furnished with 
this organocuprate reagent to give desired product 2.86 (Scheme 2.51). 
Scheme 2.51 : Synthesis of 2.86 
Me Me
Br
Me
Me Me O
1. Mg, cat. anthracene, MeI, THF;
2. CuI.MeSMe, methyl vinyl ketone, ether
5% ~ 35% yield
2.87 2.86  
However, the reaction yields varied from 5% - 35% when reaction scales varied. The 
reason was explored. For the different qualities of magnesium turnings, it was found that methyl 
iodide was sometimes needed more than 0.1 eq. to initiate the formation of magnesium*. The 
generated methyl Grignard reagent remained in the reaction mixture and reacted with cuprous 
iodide to give dimethyl cuprate which would also undergo a 1,4-addition to methyl vinyl ketone 
as well (Scheme 2.52).  
Scheme 2.52 : Formation of the byproduct 2.91 
MeI + MeMgI (CH3)RCuI Me Me
O
CuI.MeSMe
Mg
Methyl vinyl ketone
2.91  
Replacement of methyl iodide with dibromoethane solved this problem. Dibromoethane 
had the same function as methyl iodide and reacted with magnesium gave the ethylene and 
magnesium bromide which would not affect the subsequent reaction. The reaction yield became 
repeatable at 40% (Scheme 2.53). 
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Scheme 2.53 : Revised procedure for synthesis of 2.86 
Me Me
Br
Me
Me Me O
1. Mg, cat. anthracene, dibromoethane, THF;
2. CuI.MeSMe, methyl vinyl ketone, ether
40% yield
2.87 2.86  
Transformation from olefin ketone 2.86 to ketone aldehyde 2.46 was initially carried out 
by using ozone oxidation conditions. However, this reaction did not give any desired product but 
only decomposed compounds. The alternative condition was the osmium tetraoxide (OsO4) and 
sodium periodate (NaIO4) olefin oxidative cleavage reaction.
34
 OsO4 could oxidize olefin into 
1,2-diol, and the diol is cleaved and oxidized by NaIO4 to give desired aldehyde ketone 2.46. 
Scheme 2.54 : Synthesis of 2.46 
Me
Me Me O
2.86
cat. OsO4, NaIO4, dioxane, H2O
56% yield
Me
Me Me O
O
H
2.46  
The synthesis of (-)-2.76 was continued with both starting materials ready in hands. 
Mukaiyama aldol reaction
35
 was carried out with enol silyl ether (-)-2.81 and aldehyde ketone 
2.46 in DCM with BF3
.
ether as the Lewis acid, and alcohol 2.92 was obtained as a mixture of 
diastereomers. Since two carbonyl groups existed in compound 2.46, 2.0 eq. of BF3.ether was 
required to finish the reaction; otherwise, the yield of reaction would drop to half (Scheme 2.55). 
Scheme 2.55 : Synthesis of 2.92 
Me
Me Me O
O
H
2.46
O
O
OTMS
+
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oC
O
O
O
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H
H
H
H
95% yield
 
Treatment of 2.92 with methylsulfonyl chloride (MsCl) and triethylamine in diethyl ether 
gave the corrosponding mesylate. Elimination of the mesylate with 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) generated the desired enone ketone (-)-2.76 in good yield 
(Scheme 2.56). 
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Scheme 2.56 : Synthesis of (-)-2.76 
1. MsCl, Et3N, ether, 25
 oC
2. DBU, toluene, DCM
O
O
O
HO Me Me
Me
O
2.92
75% yield, two steps
O
O
O
Me
Me
Me O
(-)-2.76
H
H
H
H
H
 
The geometry of the enone in (-)-2.76 was confirmed by 
1
H NMR, NOESY and X-ray 
analysis to be the E-geometry. 
Figure 2.15 : A single crystal structure of (-)-2.76 
 
 Interestingly, only the E-isomer of enone was formed in the elimination reaction. The 
reason might be the strong steric hindrance between the carbonyl and gem-dimethyl groups in 
the Z-isomer made it difficult to form (Figure 2.16). 
Figure 2.16 : Steric hindrance between carbonyl and gem-dimethyl in (Z)-isomer of 2.76 
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O
O
H
Me
Me
Me
O
Z-isomer
H
H
 
Since the enone was successfully prepared, the constructions for D,E-rings were 
continued.  The idea was to use a base to generate the desired enolate 2.93, and the enolate 2.93 
would undergo intramolecular Michael addition to the enone to give 2.77. In the presence of a 
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catalytic amount of base, intramolecular aldol condensation of 2.77 proceeded to give 
pentacyclic compound (+)-2.45. 
Scheme 2.57 : Designed annulation for D, E-ring synthesis 
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Compound (-)-2.76 was heated with sodium ethoxide in high-diluted concentration 
(0.005 M) in ethanol for 14 hours to generate two new compounds with different polarities in 
TLC. The results of 
1
H NMR and mass spectra indicated that both of them are the annulation 
products of compound (-)-2.76 having different stereochemistry at C13, C17 and C18.   
Scheme 2.58 : Annulation reaction of (-)-2.76 
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To explain the observation of this reaction and determine the structures of the obtained 
products were quite challenging.  
This domino Michel addition aldol condensation reaction of (-)-2.76 could generate three 
new stereo-centers which were at carbon13, 17 and 18 positions; hence, a total number of 8 
possible isomers could be formed; but the reaction only gave two of them. The interpretation for 
this reaction outcome needed to be explored. As mentioned in Scheme 2.9,
12
 D-ring could be 
cyclized only when the C13-H is in axial, and this may work the same in the designed domino 
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reaction. If this hydrogen was in equatorial and the large substitution stayed in axial, there will 
be great steric hindrance against the C8-methyl group. Under thermodynamic condition, the C13-
H would stay in the axial position to give more stable conformation.
12
 For C18-H, it is the least 
acidic proton among the three, and the conformation of C18-H cannot be changed once E-ring is 
cyclized. C17-H is the most acidic proton in the final product and could be epimerized easily in 
ethanol in the presence of sodium ethoxide, and, under thermodynamic conditions, C17-H would 
stay in the conformation which made the whole system had lowest conformational energy. 
Therefore, for one possible conformation of C18-H, C17-H would only stay in one conformation 
which gives the lowest conformational energy of the whole structure. To sum up, under the 
reaction conditions, C13-H has to stayed in axial to furnish the annulation of D-ring; C18-H in 
the annulation products could stay in axial or equatorial; the conformation of C17-H relies on the 
conformation of C18-H. Hence, only two isomers were generated under the reaction conditions. 
  The next issue was to determine the exact structures of the obtained isomers. Assuming 
most of the fused six member rings were in chair conformation to maintain the lowest energy of 
the system, two structures could be constructed and shown in Figure 2.17. One isomer had 13-
H(a), 17-H(a) and 18-H(e) conformation, and the other had 13-H(a), 17-H(e) and 18 (a). In 
myriceric acid A, the 18-H is in axial position; hence, only one isomer [13-H(a), 17-H(e) and 18 
(a)] is useful for the continued synthesis of myriceric acid A. 
Figure 2.17 : Possible structures of obtained annulation products 
O
O
H H
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H
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Structure 1 Structure 2
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To assign the structures of each isomer was also difficult. NMR methods, such as 
1
H 
NMR, COSY, NOESY, do not work on this case because the peak of 18-H is merged with other 
protons’ signals. Luckily, single crystals of the more polar isomer were obtained. A successful 
X-ray analysis was carried out and gave the crystal structure of the more polar isomer (Figure 
2.18). 
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Figure 2.18 : Crystal structure of more polar (+)-2.45 from X-ray analysis showing it to be 
the desired isomer 
 
The structure of (+)-2.45 which is same as the proposed structure 2 in Figure 2.17 is 
confirmed as the desired product, and the structure 1 should belong to less polar compound (-)-
2.94, the undesired isomer. 
Since the structures of the obtained products are all assigned, the detailed mechanisms of 
the formations of these products are investigated to explain the preference of the formation of 
undesired (-)-2.94. When the -H of side-chain ketone is abstracted, two types of enolates, Z- 
and E- enolates, could be formed. Z-enolate would prefer to approach the enone from its -face 
(top) because of the less steric hindrance to give undesired product (-)-2.94; while the E-enolate 
has difficulty in approaching from the -face because of the steric hindrance between the methyl 
group of the enolate and C8-methyl group on the C-ring. Therefore, E-enolate could only 
approach the enone from its -face (bottom side) to give desired pentacyclic product (+)-2.45. 
For the methyl ketone in (-)-2.76, the Z-enolate was slightly favored to be formed because it has 
less steric hindrance comparing with E-enolate; hence, more undesired annulation product is 
formed. 
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Scheme 2.59 : Detailed mechanisms for the formations of (-)-2.94 and (+)-2.45 
 
In summary, attempts on the construction of pentacyclic compound (+)-2.45 via 
intermolecular Michael addition strategies were not successful. To overcome the problem, 
ketone aldehyde 2.46 was prepared and used to synthesize the desired compound (-)-2.76 as the 
starting material for the intramolecular Michael addition-aldol condensation reaction which 
finally gave the desired pentacyclic compound. The mechanism of this reaction was investigated 
as well. 
2.6 Functionalization of D-ring 
In this section, the progress on the functionalization of D-ring in compound (+)-2.45 to 
finish the total synthesis of myriceric acid A is introduced and discussed (Scheme 2.60). 
Scheme 2.60 : Functionalization of D-ring to finish total synthesis of myriceric acid A 
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The strategy for the transformation the compound (+)-2.45 into final target compound 
2.14 is rationally designed. Firstly, advantages of using compound (+)-2.45 to prepare target 
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molecule 2.14 are fully explored. The enone moiety in compound (+)-2.45 activates all the 
necessary position to facilitate the introductions of required functional groups. As the -H of 
enone, C17-H is the mostly activated to introduce carboxylic group via enolate (kinetic) 
chemistry; C13-H is the -H of enone which could be functionalized to furnish the formation of 
olefin double bond by either enolate chemistry or allyl system chemistry; Michael addition on 
this enone moiety could accomplish the installation of the hydroxyl methylene groups at C14 via 
few steps. Secondly, the sequence of installations of the functional groups is considered. Since 
the C17-H is the most acidic proton and could be selectively deprotonated, the installation of 
carboxylic group should be given the first priority. Functionalization of C13-H requires the 
existence of enone; so, the second priority should be given to the manipulation of C13-H to 
alkene. Michael addition of enone could be given the third priority. A few steps of functional 
group inter-conversion would give the desired compound 2.14. To sum up, the designed reaction 
sequence is depicted in Scheme 2.61. 
Scheme 2.61 : Designed reaction sequence for preparing compound 2.14 
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Following the proposed strategy, the C17-carboxylic group was firstly introduced. 
Mander and Sethi reported a method for the regio-selective synthesis of -ketoester from 
lithium enolate by using alkyl cyanoformate.
36 
Scheme 2.62 : Regioselective synthesis of -ketoester from lithium enolate36 
LDA, methyl cyanoformate, HMPA, THF
2.99 2.100
96% yield
O O O
O
Me
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The undesired pentacyclic compound (-)-2.94 was firstly used for the model study.  LDA 
was used as the base to deprotonated the -H of the enone in compound (-)-2.94, and 
hexamethylphosphoramide (HMPA) was added to increase the activity of enolate by chelating 
with lithium. Ethyl cyanoformate was finally introduced to give the compound (+)-2.101 in 
moderate yield (Scheme 2.63). 
Scheme 2.63 : Model study of the synthesis of -ketoester with (-)-2.94 
LDA, ethyl cyanoformate, HMPA, THF
45% yieldO
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The exact structure of compound (+)-2.101 was confirmed by 
1
H NMR, 
13
C NMR and X-
ray analysis of its single crystal (Figure 2.19). 
Figure 2.19 : Crystal structure of (+)-2.101 from X-ray analysis 
 
The X-ray analysis result of (+)-2.101 confirmed our postulation about the structure of 
compound (-)-2.94: the conformation of C13-H is in axial and the conformation of C18-H is in 
equatorial. The conformation of C17-H in (-)-2.94 could not be determined since it was no-
longer exist in (+)-2.101; however, the real conformation of C17-H in (-)-2.94 is not important 
because it is destroyed in the deprotonation step eventually.  
In compound (-)-2.101, the C17-ethyl ester group stays in axial which is the cis-
conformation of the C18-H. This conformation indicates that the ethyl cyanoformate approaches 
the enolate from the less hindered side which in this structure is the same side as C18-H. In other 
words, via this reaction, the conformation of formed ethyl ester depends on the conformation of 
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C18-H. Therefore, if the C18-H is pointing up, the ester would also pointing up which is the 
desired conformation of C17-ester group. 
Since this reaction condition worked well in the model study, compound (+)-2.45 was 
then treated with LDA, HMPA and ethyl cyanoformate under this condition in THF. However, 
the reaction outcome was unexpected. Before quenching the reaction with NH4Cl, TLC showed 
no (+)-2.45 left but a new less polar spot; however, after the work up, only (+)-2.45 was detected 
on the TLC (Scheme 2.64). 
Scheme 2.64 : Synthesis of -ketoester with (+)-2.45 in THF 
LDA, ethyl cyanoformate, HMPA, THF
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The unsuccessful application of cyanoformate in synthesis of -ketoester from a steric 
hindered enolate was also reported by Mander and Sethi in 1990.
37
 It was mentioned that O-
alkylation is favored to give undesired enol carbonate ester when THF is used as solvent for this 
type of reaction. This enol carbonate ester is not stable and readily hydrolyzed under acidic 
condition. The solution for this problem is to use diethyl ether instead of THF as the solvent for 
the reaction (Scheme 2.65). 
Scheme 2.65 : Synthesis of -ketoester with methyl cyanoformate in ether and THF37 
LDA, methyl cyanoformate, HMPA, THF
LDA, methyl cyanoformate, HMPA, diethyl ether
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The reason might be the reactivity differences of the cyanoformate in different solvents. 
Comparing with diethyl ether, THF is a better coordinating solvent because of its cyclic structure, 
and cyanoformate is more “solvated” in THF, which made it a “harder” electrophile (Figure 
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2.20). When enolate orients in a hindered environment, the “hard” electrophile has a better 
chance to attack the oxygen because it is a “hard” nucleophile and easy to approach as well.   
Figure 2.20 : More “solvated” cyanoformate in THF 
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Although the exact reason of the failed synthesis of desired -ketoester is not confirmed 
as the formation of enol carbonate, this revised procedure was tried. Compound (+)-2.45 was 
then treated with LDA, HMPA and ethyl cyanoformate in diethyl ether. Fortunately, the desired 
compound (-)-2.106 was obtained in a good yield (Scheme 2.66). 
Scheme 2.66 : Synthesis of -ketoester (-)-2.106 
LDA, ethyl cyanoformate, HMPA, 
diethyl ehter, -78 oC
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The formation of -ketoester in (-)-2.106 was confirmed by 1H NMR, 13C NMR, and 
mass spectrums. However, the exact stereochemistry is still not clear. Compound (-)-2.106 is oil, 
therefore the single crystal could not be obtained for X-ray analysis. Considering the formate 
would approach from the less hindered side of the enolate, it is highly possible that the ester in  (-
)-2.106 is in cis position of C18-H which is the desired conformation. 
The functionalization of (-)-2.106 is carried out; however, because of the time limit, there 
is still no progress been made.  
 
2.7 Conclusion 
The total synthesis of myriceric acid A was continued with a revised synthetic strategy. 
The traditional method for synthesizing the tricyclic compound could not afford enantio-pure 
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product; therefore, a new method was developed to stereo-selectively generate the tricyclic 
compound.   The new method started with the TBS protected bicyclic compound (-)-2.53 and -
trimethylsilylvinyl ethyl ketone via a reductive-Michael addition-silyl hydrolyzation-aldol 
condensation reaction sequence to give the enantio-pure tricyclic compound (+)-2.72 in a good 
yield. After protection of carbonyl group, deprotection of TBS group and oxidation of the 
alcohol, tricyclic intermediate (-)-2.33 was synthesized.  
With the enantio-pure tricyclic intermediate ready, the synthesis of pentacyclic 
intermediate was explored.  Initial attempts on the intermolecular Michael addition strategy were 
not successful because of the steric effect. The intramolecular reaction was designed and used as 
the alternative method. Ketone aldehyde 2.46 was synthesized over five steps and coupled to the 
tricyclic compound (-)-2.81 via Mukaiyama type of aldol condensation reaction. The desired 
enone-ketone was prepared for the designed intramolecular Michael addition aldol condensation 
reaction. The desired pentacyclic compound (+)-2.45 was prepared eventually via the protocol, 
and the structure was confirmed by X-ray analysis. 
Functionalization of the obtained pentacyclic intermediate was started with installation of 
the 17-carboxylic group. After several attempts, the successful procedure was developed, and the 
desired pentacyclic carboxyl ester was synthesized in a good yield. Further functionalization of 
the pentacyclic structure will be pursued. 
 
 
2.7 Experimental Section  
General procedure:  Melting points were measured on Thomas Hoover capillary 
melting point apparatus. Nuclear magnetic resonance spectra were obtained at 400 MHz for 
1
H 
and 100 MHz for 
13
C in deuteriochloroform and reported in ppm, unless otherwise indicated. 
Solvents and some reagents were dried over CaH2 (DCM, pyridine, Et3N, DMF, 
diisopropylamine, trimethylsilyl chloride), sodium/benzophenone (THF, ether), magnesium 
(MeOH, EtOH) and lithium aluminum hydride (toluene, benzene) and distilled under argon. All 
other reagents were obtained from commercial sources and used without further purification. 
Reactions were performed under agron unless otherwise indicated.  
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 2-Methyl-1,3-cyclohexandione. 
O O
MeI, 5 N NaOH aq. 
65 oC
84% yield
O O
Me
 
1,3-Cyclohexandione (15.0 g, 0.13 mol) was dissolved in 5N NaOH aqueous solution (26 
mL, 0.13 mol). The resulted red-brown solution was cooled to 0
o
C over an ice-water bath. To it  
at 0
o
C was added iodomethane (37.0 g, 0.26 mol) slowly. This mixture was heat to 65
o
C with 
vigorous stirring for 24 hours and cooled to 25 
o
C. The white solid was collected by filtration, 
powderized and washed with 300 mL of hexane and 50 mL of cold water to give white solid as 
the desired product (13.44 g, 84 % yield) which was sufficiently pure used in the following step. 
This is a commercial available chemical. The 
1
H NMR is provided herein for reference, and the 
chemical shifts are identical to that of reported.
13
 
1
H NMR (DMSO-d6) δ 10.28 (bs, 1H, enol-
OH), 2.28 (m, 4H), 1.81 (m, 2H), 1.53 (s, 3H, -CH3). 
 2-(1-Bromoethyl)-2-ethyl-1,3-dioxolane (2.47). 14,15 
Me
O
Me
1. Ethylene glycol, cata. PTSA,
    Hexane
2. Bromine
Me Me
O O
Br
2.47
3-Pentanone
35% yield , two steps
 
3-Pentanone (86.0 g, 1.0 mol), ethylene glycol (70.0 g, 1.1 mol) and PTSA (20 mg, 0.12 
mmol) in 100 mL hexane were heated to reflux with Dean-Stark to remove water for 48 hours. 
To the resulting light brown color solution was added 500 mL of ethylene glycol. This mixture 
was cooled to 35
o
C, and bromine (140 g, 0.75 mol) was added dropwisely via a dropping funnel 
to maintain the reaction temperature below 40 
o
C. The stirring continued for 15 minutes after the 
addition of bromine, and the reaction mixture was directly extracted with hexanes (200mL×3). 
Na2CO3 (20.0 g) was added to the combined hexane extract, stirred with for 10 minutes, and 
filtrated off.  The hexane was removed over rotavapor, and the product was distilled under 
vacuum (1~2 torr., b.p.: 49 – 53 oC) to give a colorless liquid 48 g (35% yield). 1H NMR δ 4.16 
(q, J = 6.8 Hz, 1H, BrC-H), 4.09 – 4.03 (m, 4H), 1.99 (m, 1H), 1.79 (m, 1H), 1.68 (d, J = 6.8 Hz, 
3H), 0.92 (t, J = 7.6 Hz, 3H). 
99 
 
 2-Ethyl-2-vinyl-1,3-dioxolane (2.48).15 
Me Me
O O
Br
NaOH, MeOH Me
O O
2.48
90% yield
2.47  
Compound 2.47 (48.0 g, 0.23 mol) was mixed with sodium hydroxide (32.2 g, 0.8 mol) in 
70 mL MeOH under argon. This mixture was heated to reflux for 24 hours. To the cooled 
reaction mixture was added 150 mL of water and extracted with ether (200 mL×2). The 
combined organic layer was washed with water (200 mL×2), brine and dired over MgSO4. The 
ether was removed under vacuum to give 26.1 g of desired product 2.48 (90% yield). 
1
H NMR δ 
5.73 (dd, J = 17.2, 10.4 Hz, 1H), 5.36 (dd, J = 16, 1.6 Hz, 1H), 5.17 (dd, J = 10.8, 1.6 Hz, 1H), 
3.97 – 3.87 (m, 4H), 1.73 (q, J = 7.2 Hz, 2H), 0.93 (t, J = 7.2 Hz, 3H). 
 Ethyl vinyl ketone.14  
Me
O O
cata. PTSA, H2O
O
Me
Ethyl vinyl ketone
90% yield
2.48  
Compound 2.48 (26.1 g, 0.20 mol), PTSA (0.2 g, 0.01 mmol) was stirred in 30 mL water 
at 25 
o
C under argon for 10 hours. The organic layer was separated and dried over Na2SO4 to 
give 15.2 g of pure ethyl vinyl ketone (90% yield). This is a commercial available chemical. The 
1
H NMR is provided here for reference and is identical to that of the commercial mateiral. 
1
H 
NMR δ 6.36 (dd, J = 16.8, 10.4 Hz, 1H), 6.23 (dd, J = 16.8, 1.2 Hz, 1H), 5.82 (dd, J = 10.4, 1.2 
Hz, 1H), 2.62 (q, J = 6.8 Hz, 2H), 1.11 (t, J = 6.8 Hz, 3H). 
 (-)-(4aR,5R)-5-(tert-butyldimethylsilyloxy)-1,4a-dimethyl-4,4a,5,6,7,8-
hexahydronaphthalen-2(3H)-one  [(-)-2.53]. (JL-11-057) 
OH
Me
O
(-)-2.29
TBSCl, imidazole, DMF
90% yield
OTBS
Me
O
(-)-2.53  
To (-)-2.29 (400 mg, 2.06 mmol) and imidazole (272 mg, 4.0 mmol) in 15 mL dry DMF 
under argon at 25 
o
C was added TBSCl (467 mg, 3.1 mmol) at once. Then this mixture was 
stirred overnight. The reaction mixture was diluted with 50 mL aq. NH4Cl and extracted with 
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ethyl acetate (50 mL×3). The combined organic layer was washed with water, brine, dried over 
MgSO4. Ethyl acetate was concentrated off by rota-vapor, the residue was loaded on silica gel 
column which was eluted firstly with 200 mL hexane and 150 mL the mixture of hexane and 
ether (5:1) to recover (-)-2.29 (105 mg) and give (-)-2.53 (430 mg, 90% yield, calculated based 
on recovered (-)-2.29) as colorless oil. (-)-2.53 became a white solid after stored in the fridge 
overnight. []24= -106
o
, (c = 0.345 g in 100 mL chloroform); 
1
H-NMR: δ 3.35 (dd, J = 10.8, 5.6 
Hz, 1H), 2.65 (d, J = 14.8 Hz, 1H), 2.42 - 2.38 (m, 2H), 2.09 - 2.00 (m, 2H), 1.88-1.81 (m, 1H), 
1.77 (s, 3H), 1.71 - 1.62 (m, 3H), 1.36 - 1.24 (m, 1H), 1.14 (s, 3H), 0.90 (s 9H), 0.04 (d, J = 7.2 
Hz, 6H); 
13
C-NMR (CDCl3) δ 199.4, 161.5, 129.9, 79.2, 42.7, 34.2, 33.9, 30.7, 27.3, 26.1 (3 
carbons, t-Bu), 22.9, 18.3, 16.2, 11.5, -3.7, -4.7. 
 Vinyl bromide. 
Br
Br
1,2-dibromoethane
KOH, EtOH, 60 oC
48% yield Br
Vinyl bromide  
KOH (90 g, 1.5 mol), 600 mL Ethanol were added to a three-neck flask which was 
equipped with distillation apparatus [Long Vigreux column (30 cm), distillation head, long 
condenser (circulating ice-cold water), distillation adaptor and collection flask which was cooled 
by dry-ice]. To this mixture was added 1,2-dibromoethane (100 mL, 1.2 mol) over 1 hour via a 
syringe pump at 40 
o
C under argon. Vinylbromide was distilled out (b.p. = 16 
o
C) at 60 
o
C under 
argon. The crude product was redistilled over CaSO4 to give dry vinyl bromide 61 g (48% yield). 
Obtained vinyl bromide should stor at -78
o
C all the time. 
 
 Vinyl trimethylsilane. 
Br
Vinyl bromide
Mg, THF, TMSCl
TMS
75% yield
Vinyl trimethyl silane  
To a mixture of magnesium (10 g, 0.42 mol, from Strem Chemical Co.) and catalytic 
amount of iodine in 300 mL THF was slowly added vinyl bromide (30 g, 0.28 mol). Reaction 
was initiated by adding about 1 mL of vinyl bromide and heated to reflux by heat gun. After the 
initiation, the rest of bromide was cannulated into the reaction slowly to maintain a gentle reflux 
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of THF. After the adding of vinyl bromide, the mixture was stirred at 25 
o
C for 20 mins and 
heated to reflux for 2 hours to result a brown color solution. The mixture was cooled to 25 
o
C, 
and distilled TMSCl (30 g, 0.28 mol) in 30 mL THF was added slowly. The mixture was stirred 
for 2 hours at 25 
o
C, and the product was directly distilled out from the reaction mixture as the 
azeotrope of THF. This clear distillate was washed with water several times to get rid of THF, 
and the residue was dried over Na2SO4 to give vinyltrimethylsilane (21 g, 75% yield) as a 
colorless liquid. This is a commercial available chemical. The 
1
H NMR is provided here for 
reference, and the chemical shifts are identical to that of reported.
22
  
1
H-NMR: δ 6.16 (dd, J = 20, 
16 Hz, 1H), 5.93 (dd, J = 16, 4 Hz, 1H), 5.68 (dd, J = 20, 4 Hz, 1H), 0.08 (s, 9H).  
 
 -Trimethylsilyl vinyl bromide (2.70).22 
TMS
Vinyl trimethyl silane
1. Br2, pentane
2. Diethylamine
TMS
Br
2.70
66% yield, two steps
 
To a stirred solution of vinyltrimethylsilane (36 g, 0.36 mol), at -78
o
C, in 50 mL pentane 
was added bromine (57.6 g, 0.36 mol) dropwisely under argon. The resulted orange color 
mixture was stirred at -78 
o
C for 1 hour, diluted with water and extracted with ether (150 mL×3). 
The combined organic layer was washed with aq. Na2S2O5 (to remove any excess amount of 
bromine), aq. NaHCO3, and brine, and dried over MgSO4. The diethyl ether was concentrated by 
rota-vapor with a cool water bath (<40 
o
C) to give dibromide product. To this dibromide 
compound was added diethylamine (53 g, 0.72 mol) at 25 
o
C, and this mixture was stirred for 14 
hours. The resulted white diethylamine salt was filtrated off. To the clear filtrate was added 
additional amount of diethylamine (26 g, 0.36 mol). The reaction was kept stirring for 10 hours 
and monitored by NMR. When no dibromide compound was detected, the diethylamine salt was 
filtrate off, and the clear solution was diluted with 300 mL ether. This solution was gently 
washed with 1 N HCl several times until the pH is neutral, water, brine and dried over MgSO4. 
The ether was distilled out at 1 atm to give crude product. Distillation of this crude product (1 
atm, b.p.: 165 
o
C) finally gave pure 2.70 (42 g, 66% yield) as colorless liquid.
 1
H-NMR: δ 6.28 
(d, J = 1.6 Hz, 1H), 6.19 (d, J = 1.6Hz, 1H), 0.02 (s, 9H); 
13
C-NMR 139.2, 129.6, -2.2 (3 carbons, 
Me3Si). 
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 2-(Trimethylsilyl)pent-1-en-3-ol  (2.71).22 
TMS
Br
2.70
Mg, propyl aldehyde
THF
Me
OH
TMS
2.71
86% yield
 
To a mixture of magnesium (1.4 g, 56 mmol) in 50 mL dry THF was added 0.2 mL of 
1,2-dibromoethane, and the mixture was heated to reflux for 3 minutes. Bromide 2.70 (5.0 g, 28 
mmol) was added dropwisely. The reaction was initiated by heating with heat gun, and the 
bromide was slowly added into the mixture it to maintain a gentle reflux. The mixture was stirred 
at 25 
o
C for 30 minutes, heated to reflux for 1.5 hours and then cooled to -10 
o
C. Distilled propyl 
aldehyde (2.4 g, 42 mmol) in 10 mL THF was added slowly. Reaction mixture was warmed to 25 
o
C after the addition, stirred for 2 hours and quenched by aq. NH4Cl. The product was extracted 
out with ether (60 mL×3). Combined organic layer was washed with water, brine, dried over 
MgSO4. Ether was distilled off at 1 atm, and the crude product was purified on silica gel column 
by using a mixture of hexane and ether (4:1) as eluent to give 2.71 (3.89 g, 86% yield) as 
colorless liquid.
 1
H-NMR: δ 5.77 (s, 1H), 5.42 (s, 1H), 4.20 (t, J = 6.0 Hz, 1H), 1.66 – 1.48 (m, 
3H, merged with a broad -OH), 0.91 (t, J = 7.2 Hz, 3H), 0.13 (s, 9H); 
13
C-NMR 156.3, 124.2, 
77.9, 30.2, 10.3, -0.4 (3 carbons, Me3Si). 
 
 -Trimethylsilyl vinyl ethyl ketone 
Me
OH
TMS
2.71
PDC
Me
O
TMS
-trimethylsiyl vinyl 
ethyl ketone
65% yield
 
To the mixture of PDC (7.7g, 36 mmol) in 50 mL DCM was added 2-(trimethylsilyl) 
pent-1-en-3-ol (2.71) (3.8 g, 24 mmol) in 50 mL of DCM slowly at 0 
o
C. The mixture was 
warmed up to 25 
o
C and stirred for 14 hours. The resulted brown solid was filtrated off through a 
short silica gel pad, and the silica gel was washed with 20 mL DCM. The combined DCM was 
distilled off at 1 atm, and the crude product was purified on silica gel column with a mixture of 
ether and hexane (1:4) was eluent to give desired product 2.28 g (61 % yield) as yellow liquid. .
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1
H-NMR: δ 6.45 (d, J = 1.6 Hz, 1H), 6.09 (d, J = 1.6 Hz, 1H), 2.66 (q, J = 7.2 Hz, 2H), 1.08 (t, J 
= 7.2 Hz, 3H), 0.16 (s, 9H); 
13
C-NMR 207.2, 154.1, 135.1, 31.8, 8.3, -1.2 (3 carbons, Me3Si). 
 
 (+)-(4aR,8R,8aR)-8-(tert-Butyldimethylsilyloxy)-1,4a,8a-trimethyl-
4,4a,4b,5,6,7,8,8a,9,10-decahydrophenanthren-2(3H)-one  [(+)-2.72].(JL-12-059) 
OTBS
Me
O
(-)-2.53
1. Li, liq. NH3, t-BuOH, -35
 oC,
2. -Trimethylsilyl vinyl ethyl ketone,
3. 6% KOH, MeOH, reflux
58% yield, 4 steps
OTBS
Me
O
(+)-2.72  
To liquid NH3 (40 mL) at -78 
o
C was added lithium (56 mg, 8.1 mmol). After stirring for 
30 minutes at this temperature, a solution of (4aR,5R)-5-(t-butyldimethylsilyloxy)-1,4a-
dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one [(-)-2.53] (1.0 g, 3.2 mmol) and t-butanol 
(179 mg, 2.56 mmol) in 10 mL dry ether was injected. Then this mixture was refluxed at -35 
o
C 
for 2 hours. A few drops of isoprene (freshly distilled over sodium) were injected to quench the 
excess amount of lithium. Liquid NH3 was evaporated off at room temperature, and the residue 
was connected to the high vacuum at 40
o
C for 10 minutes. The resulting white residue was 
dissolved in 40 mL dry ether again, cooled to -78
o
C and protected from light by covering with a 
black cloth. -Trimethylsilylvinyl ethyl ketone (0.75 g, 4.8 mmol) in 10 mL dry ether was added 
into this mixture over 30 minutes by syringe pump. The reaction mixture was warmed up to -40 
o
C and allow the temperature gradually warmed up to -10 
o
C over 2 hours with stirring. NH4Cl 
aq. was added into this mixture, and extracted with ethyl acetate (60 mL×3). The combined 
organic layer was washed with water, and concentrated off under reduced pressure. The residue 
was dissolved with 100 mL methanol and 20 mL 6% KOH aq., and this mixture was heated to 
reflux for 2 hours. Acetic acid was added to neutralize excess amount of base, and the methanol 
was evaporated under a rotary evaporator. The residue was diluted with aq. NH4Cl, extracted 
with ethyl acetate (60 mL×3). Combined organic layer was washed with water, brine, dried over 
MgSO4. The crude product was purified by column chromatography using a mixture of hexane 
and diethyl ether (3:1) to give desired product 680 mg (58% yield) as colorless oil. []27= +45.2
o
, 
(c = 0.25 in chloroform); 
1
H-NMR: (CDCl3) δ 3.06 (dd, J = 11.2, 4.8 Hz, 1H), 2.67 (dt, J =11.6, 
3.2 Hz, 1H), 2.49 – 2.31 (m, 2H), 2.23 (td, J = 12.8, 2.8 Hz, 1H), 2.04 - 1.97 (m, 2H), 1.79 (s, 
104 
 
3H), 1.78 – 1.75 (m, 1H), 1.59 – 1.11 (m, 6H), 1.15 (s, 3H), 1.11 – 1.02 (m, 2H), 1.05 (s, 3H), 
0.89 (s, 9H), 0.02 (d, J = 1.6 Hz, 6H); 
13
C-NMR (CDCl3) δ 199.2, 164.6, 128.4, 81.1, 55.6, 40.0, 
39.4, 38.2, 36.5, 33.5, 31.1, 26.1 (3 carbons, t-Bu), 24.6, 24.5, 20.6, 18.6, 18.3, 12.5, 11.3, -3.7, -
4.6. 
 
 (+)-(4aR,8R,8aR)-8-(tert-Butyldimethylsilyloxy)-1,1,4a,8a-tetramethyl-
decahydrophenanthren-2(1H,3H,4bH)-one [(+)-2.73].(JL-12-087) 
OTBS
Me
O
(+)-2.72
Li, NH3, THF, MeI
OTBS
O
(+)-2.73
65% yield
H H
H
 
To liquid NH3 (20 mL) at -78 
o
C was added lithium (30 mg, 4.3 mmol). After stirring for 
30 minutes at this temperature, (+)-2.72 (400 mg, 1.1 mmol) in 2 mL dry THF was added slowly. 
Then the mixture was refluxed at -35 
o
C for 2 hours and cooled to -78 
o
C degree. Dry THF (35 
mL) was injected and the mixture was stirred at -78 
o
C for 10 minutes. Methyl iodide (1.4 mL, 
22 mmol, 20 eq.) was added into the bottom part of the reaction by a long needle. After stirring 
at -78
 o
C for 30 minutes, another batch of methyl iodide (1.4 mL, 22 mmol, 20 eq.) was added. 
This mixture was allowed to warm up to room temperature slowly over 14 hours and diluted with 
NH4Cl aq., and extracted with ethyl acetate (40 mL×3). The combined organic layer was washed 
with water, brine, and dried over MgSO4. The organic layer was concentrated and purified by 
column chromatography using a mixture of hexane and diethyl ether (10:1) to give desired 
product 265 mg (65% yield) of (+)-2.73 as colorless solid. []27= +8.2
o
, (c = 0.25 in chloroform); 
1
H-NMR: (CDCl3) δ 3.06 (dd, J = 11.2, 4.8 Hz, 1H), 2.56 – 2.38 (m, 2H), 1.96 - 1.90 (m, 2H), 
1.78 - 1.69 (m, 1H), 1.55 - 1.17 (m, 11H), 1.08 (s, 3H), 1.04 (s, 3H), 0.94 (s, 3H), 0.90 (s, 3H), 
0.89 (s, 9H), 0.03 (6H); 
13
C-NMR (CDCl3) δ 218.2, 81.5, 56.7, 55.4, 47.7, 40.4, 39.6, 39.5, 37.0, 
34.4, 31.3, 26.8, 26.1 (3 carbons, t-Bu), 24.8, 21.3, 20.7, 19.6, 18.3, 16.4, 13.2, -3.7, -4.5. 
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 (-)-(4a'R,8'R,8a'R)-1',1',4a',8a'-8-t-Butyldimethylsilyoxy-tetramethyldodecahydro-
1'H-spiro[1,3]dioxolane-2,2'-phenanthren[(-)-2.74]. 
OTBS
O
(+)-2.73
Ethylene glycol, 
PTSA,benzene OTBS
(-)-2.74
O
O
95% yield
H
H
H
H
 
(4aR,8R,8aR)-8-(tert-Butyldimethylsilyloxy)-1,1,4a,8a-tetramethyl dodecahydro 
phenanthren -2 (1H)-one (+)-2.73 (2.0 g, 5.25 mmol), PTSA (50 mg, 0.3 mmol) and ethylene 
glycol (3.25 g, 52 mmol) were refluxed in benzene with a Dean-Stark apparatus to remove water 
for 2 hours. The solution was cooled to room temperature, diluted with aq. NaHCO3, and 
extracted with ether (50 mL×3). The combined organic layer was washed with water, brine, and 
dried over MgSO4. The crude product was purified by column chromatography using a mixture 
of hexane and ethyl acetate (5:1) to give desired product 2.1 g (95% yield) as a colorless solid. 
[]27= - 49
o
, (c = 0.23 in chloroform); 
1
H-NMR: δ 3.97 – 3.87 (m, 4H), 3.05 (dd, J = 11.2, 4.8 
Hz, 1H), 1.88 – 1.76 (m, 2H), 1.73 – 1.65 (m, 1H), 1.60 (ddd, J = 13.2, 7.2, 3.6 Hz, 1H), 1.52 – 
1.32 (m, 6H), 1.29 – 1.10 (m, 5H), 1.04 – 0.95 (m, 1H), 0.93 (s, 3H), 0.87 (s, 12 H), 0.86 (s, 3H), 
0.84 (s, 3H), 0.00 (s, 6H) ; 
13
C-NMR δ 113.6, 81.7, 65.09, 65.07, 57.2, 54.0, 42.4, 40.4, 40.3, 
37.3, 37.1, 31.4, 27.1, 26.2 (3 carbons, t-Bu), 24.8, 23.1, 20.3, 20.1, 18.4, 18.3, 16.4, 13.6, -3.7, -
4.6. 
 
 (-)-(4a'R,8'R,8a'R)-1',1',4a',8a'-Tetramethyldodecahydro-1'H-spiro[[1,3]dioxolane-
2,2'-phenanthren] -8'-ol [(-)-2.32].(JL-14-044) 
OTBS
(-)-2.74
O
O
H
H
TBAF
OH
(-)-2.32
O
O95% yield
H
H
 
27 mL of 1.0 M tetrabutylamnium fluoride in THF was diluted with 20 mL dry THF. 
This solution was pre-dried by 3Å molecular sieves and transferred into tert-
butyldimethyl((4a'R,8'R,8a'R)-1',1',4a',8a'-tetramethyldodecahydro-1'H-spiro[[1,3] dioxolane -
2,2'- phenanthrene]-8'-yloxy)silane  [(-)-2.74] (2.0 g, 4.6 mmol) in 30 mL dry THF. The resulting 
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solution was stirred at 60 
o
C under argon for 14 hours, diluted with NH4Cl aq., and extracted 
with ethyl acetate (50 mL×3). The combined organic layer was washed with water, brine, dried 
over MgSO4, and concentrated off under vacuum, and the crude product was purified on silica 
gel column with a mixture of ether and hexane (1:1) as eluent to give 1.4 g of pure (+)-2.32 (95% 
yield) as white solid. []25= - 45
o
, (c = 0.1 in chloroform; lit 
24
: []25= - 44
o
, c = 0.1, 98 %ee); 1H 
NMR δ 3.99 – 3.86 (m, 4 H), 3.13 (ddd, J = 11.4, 8.4, 4.1 Hz, 1 H), 1.90 – 1.74 (m, 2 H), 1.73 – 
1.08 (m, 15 H), 0.93 (s, 3 H), 0.88 (s, 6 H), 0.85 (s, 3 H) ; 
13
C-NMR (CDCl3) δ ppm 113.5, 81.4, 
65.1, 56.8, 53.8, 42.4, 39.8, 39.4, 37.2, 37.0, 30.4, 27.1, 26.1, 24.8, 23.2, 20.2, 20.1, 18.3, 16.5, 
13.3.  
 
 (-)-(4a'S,8a'R)-1',1',4a',8a'-Tetramethyldecahydro-1'H-spiro[[1,3]dioxolane-2,2'-
phenanthren ]-8'(3'H)-one [(-)-2.33].(JL-14-045) 
OH
(-)-2.32
O
O
IBX O
(-)-2.33
O
O95% yield
H
H
H
H
 
To the (-)-2.32 (240 mg, 0.75 mmol) in 5 mL DMSO was added IBX (208 mg, 0.89 
mmol) at 25 
o
C under argon. This solution was stirred for 14 hours. The white participate was 
filtrated off. The filtrate was diluted with aq. NaHCO3, and extracted with ether (60 mL×3). 
Combined organic layer was washed with water, brine, and dried over MgSO4 and concentrated 
under vacuum, and the crude product was purified on silica gel column with a mixture of hexane, 
DCM, ether (5:3:1) as eluent to give 220 mg of pure (-)-2.33 (95% yield) as white solid. []25= - 
27
o
, (c = 0.27 in chloroform, 100%ee; lit.
24
: []25= - 26
o
, c = 0.14, 98 %ee); 1H NMR δ 3.98 – 
3.86 (m, 4 H), 2.54 (td, J = 14.0, 6.9 Hz, 1 H), 2.18 (dm, 1 H), 2.08 – 2.01 (m, 1 H), 1.82 (td, J = 
13.9, 4.0 Hz, 1 H), 1.75 – 1.35 (m, 10 H), 1.26 (dd, J = 12.3, 2.1 Hz, 1 H), 1.18 (dd, J = 11.8, 3.0 
Hz, 1 H), 1.14 (s, 3 H), 0.98 (s, 3 H), 0.94 (s, 3 H), 0.84 (s, 3 H); 
13
C-NMR δ 215.9, 113.2, 65.1, 
65.1, 57.6, 53.2, 49.4, 42.4, 38.3, 37.9, 37.1, 34.7, 27.0, 26.4, 23.1, 20.3, 20.07, 20.04, 18.0, 16.8.  
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 N, N, -diethylgeranylamine (2.78).25 
Me
+ Me N
H
Me
cata. n-Butyllithium;
N
Me
Me
Isoprene Diethylamine 2.78
75% yield
 
Isoprene was distilled over sodium; and diethylamine was distilled over CaH2 before use.  
To a dry sealed tube was added isoprene (20 mL, 0.20 mol) and diethylamine (6 mL, 0.04 
mol) at 0 
o
C under argon. To this solution was added 1.6 M n-BuLi (2.5 mL) to result a light 
yellow color solution. The tube was capped tightly and heated to 65 
o
C 12 hours. The reaction 
mixture was cooled to 0 
o
C, and 15 mL of water was added to quench the reaction. The mixture 
was extracted by ether (20 mL×2), and the combined organic layer was dried over MgSO4. The 
ether was concentrated under vacuum, and the crude product was purified by vacuum distillation 
(b.p: 90 – 95 oC, 3 torr.) to give pure amine 5.65 g (75% yield) as colorless oil. 1H NMR δ 5.24 (t, 
J = 6.8 Hz, 1H), 5.09 (s, 1H), 3.04 (dd, J = 7.2, 1.2 Hz, 2H), 2.49 (q, J = 6.0 Hz, 4H), 2.04 (d, J = 
3.2 Hz, 4H), 1.71 – 1.60 (m, 9H), 1.01 (t, J = 6.0 Hz, 6H). 
 
 1-(4,4-dimethylcyclohex-1-enyl)ethanone (2.75).26 
N
Me
Me
2.78
(1), H2O2.
(2), H2SO4, H2O;
(3), NaOH, H2O.
45 % yield, 
three steps
O Me
2.75  
A 50 % of hydrogen peroxide aqueous solution was added to compound 2.78 (1.05 g, 5 
mmol) in 10 mL methanol at 25 
o
C. This solution was stirred for 48 hours. Then PtO2 (3 mg) was 
added to the reaction solution and stirred for 2 hours to destroy the excess amount of hydrogen 
peroxide. Removal of the methanol to give desired N-oxide. The N-oxide residue was diluted 
with 500 mL H2O. To this diluted solution was added 10 mL of 50 % H2SO4, and the mixture 
was heated to 100 
o
C for 24 hours and cooled to 0 
o
C with ice bath. To the resulted light brown 
solution was added 10 g of NaOH in 20 mL water. This mixture was heated to 100 
o
C for 24 
hours and cooled to 25 
o
C. The excess amount of NaOH was neutralized with 10 % HCl, and the 
product was extracted with ether (100 mL×3). The combined organic layer washed with water, 
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brine, dried over MgSO4, and distilled at 1atm to remove ether, and the crude product was 
purified on silica gel column with a mixture of hexane and ether (1:1) as eluent to give 340 mg 
of pure 2.75 (45 % yield) as colorless oil with pleasant ordor.
 1
H NMR δ 6.82 (m, 1H), 2.31 (s, 
3H, -CH3), 2.26 – 2.24 (m, 2H), 2.05 – 2.03 (m, 2H), 1.41 (t, J = 4.8 Hz, 2H), 0.8 (s, 6H). 
 
 (-)-Trimethyl((4a'R,8a'R)-1',1',4a',8a'-tetramethyl-3',4',4a',4b',5',6',8a',9',10',10a'-
decahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthrene]-8'-yloxy)silane [(-)-2.81]. 
O
O
O
LDA, TMSCl,THF
(-)-2.33
98 %
O
O
OTMS
(-)-2.81
H
H
H
H
 
Trimethylsilyl chloride (TMSCl) was distilled twice over CaH2, and to the distilled 
TMSCl was added distilled Et3N (volume ratio: TMSCl : Et3N = 7 : 1). The mixture was 
centrifuged for 2 minutes, and the clear supernatant was used for the reaction. 
To the solution of diisopropylamine (0.05 mL, 0.35 mmol) in 1.5 mL dry THF was added 
1.6 M n-BuLi (0.21 mL, 0.33 mmol) at -78 
o
C under argon. The solution was stirred for 30 
minutes and transfered into compound (-)-2.33 (100 mg, 0.33 mmol) in 2 mL THF at -78 
o
C 
under argon. The mixture was warmed up to 25 
o
C, stirred for 2 hours and cooled to -78 
o
C. To it 
was added TMSCl (0.136 mL, 1 mmol), and the mixture stirred at -78 
o
C for 30 minutes. The 
reaction was diluted with 5% aqueous NH4OH solution, extracted with ether (20 mL×3). The 
combined organic layer washed with water, brine and dried over Na2SO4. The combined ether 
was distilled under vacuum, and the crude product was chromatographed on silica gel column 
with a mixture of hexane, DCM and ether (5:3:1) as eluent to give 110 mg of pure (-)-2.81 (98 % 
yield) as white solid. []25= - 32
o
, (c = 0.55 in chloroform); 1H NMR δ 4.50 – 4.87 (m, 1H), 3.98 
– 3.87 (m, 4H), 2.06 – 1.78 (m, 4H), 1.67 – 1.11 (m, 10H), 1.05 (s, 3H), 0.93 (s, 3H), 0.88 (s,3H), 
0.83 (s, 3H), 0.15 (s, 9H); 
13
C-NMR δ 159.0, 113.6, 100.0, 65.1 (2 carbons, acetal), 55.9, 53.8, 
42.5, 39.6, 37.1 (2 carbons, gem-dimethyl), 36.9, 27.1, 24.9, 23.1, 20.9, 20.0, 18.5, 17.9, 16.7, 
0.6 (3 carbons. TMS). 
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 2,2-Dimethylpent-4-enal (2.89). 
OH +
Me
Me
H
O cat. PTSA, mesitylene, Dean-Stark reflux
90% yield
Me Me
H
O
2.89Allyl alcohol Isobutyraldehyde  
Allyl alcohol (21.7g, 0.375 mol), isobutyraldehyde (40.5 g, 0.56 mol) and p-
toluenesulfonic acid(0.125g, 6.5 mmol) in mesitylene (70 mL)was heated at 220 
o
C by heating 
mental for 48 hours with Dean-Stark apparatus and a long Vigreux column (30 cm). The product 
was distilled at 1 atm to give 40 g (90 % yield) as colorless liquid. (The product was distilled out 
as the azeotrope of mesitylene which can be separated at next step); 1H NMR δ 9.50 (s, 1H), 5.77 
– 5.67 (m, 1H), 5.11 – 5.06 (m, 2H), 2.23 (d, J = 7.6 Hz, 2H), 1.07 (s, 6H).  
  
2,2-Dimethylpent-4-en-1-ol (2.88).  
Me Me
H
O
2.89
NaBH4, 5% NaOH aq.  MeOH Me Me
OH
2.88
90% yield
 
The sodium borohydride (4.8 g, 0.132 mol) in 60 mL 0.2 M NaOH aq. solution was 
added slowly in to a solution of aldehyde 2.89 (40 g,  0.35 mol) inMeOH (400 mL) over 30 
minutes. It was stirred at 25 
o
C for 10 hours. The MeOH was distilled off, and the residue was 
diluted with NH4Cl aq., extracted with ether (100 mL×3). The combined organic layer was 
washed with water, brine, and dried over MgSO4. The ether was removed under reduced pressure, 
and the residue was purified by column chromatography with pure hexane and the mixture of 
hexane ether (1:1) to give pure product as colorless oil (38 g, 90% yield); 1H NMR δ 5.94 – 5.82 
(m, 1H), 5.07 – 5.04 (m, 2H), 3.34 (s, 2H), 2.03 (d, J = 8.0 Hz, 2H), 0.89 (s, 6H). 
 
 5-Bromo-4,4-dimethyl-pent-1-ene (2.87).31 
Me Me
OH
2.88
PPh3, Br2, DMF Me Me
Br
2.87
65% yield
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Bromine (7.7 g, 48.8 mmol) was added to triphenylphsophine (12 g, 45.9mmol) in 30 mL 
DMF (dried over 3 Å molecular sieve), and the mixture was stirred for 30 minutes. To it, a 
solution of alcohol 2.88 (5.0 g, 43.8 mmol) in 30 mL DMF was added slowly. The resulting 
black solution was heated to 130 
o
C for 2 hours, cooled to 25 
o
C and diluted with 70 mL water. 
The mixture was extracted with pentane (60 mL×10), and the combined organic layer was 
washed with water, brine, and dried with MgSO4. The pentane was distilled off at 1 atm, and the 
product was distilled from this residue at 180 
o
C to give a colorless liquid with pleasant odor (4.5 
g, 65 % yield).1H NMR δ 5.83 – 5.72 (m, 1H), 5.12 – 5.07 (m, 2H), 3.28 (s, 2H), 2.11 (d, J = 7.4 
Hz, 2H), 1.02 (s, 6H). 
 
 6,6-Dimethylnon-8-en-2-one (2.86). 
Me Me
Br
Me
Me Me O
1. Mg, cat. anthracene, dibromoethane, THF;
2. CuI.MeSMe, methyl vinyl ketone, ether
40% yield
2.87 2.86  
[Activation of magnesium: If the magnesium is not new purchased, it should be activiated 
by the following procedure: the metal was washed with 1 N HCl several times until a shiny 
surface appeared, then washed with distilled water several times to remove excess acid; the 
washed magnesium could be transferred into a Hirsh funnel (without filtering paper) and wash 
with water, THF and dried under high vacuum for 1 hour with heating to give activiated 
magnesium] 
To a mixture of magnesium (7.0 g, 227 mmol), anthracene (1.0 g, 5.6 mmol) in 100 mL 
of dry THF under argon was added 1,2-dibromoethane (0.5 mL, 5.7 mmol), and this mixture was 
heated to reflux with heat gun for 5 minutes. After cooling to 25 
o
C, the mixture stirred for 14 
hours to give green-orange color mixture (a green color normally showed up after stirring for 1 
hour). 
To this green-orange mixture was added bromide 2.87 (8.0 g, 45.5 mmol) to form the 
Grignard reagent.  Firstly, about 1 g of bromide was added into the mixture, the mixture was 
heated up to reflux with heat gun. The rest of bromide was injected slowly to maintain a gentle 
reflux of the THF. The mixture was stirred at 25 
o
C for 30 minutes after the addition of the 
bromide, heated to reflux for 2 hours and cooled to 25 
o
C to give a black color solution.  
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To a three neck flask equipped with low temperature thermometer were added cuprous 
iodide dimethyl sulfide complex (CuI
.
Me2S)
31
 (5.75 g, 27.8 mmol), 15 mL dimethlsulfide, and 
20 mL of dry ether under argon.  The mixture was cooled to -40 
o
C, and the prepared Grignard 
reagent was cannulated into this mixture slowly to maintain the temperature below -30 
o
C. The 
mixture was stirred for 40 minutes to let temperature rise to -20 
o
C.  This mixture was cooled to -
40 
o
C, and methyl vinyl ketone (1.4 g, 26.1 mmol) in 3 mL ether was added. The mixture stirred 
for 2 hours to allow the temperature raise to 10 
o
C.  To it, 200 mL mixture of NH4Cl aq. and 
NH4
.
OH aq. (4:1) was added into the reaction, and the mixture stirred for 1 minute. The crude 
product was extracted with ether (50 mL × 4). The combined organic layer was washed with 10 % 
aqueous NH4
.
OH two times, water, brine and dried over MgSO4. The ether and THF was 
distilled out at 1 atm., and the residue was purified by column using a mixture of hexane ether 
(15:1) as eluent to give pure product as a yellow oil (1.6 g, 40% yield); 1H NMR chromatography 
with δ 5.84 – 5.73 (m, 1H), 5.01 – 4.94 (m, 2H), 2.38 (t, J = 7.6 Hz, 2H), 2.12 (s, 3H), 1.94 (d, J 
= 7.6 Hz, 2H), 1.58 – 1.49 (m, 2H), 1.16 – 1.12 (m, 2H), 0.85 (s, 6H); 13C NMR δ 209.4, 135.8, 
116.9, 46.5, 44.7, 41.5, 33.3, 30.1, 27.1 (2 carbons, gem-dimethyl), 18.7. 
 
 3,3-Dimethyl-7-oxooctanal (2.46). 
Me
Me Me O
2.86
cat. OsO4, NaIO4, dioxane, H2O
56% yield
Me
Me Me O
O
H
2.46  
Caution: OsO4 is extremely toxic! 
To compound 2.86 (1.0 g, 6.0 mmol) in 30 mL dioxane and 6 mL H2O was added OsO4 
(12 mg, 0.06 mmol) at 25 
o
C. The mixture was stirred for 40 minutes to give a dark brown 
solution. To this solution, sodium perioddate (2.5 g, 12 mmol) was added slowly over 20 minutes. 
The mixture was stirred at 25 
o
C for 4 hours, diluted with water, and extracted with ether (40 
mL×4). The combined organic layer washed with water, brine, and dried over MgSO4. Ether and 
most of the dioxane were distilled off at 1 atm., and the crude product was purified by column 
chromatography with the mixture of hexane ether (1:1) to give pure product as yellow oil (0.52 g, 
56% yield). 1H NMR δ 9.83 (t, J = 3.2 Hz, 1H), 2.42 (t, J = 6.8 Hz, 2H), 2.27 (d, J = 3.2 Hz, 2H), 
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2.13 (s, 3H), 1.61 – 1.53 (m, 2H), 1.32 – 1.27 (m, 2H), 1.05 (s, 6H); 13C NMR δ 208.9, 203.8, 
54.8, 44.2, 42.2, 33.7, 30.0, 27.6 (2 carbons, gem-dimethyl), 18.5. 
 
 (-)-(4a'S,8a'R,E)-7'-(3,3-dimethyl-7-oxooctylidene)-1',1',4a',8a'-
Tetramethyldecahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthren]-8'(3'H)-one [(-)-
2.76]. 
Me
Me Me O
O
H
2.46
O
O
OTMS
(-)-2.81
H
H
+
1. BF3.ether, DCM, 95% yield,
2. MsCl, Et3N, ether
3. DBU, toluene, DCM, 75% two steps O
Me O
O
O
(-)-2.76  
To a solution of compound (-)-2.81 (0.50 g, 1.1 mmol) and ketone aldehyde 2.46 (0.23 g, 
1.3 mmol) in 25 mL distilled DCM at -78 
o
C under argon was added BF3.ether (0.34 mL, 2.7 
mmol). This mixture stirred at -78 
o
C for 2 hours and stored in dry-ice for 10 hours. To it (at -78 
o
C) was added 5 mL saturated aqueous NaHCO3 solution to quench the reaction. The mixture 
was diluted with water, and extracted with ethyl acetate (30 mL×3). The combined organic layer 
was washed with water, brine, and dried over MgSO4. Ethyl acetate was evaporated off under 
vacuum, and the residue was column chromatographed on the silica gel column to recover the 
compound (-)-2.33 (30 mg, 9% revovery) and get desired aldol product 2.92 [430 mg, 92 % yield, 
calculated based on the recovery of ketone (-)-2.33]. 
To a solution of compound 2.92 (430 mg, 0.91 mmol) and Et3N (1.3 mL, 8.1 mmol) in 30 
mL distilled ether was added MsCl (342mg, 3 mmol) at 0 
o
C under argon. The mixture was 
stirred for 14 hours, quenched with 5 % aqueous NH4Cl, and extracted with ethyl acetate (30 
mL×3). The combined organic layer was washed with 10 % aqueous NaHCO3, water, brine, 
dried over Na2SO4, and concentrated under vacuum. The residue was dissolved in 20 mL of a 
mixture of DCM and toluene (1:1).  To it was added DBU (276 mg, 1.82 mmol) at 25 
o
C. This 
mixture was stirred for 15 hours, diluted with aqueous NH4Cl, and extracted with ethyl acetate 
(30 mL×3). The combined organic layer washed with water, brine, and dried over MgSO4. Ethyl 
acetate was evaporated off under vacuum, the crude product was purified by column 
chromatography using a mixture of hexane, DCM and ether (5:3:1) as eluent to give pure product 
as a white solid (0.35 g, 83% yield, two steps). []25= - 32.5
o
, (c = 0.385 in chloroform); 1H 
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NMR δ 6.39 (t, J = 9.6 Hz, 1H), 3.99 – 3.85 (m, 4H), 2.77 (d, J =15.6, 5.6 Hz, 1H), 2.39 (t, J = 
7.6 Hz, 2H), 2.13 (s, 3H), 2.12 – 1.62 (m, 9H), 1.58 – 1.16 (m, 10H), 1.05 (s, 3H), 0.95 (s, 3H), 
0.93 (s, 3H), 0.89 (s, 6H), 0.85 (s, 3H); 13C NMR δ 209.4, 208.0, 137.1, 135.2, 113.2 (2 carbons, 
acetal), 65.12, 65.11, 54.2, 53.1, 47.8, 44.6, 42.4, 41.7, 39.9, 38.0, 36.9, 35.9, 34.4, 30.2, 27.23, 
27.19, 27.0, 26.8, 23.1, 20.1, 19.1, 18.7, 18.3, 16.7. 
 
 (+)-(6a'R,8a'R,12a'S,12b'R,14b'R)-4',4',6a',11',11',14b'-Hexamethyl-4', 4a', 5', 6', 6a', 
8a', 9', 10', 11',12',12a',12b',13',14',14a',14b'-hexadecahydro-1'H-
spiro[[1,3]dioxolane-2,3'-picen]-8'(2'H)-one [(+)-2.45]; (-)-
(6a'R,8a'S,12a'R,12b'R,14b'R)-4',4',6a',11',11',14b'-hexamethyl-
4',4a',5',6',6a',8a',9',10',11',12',12a',12b',13',14',14a',14b'-hexadecahydro-1'H-spiro 
[[1,3]dioxolane-2,3'-picen]-8'(2'H)-one [(-)-2.94]. 
O
O
O
Me
Me
Me O
(-)-2.76
H
O
O
O
EtONa, EtOH, 60 oC
C = 0.005M O
O
O
+
(-)-2.94 (40% yield), less polar (+)-2.45 (30% yield), more polar
13
18
17
H
H
H
H
H
H
H
H
H
H
 
A solution of sodium methoxide was prepared as followed: sodium (11mg, 0.46 mmol) 
was added into 5 mL distilled ethanol at 25 
o
C under argon. The mixture was stirred until all the 
metal dissolved.  
To compound (-)-2.76 (110 mg, 0.23 mmol) in 40 mL distilled ethanol, above sodium 
ethoxide solution was cannulated. This mixture was stirred at 55 
o
C under argon for 14 hours. 1 
Drop of acetic acid was added into the yellow solution to quench the excess amount of base. 
Ethanol was evaporated off under vacuum; the residue was diluted with water, and extracted 
with ethyl acetate (30 mL×3). The combined organic layer washed with water, brine, dried over 
MgSO4, concentrated under vacuum. The crude product was purified by column chromatography 
using a mixture of hexane, DCM and ether (7.5:3:1) as eluent to give pure (-)-2.45 (35 mg, 30 % 
yield) as white solid and (-)-2.94 (45 mg, 40 %) as white solid.  (-)-2.94 (Less polar compound, 
undesired product): []25= -34.0, (c = 0.15 in chloroform); 
1H NMR δ 5.81 (d, J = 2.0 Hz, 1H), 
3.98 – 3.87 (m, 4H), 2.33 – 2.25 (m, 1H), 2.17 – 2.09 (m 1H), 2.02 (ddd, J = 15.6, 8.4, 4.4 Hz, 
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1H), 1.87 – 1.57 (m, 5H), 1.52 – 1.29 (m, 9H), 1.26 – 1.09 (m, 6H),  1.09 (s, 3H), 0.94 (s, 3H), 
0.93 (s, 6H), 0.86 (s, 6H); 13C NMR δ 202.9, 174.7, 119.5, 113.2 (2 carbons, acetal), 65.1, 56.7, 
53.3, 48.5, 44.4, 42.3, 41.2, 41.1, 40.5, 38.8, 38.1, 37.9, 37.0, 33.4, 32.8, 30.6, 27.1, 24.8, 23.1, 
23.0, 21.5, 20.4, 20.1, 18.7, 16.6; (+)-2.45 (More polar compound, desired product): []25= + 
222.5
o
, (c = 0.19 in chloroform); 1H NMR δ 5.75 (s, 1H), 4.02 – 3.84 (m, 4H), 2.37 (ddd, J = 
13.2, 9.2, 4.4 Hz, 1H), 2.09 – 1.61 (m, 6 H), 1.58 – 1.17 (m, 12 H), 1.14 – 0.98 (m, 4H), 1.13 (s, 
3H), 0.94 (s, 9H), 0.87 (s, 3H), 0.84 (s, 3H); 13C NMR δ  202.7, 176.6, 118.1, 113.1 (2 carbons, 
acetal), 65.08, 65.02, 59.7, 53.7, 44.0, 43.2, 42.3, 41.9, 39.3, 38.38, 38.35, 37.9, 37.1, 36.7, 33.5, 
30.6, 28.0, 27.0, 24.2, 23.1, 22.0, 20.7, 20.1, 18.6, 16.2; the single srystal was grown from a 
mixture of diethyl ether and hexane (1:1) for X-ray analysis. 
 
  (+)-(6a'R,8a'S,12a'R,12b'R,14b'R)-Ethyl 4',4',6a',11',11',14b'-hexamethyl-8'-oxo-
2',4',4a',5',6', 6a', 8',8a',9',10',11',12',12a',12b',13',14',14a',14b'-octadecahydro-1'H-
spiro[[1,3]dioxolane-2,3'-picene]-8a'-carboxylate [(+)-2.101]. 
LDA, ethyl cyanoformate, HMPA, THF
45% yieldO
O
O
H
H
H
O
O
O
H
H
OEt
O
(-)-2.94 (+)-2.101  
[LDA was prepared followed the same procedure of (-)-2.81 and titrated before using. 
The procedure for the titration is: to the solution of diphenylacetic acid (9.3 mg, 0.043 mmol) in 
1 mL dry THF [or ether for (-)-2.105]. When a light yellow was shown and last for 10 seconds, 
the titration was stopped, the volume of LDA solution was recorded and used to calculate the 
concentration.] 
To (-)-2.94 (173 mg, 0.38 mmol) in 2 mL THF was added freshly made LDA (0.57mmol) 
in 1 mL THF. The mixture was stirred at -78 
o
C for 1 hour. To it, HMPA (102 mg, 0.57 mmol) 
was injected, and the mixture was stirred at -78 
o
C for 15 minutes, and ethyl cyanoformate (75 
mg, 0.76 mmol) was added. The mixture was stirred at -78 
o
C for 30 minutes, diluted with aq. 
NH4Cl solution, and extracted with ethyl acetate (20 mL×3). The combined organic layer was 
washed with water, brine, dried over MgSO4. Ethyl acetate was evaporated off under vacuum, 
115 
 
and the crude product was purified by column chromatography using a mixture of hexane, DCM 
and ether (7.5:3:1) as eluent to give 90 mg (45 % yield) of pure (+)-2.101 as white solid. []25= + 
91.3
o
, (c = 0.425 in chloroform);  1H NMR δ 5.79 (s, 1H), 4.16 – 4.06 (m, 2H), 3.95 – 3.84 (m, 
4H), 2.54 (dd, J = 12.8, 4.4 Hz, 1H), 2.34 (ddd, J = 13.6, 7.2, 3.2 Hz, 1H), 2.15 (dd, J = 13.6, 3.6 
Hz, 1H), 1.92 (d, J = 12.0 Hz, 1H), 1.80 (td, J = 13.6, 3.2 Hz, 2H), 1.71 – 1.57 (m, 5H), 1.51 – 
1.28 (m, 6H), 1.24 (t, J = 7.6 Hz, 3H), 1.18 – 1.10 (m, 5H), 1.08 (s, 3H), 0.98 (s, 3H). 0.94 (s, 
3H), 0.92 (s, 3H), 0.85 (s, 3H), 0.83 (s, 3H); 13C NMR δ  197.2, 174.6, 172.3, 117.8, 113.2 (2 
carbons, acetal), 65.2, 61.4, 58.6, 55.6, 53.6, 43.6, 42.9, 42.4, 41.4, 39.5, 38.3, 38.1, 37.1, 34.96, 
34.95, 32.9, 30.6, 27.5, 27.1, 24.6, 23.2, 22.0, 21.3, 20.2, 18.7, 16.4, 14.3; the single srystal was 
grown from a mixture of diethyl ether and hexane (1:1) for X-ray analysis. 
 
 (-)-(6a'R,8a'R,12a'S,12b'R,14b'R)-ethyl 4',4',6a',11',11',14b'-hexamethyl-8'-oxo-
2',4',4a',5',6', 6a', 8', 8a', 9',10',11',12',12a',12b',13',14',14a',14b'-octadecahydro-1'H-
spiro[[1,3] dioxolane - 2, 3 '- picene]-8a'-carboxylate [(-)-2.106]. 
LDA, ethyl cyanoformate, HMPA, 
diethyl ehter, -78 oC
O
O
O
H
H
H
(+)-2.45
O
O
O
H
H
O
OEt
(-)-2.106 (assumed structure)
65% yield
 
To (+)-2.45 (40 mg, 0.088 mmol) in 1 mL distilled diethyl ether was added freshly 
prepared LDA (0.12mmol) in 1 mL diethyl ether. The mixture was stirred at -78 
o
C for 1 hour. 
To it, HMPA (24 mg, 0.12 mmol) was added, and the mixture was stirred at -78 
o
C for 15 
minutes. Ethyl cyanoformate (18 mg, 0.17 mmol) was added. The mixture was stirred at -78 
o
C 
for 30 minutes, diluted with aq. NH4Cl solution, and extracted with ethyl acetate (10 mL×3). The 
combined organic layer was washed with water, brine, and dried over MgSO4. Ethyl acetate was 
evaporated off under vacuum, the crude product was purified by column chromatography with 
the mixture of hexane, DCM and ether (6:3:1) to give 30 mg (65 % yield) of pure (-)-2.106 as 
white solid. []25= -62.8
o
, (c = 0.20 in chloroform);  1H NMR δ 5.88 (d, J = 2.4 Hz, 1H), 4.16 – 
4.05 (m, 2H), 3.96 – 3.86 (m, 4H), 2.89 – 2.82 (m, 1H), 2.59 (dt, J = 14.0, 4.4 Hz, 1H), 2.35 (dt, 
J = 13.2, 2.8 Hz, 1H), 1.90 – 1.78 (m, 2H), 1.74 – 1.60 (m, 4H), 1.50 – 1.40 (m, 5H), 1.33 – 1.23 
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(m, 8H), 1.19 (t, J = 7.6 Hz, 3H), 1.05 (s, 3H), 0.93 (s, 6H), 0.91 (s, 3H), 0.85 (s, 6H); 13C NMR 
δ  197.1, 173.3, 172.4, 120.4, 113.4 (2 carbons, acetal), 65.2, 61.4, 58.3, 57.0, 53.2, 42.4, 42.3, 
38.7, 38.2, 37.9, 37.1, 36.1, 35.6, 34.7, 33.4, 31.0, 30.4, 27.13, 27.05, 24.8, 23.8, 23.0, 20.5, 20.0, 
18.6, 16.8, 14.4. 
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C:\NMR_nuts_2008\DATA\$PQ-12.fid
Std Proton parameters
May 28 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2398.5654 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  87.70
      B =  112.78 
      C =   0.00 
Appendix A - Chaper 1 
1
H NMR and 
13
C NMR 
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Std Proton parameters
Apr 22 2014
USER: 
SOLVENT: CDCl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     36
Solvent  = CDCl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2399.9854 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -190.70
      B =  71.55 
      C =   0.00 
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Std Carbon experiment
Apr 22 2014
USER: 
SOLVENT: CDCl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  16808
Solvent  = CDCl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10556.6953 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -30.16
      B =  263.34 
      C =   0.00 
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Std Proton parameters
Apr  5 2014
USER: 
SOLVENT: CDCl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     64
Solvent  = CDCl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2399.9854 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -201.01
      B =  73.69 
      C =   0.00 
N
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Std Carbon experiment
Apr 14 2014
USER: 
SOLVENT: CDCl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  21016
Solvent  = CDCl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10557.4316 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -35.16
      B =  258.75 
      C =   0.00 
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Std proton;blank line
Mar 29 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.400 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 13102 
PTS1d = 16384 
F1  =  399.723083 MHz
F2  =  100.519333 MHz
SW1 =    6395.40 Hz 
AT1 =   2.05 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2404.0581 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -79.22
      B =  40.78 
      C =   0.00 N
HN
O
Me
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Std Carbon experiment
May  2 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    2.000 sec
NA  =  16520
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.6436 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -36.09
      B =  271.41 
      C =   0.00 
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Std Proton parameters
Jun  8 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    2.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5210 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -265.57
      B =  100.41 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$LJY-2-015-Carbon.fid
Std proton;blank line
Aug 22 2010
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    9.000 usec
Recycle delay =    1.000 sec
NA  =  14576
Solvent  = cdcl3
FID PTS1d = 31375 
PTS1d = 32768 
F1  =  100.524467 MHz
F2  =  399.738953 MHz
SW1 =   24125.45 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10557.4961 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -84.27
      B =  168.66 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$PQ-23.fid
Std Proton parameters
Jul  2 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.9084 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  117.58
      B =  73.56 
      C =   0.00 
N
HN
O
Me
MeOF3C
OO
OH
1.6
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C:\NMR_nuts_2008\DATA\$PQ-23-13-C-2.fid
Std Carbon experiment
Apr 15 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    3.000 sec
NA  =  12132
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.6436 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -13.32
      B =  256.59 
      C =   0.00 
N
HN
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MeOF3C
OO
OH
1.6
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C:\NMR_nuts_2008\DATA\$PQ-25.fid
Std Proton parameters
Jun 27 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  106.88
      B =  86.86 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$PQ-25-13C-2.fid
Std Carbon experiment
Apr 18 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    2.000 sec
NA  =  17148
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10561.1172 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  -9.84
      B =  229.22 
      C =   0.00 
N
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Me
MeOF3C
N
1.7
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C:\NMR_nuts_2008\DATA\$r-18.fid
Std Proton parameters
Apr 28 2014
USER: 
SOLVENT: CDCl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = CDCl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.2253 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -215.60
      B =  97.35 
      C =   0.00 
N
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C:\NMR_nuts_2008\DATA\$r-18-13c.fid
Std Carbon experiment
Apr 17 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    2.000 sec
NA  =  14956
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.6436 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -30.47
      B =  255.94 
      C =   0.00 
N
HN
O
Me
MeOF3C
NH2
O
1.8
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C:\NMR_nuts_2008\DATA\$jyl-3-048.fid
Std proton;blank line
Jan 21 2011
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    4.900 usec
Recycle delay =    1.000 sec
NA  =      4
Solvent  = cdcl3
FID PTS1d = 13102 
PTS1d = 16384 
F1  =  399.729584 MHz
F2  =  100.520966 MHz
SW1 =    6395.40 Hz 
AT1 =   2.05 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2398.4280 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -159.99
      B =   1.89 
      C =   0.00 
N
HN
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136 
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C:\NMR_nuts_2008\DATA\$jyl-3-048-13C.fid
Std proton;blank line
Jan 21 2011
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.650 usec
Recycle delay =    1.000 sec
NA  =   6900
Solvent  = cdcl3
FID PTS1d = 31375 
PTS1d = 32768 
F1  =  100.522011 MHz
F2  =  399.729187 MHz
SW1 =   24125.45 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10553.6523 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  177.18
      B =  13.69 
      C =   0.00 N
HN
O
Me
MeOF3C
O
O
1.9
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C:\NMR_nuts_2008\DATA\$JN_I_59.fid
Std Proton parameters
Jul 10 2013
USER: 
SOLVENT: CDCl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = CDCl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5188 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  106.68
      B =  93.67 
      C =   0.00 
N
NH2
HO
O MeF3C
1.19
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C:\NMR_nuts_2008\DATA\$jyl-13-PQ3713C-2.fid
Std Carbon experiment
Oct 19 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  21936
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10560.7607 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -31.64
      B =  123.75 
      C =   0.00 
N
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139 
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C:\NMR_nuts_2008\DATA\$PQ38.fid
Std Proton parameters
Oct 21 2013
USER: 
SOLVENT: dmso
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     64
Solvent  = dmso
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.964050 MHz
F2  =  100.579926 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2406.7664 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -200.94
      B =  76.98 
      C =   0.00 
1.10
N
HN
HO
MeOF3C
OH
140 
 
 
 1
6
0
.1
0
9
 1
5
7
.1
1
8
 1
4
9
.4
5
1
 1
4
4
.4
3
0
 1
4
4
.3
7
2
 1
4
1
.2
9
3
 1
3
3
.6
4
1
 1
3
1
.6
5
4
 1
3
1
.3
7
6
 1
3
1
.0
8
3
 1
3
0
.8
7
0
 1
3
0
.4
7
4
 1
3
0
.0
9
3
 1
2
9
.1
4
0
 1
2
5
.9
8
1
 1
2
5
.4
8
3
 1
2
4
.5
9
6
 1
2
3
.2
7
6
 1
1
9
.4
9
4
 1
1
8
.0
9
4
 1
1
5
.9
0
3
 1
1
2
.0
0
3
 9
7
.1
6
8
 6
7
.6
9
4
 4
6
.7
1
6
 4
0
.8
3
1
 4
0
.6
2
5
 4
0
.4
1
3
 4
0
.2
0
8
 3
9
.9
9
5
 3
9
.7
9
0
 3
9
.5
7
7
 2
5
.8
7
8
 2
3
.0
7
8
150 100 50 PPM
C:\NMR_nuts_2008\DATA\$PQ-38-13C.fid
Std Carbon experiment
Oct 21 2013
USER: 
SOLVENT: dmso
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  21616
Solvent  = dmso
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580971 MHz
F2  =  399.963623 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.8418 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -57.19
      B =  244.69 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$jyl-7-045.fid
Std Proton parameters
Mar 12 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =      4
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.9084 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  101.25
      B =  94.59 
      C =   0.00 NO2
NHAc
O
O
Me
F
1.21
142 
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C:\NMR_nuts_2008\DATA\$JYL-7-045-13C.fid
Std Carbon experiment
Mar 12 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =   3032
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10558.5488 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  17.47
      B =  299.94 
      C =   0.00 
NO2
NHAc
O
O
Me
F
1.21
143 
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C:\NMR_nuts_2008\DATA\$an.fid
Std Proton parameters
Mar 20 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -249.25
      B =  88.91 
      C =   0.00 
NO2
NHAc
O
O
Me
1.22
144 
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C:\NMR_nuts_2008\DATA\$an-13.fid
Std Carbon experiment
Mar 20 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  23428
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.8691 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  66.56
      B =  216.56 
      C =   0.00 
NO2
NHAc
O
O
Me
1.22
145 
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C:\NMR_nuts_2008\DATA\$jyl-7-051.fid
Std Proton parameters
Mar 13 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.1274 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  115.78
      B =  82.97 
      C =   0.00 
NO2
NH2
O
O
Me
F
1.23
146 
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C:\NMR_nuts_2008\DATA\$JYL-7-051-13C.fid
Std proton;blank line
Mar 14 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    7.800 usec
Recycle delay =    1.000 sec
NA  =    556
Solvent  = cdcl3
FID PTS1d = 31375 
PTS1d = 32768 
F1  =  100.520370 MHz
F2  =  399.722687 MHz
SW1 =   24125.45 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10546.8574 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =   1.41
      B =  158.91 
      C =   0.00 
NO2
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O
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C:\NMR_nuts_2008\DATA\$jyl-7-064.fid
Std Proton parameters
Mar 21 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2401.2991 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  114.48
      B =  68.47 
      C =   0.00 
NO2
NH2
O
O
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1.24
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C:\NMR_nuts_2008\DATA\$jyl-7-064-13C.fid
Std Carbon experiment
Mar 21 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    824
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10556.3379 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  26.72
      B =  258.75 
      C =   0.00 
NO2
NH2
O
O
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1.24
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C:\NMR_nuts_2008\DATA\$jyl-7-055.fid
Std proton;blank line
Mar 15 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.400 usec
Recycle delay =    1.000 sec
NA  =      4
Solvent  = cdcl3
FID PTS1d = 13102 
PTS1d = 16384 
F1  =  399.723083 MHz
F2  =  100.519333 MHz
SW1 =    6395.40 Hz 
AT1 =   2.05 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2410.3040 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -62.64
      B =  16.34 
      C =   0.00 
NO2
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C:\NMR_nuts_2008\DATA\$jyl-7-055-C13.fid
Std proton;blank line
Mar 15 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    7.800 usec
Recycle delay =    1.000 sec
NA  =   1064
Solvent  = cdcl3
FID PTS1d = 31375 
PTS1d = 32768 
F1  =  100.520370 MHz
F2  =  399.722687 MHz
SW1 =   24125.45 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10550.5391 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -11.72
      B =  165.94 
      C =   0.00 NO2
O
O
Me
F
N
Me
1.25
151 
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C:\NMR_nuts_2008\DATA\$jyl-7-065.fid
Std Proton parameters
Apr 29 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    2.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942657 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2435.5234 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -225.82
      B =  115.56 
      C =   0.00 
NO2
O
O
Me
N
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1.26
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C:\NMR_nuts_2008\DATA\$jyl-7-065-13C.fid
Std Carbon experiment
Mar 22 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    844
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10554.8633 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  52.50
      B =  236.25 
      C =   0.00 
NO2
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C:\NMR_nuts_2008\DATA\$jyl-7-056.fid
Std Proton parameters
Mar 17 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2401.2991 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  96.08
      B =  111.06 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$jyl-7-056-13C.fid
Std Carbon experiment
Mar 17 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  34896
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10557.0742 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  63.75
      B =  213.75 
      C =   0.00 NH2
O
O
Me
F
N
Me
1.27
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C:\NMR_nuts_2008\DATA\$jyl-7-066.fid
Std proton;blank line
Mar 23 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.400 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 13102 
PTS1d = 16384 
F1  =  399.723083 MHz
F2  =  100.519333 MHz
SW1 =    6395.40 Hz 
AT1 =   2.05 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2402.3093 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -42.31
      B = -26.17 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$jyl-7-066-13C.fid
Std proton;blank line
Mar 23 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    7.800 usec
Recycle delay =    1.000 sec
NA  =    424
Solvent  = cdcl3
FID PTS1d = 31375 
PTS1d = 32768 
F1  =  100.520370 MHz
F2  =  399.722687 MHz
SW1 =   24125.45 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10549.0664 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  -7.02
      B =  160.34 
      C =   0.00 
NH2
O
O
Me
N
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1.28
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C:\NMR_nuts_2008\DATA\$jyl-7-095.fid
Std Proton parameters
Apr 25 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.1274 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  105.42
      B =  90.94 
      C =   0.00 
NO2
NH2
O
Me
1.29
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C:\NMR_nuts_2008\DATA\$jyl-7-096-crude.fid
Std Proton parameters
Apr 26 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.1274 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -264.95
      B =  104.92 
      C =   0.00 
NO2
O
Me
N
Me
1.30
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C:\NMR_nuts_2008\DATA\$jyl-7-096-13C.fid
Std Carbon experiment
Apr 25 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    2.000 sec
NA  =  16752
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.3271 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -46.41
      B =  289.69 
      C =   0.00 
NO2
O
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Me
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C:\NMR_nuts_2008\DATA\$jyl-7-097.fid
Std Proton parameters
Apr 26 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -269.88
      B =  116.28 
      C =   0.00 
NH2
O
Me
N
Me
1.31
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C:\NMR_nuts_2008\DATA\$jyl-7-097-13C.fid
Std Carbon experiment
Apr 26 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    512
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10556.3379 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -299.53
      B =  210.94 
      C =   0.00 
NH2
O
Me
N
Me
1.31
162 
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C:\NMR_nuts_2008\DATA\$jyl-7-062.fid
Std proton;blank line
Mar 23 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.400 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 13102 
PTS1d = 16384 
F1  =  399.723083 MHz
F2  =  100.519333 MHz
SW1 =    6395.40 Hz 
AT1 =   2.05 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2404.8389 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -82.50
      B =  22.30 
      C =   0.00 
N
HN
O
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O Me
N
O
O
F
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163 
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C:\NMR_nuts_2008\DATA\$jyl-7-062-13C.fid
Std proton;blank line
Mar 23 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    7.800 usec
Recycle delay =    1.000 sec
NA  =  25996
Solvent  = cdcl3
FID PTS1d = 31375 
PTS1d = 32768 
F1  =  100.520370 MHz
F2  =  399.722687 MHz
SW1 =   24125.45 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10553.4844 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -36.36
      B =  206.13 
      C =   0.00 
N
HN
O
Me
O Me
N
O
O
F
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164 
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C:\NMR_nuts_2008\DATA\$jyl-7-067.fid
Std Proton parameters
Apr 13 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     20
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  106.45
      B =  92.42 
      C =   0.00 
N
HN
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N
O
O
1.34
165 
 
 
 1
6
8
.7
0
9
 1
5
9
.7
8
9
 1
5
1
.1
9
8
 1
4
4
.9
0
2
 1
4
3
.9
9
3
 1
4
3
.0
6
9
 1
3
4
.1
7
8
 1
3
3
.9
5
8
 1
3
2
.2
5
8
 1
2
9
.6
3
4
 1
2
6
.4
6
0
 1
2
4
.9
7
2
 1
2
4
.7
8
9
 1
2
3
.4
5
5
 1
2
1
.3
2
2
 1
1
5
.0
2
5
 9
3
.3
7
3
 7
7
.5
5
5
 7
7
.2
4
0
 7
6
.9
1
7
 5
6
.9
6
6
 5
6
.9
5
1
 4
1
.2
4
3
 3
6
.2
4
4
 2
8
.2
1
8
 2
3
.3
5
1
150 100 50 0PPM
C:\NMR_nuts_2008\DATA\$jyl-7-067-13C.fid
Std Carbon experiment
Apr 13 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  25128
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10557.0742 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  58.13
      B =  213.75 
      C =   0.00 
N
HN
O
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O Me
N
O
O
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C:\NMR_nuts_2008\DATA\$jyl-7-098.fid
Std Proton parameters
Apr 30 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.9084 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  99.83
      B =  99.38 
      C =   0.00 
N
HN
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N
O
O
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C:\NMR_nuts_2008\DATA\$JYL-7-098-13C.fid
Std Carbon experiment
Apr 30 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  15744
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10558.5488 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  83.91
      B =  165.94 
      C =   0.00 
N
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C:\NMR_nuts_2008\DATA\$jyl-7-075.fid
Std Proton parameters
Apr 11 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  89.91
      B =  120.38 
      C =   0.00 
N
HN
O
Me
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NH2
1.11
169 
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C:\NMR_nuts_2008\DATA\$jyl-7-075-13C.fid
Std Carbon experiment
Apr 11 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  20416
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10557.8125 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  29.16
      B =  258.66 
      C =   0.00 
N
HN
O
Me
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NH2
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170 
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C:\NMR_nuts_2008\DATA\$jyl-7-084.fid
Std Proton parameters
Apr 17 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.1274 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  112.53
      B =  85.47 
      C =   0.00 
N
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O
Me
MeO
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C:\NMR_nuts_2008\DATA\$jyl-7-084-13C.fid
Std Carbon experiment
Apr 17 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  16976
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10557.8125 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  35.16
      B =  266.48 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$jyl-7-103.fid
Std Proton parameters
May  1 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  118.06
      B =  71.47 
      C =   0.00 
N
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C:\NMR_nuts_2008\DATA\$sw-3-63dp.fid
Std Proton parameters
Jun 24 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     56
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.9084 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  97.62
      B =  86.00 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$sw-3-63dpcarbon.fid
Std Proton parameters
Jun 24 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =   5000
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.2305 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  58.59
      B =  187.03 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$sw-3-73DPcorrect.fid
Std Proton parameters
Jun 26 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     64
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  96.78
      B =  109.06 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$sw-3-73-dpcarbon-13.fid
Std Carbon experiment
Jun 26 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  20768
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.2861 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  15.47
      B =  265.78 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$PQ-36.fid
Std Proton parameters
Nov 11 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =      3
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.1274 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -227.86
      B =  115.03 
      C =   0.00 
N
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C:\NMR_nuts_2008\DATA\$JYL-14-096-13C-2.fid
Std Carbon experiment
Apr 26 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    2.000 sec
NA  =   7560
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.6436 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -57.19
      B =  299.53 
      C =   0.00 
N
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Me
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E:\Thesis\NMR\NMR_nuts_2008\DATA\$jyl-13-094-SM.fid
Std Proton parameters
Jan 22 2014
USER: 
SOLVENT: dmso
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = dmso
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.944519 MHz
F2  =  100.575020 MHz
SW1 =    6398.00 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2405.5459 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -191.94
      B =  91.66 
      C =   0.00 O OH
Me
2-Methyl-1,3-cyclohexandione
Appendix B - Chaper 2 
1
H NMR and 
13
C NMR 
O
Me
2-Methyl-1 yclohexandione
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Ethyl vinyl ketone
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C:\NMR_nuts_2008\DATA\$JYL-13-tworingTBS-13C.fid
Std Proton parameters
Nov 13 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     24
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -192.24
      B =  45.11 
      C =   0.00 
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C:\NMR_nuts_2008\data\$JYL-13-tworingtbs-13C-new.fid
Std Carbon experiment
Nov 13 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  14536
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10560.0234 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -129.94
      B =  234.16 
      C =   0.00 
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E:\Thesis\NMR-whole data\NMR_nuts_2008\DATA\$SK-1-026.fid
Std Proton parameters
Mar  5 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2403.5942 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -167.22
      B =  59.03 
      C =   0.00 
 T M S
TMS
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E:\Thesis\NMR-whole data\NMR_nuts_2008\DATA\$jyl-14-022-secdis.fid
Std Proton parameters
Mar 17 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2403.9846 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -175.36
      B =  63.98 
      C =   0.00 
T M S
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C:\NMR_nuts_2008\DATA\$jyl-allylTMSalcohol.fid
Std Proton parameters
Mar 20 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    4.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2403.9846 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -196.03
      B =  57.42 
      C =   0.00 
 
Me
OH
TMS
2 .7 1
Me
OH
TMS
2.71
189 
 
 
 1
5
5
.3
3
3
 1
2
4
.1
8
7
 7
7
.8
9
7
 7
7
.2
3
7
 7
6
.9
2
2
 3
0
.2
2
8
 1
0
.2
5
3
 -
0
.3
6
1
150 100 50 0 PPM
C:\NMR_nuts_2008\DATA\$jyl-14-allylTMSalcool-13C.fid
Std Carbon experiment
Mar 20 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    980
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.3271 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -13.59
      B =  209.53 
      C =   0.00 
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C:\NMR_nuts_2008\DATA\$jyl-12-056.fid
Std Proton parameters
Aug  7 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2405.2988 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -225.52
      B =  83.83 
      C =   0.00 
DCM
-Trimethylsilyl vinyl ethyl ketone
Me
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C:\NMR_nuts_2008\data\$sk-1-37-2cc-13c.fid
Std Carbon experiment
Mar 14 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    372
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.6436 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  -3.65
      B =  223.25 
      C =   0.00 
Me
TMS
-Trimethylsilyl vinyl ethyl ketone
O
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E:\Thesis\NMR-whole data\NMR_nuts_2008\DATA\$jyl-12-028-fr1.fid
Std Proton parameters
Jul 12 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    2.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6398.00 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2404.5137 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  102.25
      B =  90.09 
      C =   0.00 
O T B S
O
(+ ) -2 .7 2
OTBS
Me
O
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C:\NMR_nuts_2008\data\$JYL-12-062-13C.fid
Std Carbon experiment
Aug 14 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    972
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.2861 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -124.78
      B =  253.00 
      C =   0.00 
OTBS
Me
O
(+)-2.72
194 
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C:\NMR_nuts_2008\data\$jyl-12-087.fid
Std Proton parameters
Sep  5 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -195.91
      B =  79.27 
      C =   0.00 
OTBS
O
(+)-2.73
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C:\NMR_nuts_2008\data\$MA-3-13C.fid
Std Carbon experiment
Nov 14 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  17164
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10560.7607 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -83.91
      B =  201.09 
      C =   0.00 
OTBS
O
(+)-2.73
196 
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C:\NMR_nuts_2008\data\$jyl-13-023.fid
Std Proton parameters
Nov 13 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -208.31
      B =  67.63 
      C =   0.00 
OTBS
(-)-2.74
O
O
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C:\NMR_nuts_2008\data\$JYL-13-023-13C.fid
Std Carbon experiment
Nov 13 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =   5748
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10560.7607 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -84.84
      B =  194.06 
      C =   0.00 
OTBS
(-)-2.74
O
O
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C:\NMR_nuts_2008\DATA\$jyl-12-096.fid
Std Proton parameters
Sep 18 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2404.1270 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -186.36
      B =  66.19 
      C =   0.00 
(-)-2.32
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O
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C:\NMR_nuts_2008\DATA\$jyl-13-030-13c.fid
Std Carbon experiment
Nov 17 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  15888
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.8418 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -89.53
      B =  202.50 
      C =   0.00 
(-)-2.32
O
O
OH
200 
 
 
  
3
.9
6
9
  
3
.9
5
7
  
3
.9
5
2
  
3
.9
4
0
  
3
.9
2
5
  
3
.9
0
1
  
2
.5
8
5
  
2
.5
6
8
  
2
.5
5
0
  
2
.5
3
2
  
2
.5
1
5
  
2
.4
9
8
  
2
.2
0
9
  
2
.1
6
8
  
2
.1
0
3
  
2
.0
0
8
  
1
.8
2
2
  
1
.7
0
5
  
1
.6
9
6
  
1
.6
8
7
  
1
.6
7
9
  
1
.6
7
1
  
1
.6
6
2
  
1
.6
3
3
  
1
.6
2
5
  
1
.6
1
7
  
1
.5
9
9
  
1
.5
9
1
  
1
.5
8
3
  
1
.5
7
4
  
1
.5
6
5
  
1
.5
6
3
  
1
.5
5
1
  
1
.5
2
6
  
1
.5
1
7
  
1
.5
0
7
  
1
.4
9
0
  
1
.4
8
3
  
1
.4
7
3
  
1
.3
4
7
  
1
.2
8
5
  
1
.2
8
0
  
1
.2
5
3
  
1
.2
4
9
  
1
.2
0
5
  
1
.1
9
7
  
1
.1
7
5
  
1
.1
6
7
  
1
.1
4
5
  
0
.9
8
9
  
0
.9
4
2
  
0
.8
5
0
 4.00
 1.09  1.12  1.23  1.26
 6.11
 4.22
 1.84
 1.38
 2.59  2.70
 2.94  3.02
7 6 5 4 3 2 1 0 PPM
C:\NMR_nuts_2008\DATA\$jyl-13-037.fid
Std Proton parameters
Nov 19 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2403.7366 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -202.08
      B =  59.14 
      C =   0.00 
(-)-2.33
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O
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C:\NMR_nuts_2008\DATA\$jyl-13-037-13c.fid
Std Carbon experiment
Nov 18 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  13596
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.8418 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -85.28
      B =  206.81 
      C =   0.00 
(-)-2.33
O
O
O
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C:\NMR_nuts_2008\data\$jyl-distall ization-residue.fid
Std proton;blank line
Mar 13 2011
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    4.900 usec
Recycle delay =    2.000 sec
NA  =     20
Solvent  = cdcl3
FID PTS1d = 13102 
PTS1d = 16384 
F1  =  399.729584 MHz
F2  =  100.520966 MHz
SW1 =    6395.40 Hz 
AT1 =   2.05 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2410.7415 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -91.09
      B =  10.75 
      C =   0.00 
(-)-2.78
N
Me
Me
203 
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C:\NMR_nuts_2008\DATA\$jyl-13-116.fid
Std Proton parameters
Feb 18 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2403.9846 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -180.53
      B =  55.99 
      C =   0.00 
O
O
OTMS
(-)-2.81
204 
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C:\NMR_nuts_2008\DATA\$JYL-13-116-13C.fid
Std Carbon experiment
Feb 18 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =   1804
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.3271 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =   3.28
      B =  203.91 
      C =   0.00 
O
O
OTMS
(-)-2.81
205 
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C:\NMR_nuts_2008\DATA\$ALdehyde.fid
Std Proton parameters
Nov 30 2013
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2399.7554 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  125.97
      B =  89.23 
      C =   0.00 
Mesitylene
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Me Me
H
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C:\NMR_nuts_2008\DATA\$jyl-6-071.fid
Std Proton parameters
Dec 13 2011
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2404.9080 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  137.93
      B =  53.19 
      C =   0.00 
Mesitylene
Mesitylene
Me Me
OH
2.88
207 
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C:\NMR_nuts_2008\DATA\$jyl-7-033.fid
Std Proton parameters
Feb 28 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2404.5176 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -226.09
      B =  57.59 
      C =   0.00 
Me Me
Br
2.87
208 
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C:\NMR_nuts_2008\data\$jyl-7-035.fid
Std Proton parameters
Mar  1 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =      4
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  130.30
      B =  65.92 
      C =   0.00 
Me Me
Me
O
2.86
209 
 
 
 2
0
9
.4
2
5
 1
3
5
.8
1
8
 1
1
6
.9
2
2
 7
7
.5
6
1
 7
7
.2
3
8
 7
6
.9
2
3
 4
6
.5
3
3
 4
4
.7
3
0
 4
1
.5
0
5
 3
3
.2
9
6
 3
0
.0
7
8
 2
7
.0
6
5
 1
8
.6
8
0
200 150 100 50 0 PPM
C:\NMR_nuts_2008\DATA\$jyl-7-035-13C.fid
Std Carbon experiment
Mar  1 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    216
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.8418 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -284.66
      B =  195.66 
      C =   0.00 Me Me
Me
O
2.86
210 
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dioxane
C:\NMR_nuts_2008\data\$jyl-13-115.fid
Std Proton parameters
Feb 17 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     20
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2399.9854 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -213.61
      B =  123.11 
      C =   0.00 
Me Me
Me
O
2.86
H
O
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C:\NMR_nuts_2008\data\$jyl-13-115- 3C.fid
Std Carbon experiment
Feb 17 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  17268
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10560.3809 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -31.88
      B =  258.75 
      C =   0.00 
Me Me
Me
O
2.86
H
O
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C:\NMR_nuts_2008\data\$jyl-8-027-A.fid
Std Proton parameters
May 22 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     16
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2399.7371 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -247.71
      B =  90.97 
      C =   0.00 
O
Me O
(-)-2.76
O
O
213 
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C:\NMR_nuts_2008\data\$JYL-8-027-13C.fid
Std Carbon experiment
May 22 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =   5760
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.0859 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -290.97
      B =  204.84 
      C =   0.00 
O
Me O
(-)-2.76
O
O
214 
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C:\NMR_nuts_2008\data\$jyl-7-031-fr1.fid
Std Proton parameters
Feb 21 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    5.000 sec
NA  =    108
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.5181 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  114.19
      B =  74.34 
      C =   0.00 
O
O
O
(-)-2.94
H
H
H
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C:\NMR_nuts_2008\data\$jyl-8-060-isomer1-13C.fid
Std Carbon experiment
Jul  2 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  16332
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10557.8125 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -293.71
      B =  202.28 
      C =   0.00 
O
O
O
(-)-2.94
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H
H
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C:\NMR_nuts_2008\data\$jyl-8-060-isomer2.fid
Std Proton parameters
Jul  2 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.962158 MHz
F2  =  100.579445 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2399.7371 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  107.93
      B =  90.53 
      C =   0.00 
O
O
O
(+)-2.45
H
H
H
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C:\NMR_nuts_2008\data\$jyl-8-060-isomer2-C13.fid
Std Carbon experiment
Jul  2 2012
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =    488
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.580498 MHz
F2  =  399.961731 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10554.1260 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -280.78
      B =  198.28 
      C =   0.00 
O
O
O
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Std Proton parameters
May  3 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    1.000 sec
NA  =     64
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2399.9854 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -195.47
      B =  70.31 
      C =   0.00 
O
O
O
H
H
OEt
O
(+)-2.101
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Std Carbon experiment
May  6 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  23140
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10559.6436 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -56.48
      B =  282.09 
      C =   0.00 
O
O
O
H
H
OEt
O
(+)-2.101
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Std Proton parameters
Mar  7 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    6.650 usec
Recycle delay =    3.000 sec
NA  =     32
Solvent  = cdcl3
FID PTS1d = 12783 
PTS1d = 16384 
F1  =  399.942596 MHz
F2  =  100.574539 MHz
SW1 =    6397.95 Hz 
AT1 =   2.00 sec
Hz per Pt 1stD =   0.39 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =    2400.3760 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A = -168.54
      B =  37.74 
      C =   0.00 
O
O
O
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H
OEt
O
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C:\NMR_nuts_2008\data\$jyl-14-023-13C.fid
Std Carbon experiment
Mar  7 2014
USER: 
SOLVENT: cdcl3
Experiment = s2pul
Pulse length =    8.050 usec
Recycle delay =    1.000 sec
NA  =  24876
Solvent  = cdcl3
FID PTS1d = 31413 
PTS1d = 32768 
F1  =  100.575584 MHz
F2  =  399.942200 MHz
SW1 =   24154.59 Hz 
AT1 =   1.30 sec
Hz per Pt 1stD =   0.74 Hz 
SW2 =       1.00 Hz 
Hz per Pt 2ndD =   1.00 Hz 
O1  =   10560.3809 Hz 
O2  =      -0.5000 Hz 
LB1 =  0.00      Hz 
TP    A =  21.98
      B =  179.28 
      C =   0.00 O
O
O
H
H
OEt
O
(-)-2.106
